Apparatus and method for securing a portion of a body

Information

  • Patent Grant
  • 8808329
  • Patent Number
    8,808,329
  • Date Filed
    Tuesday, April 3, 2012
    13 years ago
  • Date Issued
    Tuesday, August 19, 2014
    10 years ago
Abstract
An anchor connected with a suture is moved through a passage between opposite sides of a bone. The anchor is then pivoted to change its orientation. A second anchor is connected with the suture. While tension is maintained in the suture, the suture is secured against movement relative to the anchors. This may be done by tying the suture or by using a suture retainer to hold the suture. A suture retainer may be used in place of the second anchor. The passage may extend across a fracture in the bone. The passage may have either a nonlinear or linear configuration. The passage may be formed by first moving a thin elongated member through the bone. The thin elongated member is then used as a guide for a drill. The thin elongated member is withdrawn from the drill and the suture anchor is moved through a passage in the drill.
Description
BACKGROUND OF THE INVENTION

The present invention relates to a new and improved method and apparatus for securing sections of a fractured bone and/or securing body tissue to bone.


When a bone is broken or fractured, it is necessary to press sections of the bone on opposite sides of the fracture together in order to promote healing of the bone. Bone screws have been used with or without metal plates to hold the sections of the fractured bone against movement relative to each other. In addition, it has been suggested that avulsion fractures could be treated by using wire sutures between sections of bone in a matter similar to that disclosed in U.S. Pat. No. 5,474,554. It has also been suggested that an anchor could be retained in a bone is a manner disclosed in U.S. Pat. Nos. 5,527,343 and 5,534,012.


SUMMARY OF THE INVENTION

The present invention relates to a method of securing sections of a fractured bone. Sections of a fractured bone are held against movement relative to each other.


In accordance with one aspect of the present invention, there is provided a bone suture assembly for treating a fracture of a bone. The bone suture assembly includes a first bone plate positioned proximate to the bone and a suture positioned through the first bone plate and across the fracture of the bone to thereby stabilize the fracture. The suture assembly may include a second bone plate positioned proximate to the bone generally opposite the first bone plate. The suture may be positioned through the second bone plate to stabilize the fracture. The suture assembly may also include a passage through the bone and across the fracture, wherein the suture is disposed within the passage. The passage may be nonlinear and may include a tubular member. The suture may be disposed within the tubular member.


Furthermore, the bone suture assembly may include at least one fastener to hold the first bone plate to the bone. At least one fastener may extend across the fracture of the bone and may extend through the bone and through the second bone plate. At least one fastener may also include a screw and nut. Additionally, the suture assembly may include a tubular member in the bone positioned across the fracture, and the suture may be disposed within the tubular member. The tubular member may be packed with bone particles or bone osteoinductive protein.


In accordance with another aspect of the present invention, the bone suture assembly includes a first suture anchor positioned proximate to the bone, a first bone plate positioned between the first suture anchor and the bone, and a suture positioned across the fracture of the bone to stabilize the fracture. The suture has a first end portion disposed through the bone plate and attached to the first suture anchor. The suture assembly may also include a second suture anchor positioned proximate to the bone generally opposite the first suture anchor. The second suture anchor may be attached to a second end portion of the suture.


Moreover, the bone suture assembly may include a second bone plate positioned between the second suture anchor and the bone. The suture assembly may also include a passage through the bone and across the fracture, wherein the suture is disposed within the passage. In the present invention, the first and second suture anchors may be suture retainers which may have deformable material to hold the suture retainers to the suture.


In accordance with still another aspect of the present invention, a method for treating a fracture of a bone is provided. The method includes positioning at least one suture anchor proximate to the bone, positioning at least one bone plate between at least one suture anchor and the bone, and moving at least one suture across the fracture of the bone and through at least one bone plate. The method also includes attaching at least one suture to at least one suture anchor and tensioning at least one suture to stabilize the fracture of the bone. At least one suture anchor may be a suture retainer.


In addition, the method may include fastening at least one bone plate to the bone with at least one screw. At least one screw may have a length less than the diameter of the bone, and at least one screw may have a length greater than the diameter of the bone. At least one screw may include at least one nut, and at least one screw may extend across the fracture of the bone.


Furthermore, the method may include forming at least one passage through the bone and moving at least one suture through at least one passage. Also, at least one suture attached to at least one suture anchor may be moved through at least one passage. The method may also include changing the orientation of at least one suture anchor from a first to a second configuration thereby causing at least one suture anchor to become proximate to the bone and impassable through at least one passage. Finally, the method may include tensioning at least one suture between at least two suture anchors to stabilize the fracture of the bone.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other features of the invention will become more apparent upon a consideration of the following description taken in connection with the accompanying drawings wherein:



FIG. 1 is a schematic illustration of a bone having a fracture which has been treated with sutures and suture anchors;



FIG. 2 is an enlarged fragmentary schematic sectional view of a portion of the bone of FIG. 1 and illustrating the manner in which a suture extends across the fracture and interconnects suture anchors on opposite sides of the fracture;



FIG. 3 is a schematic illustration, generally similar to FIG. 2, illustrating the manner in which a suture retainer is used to maintain tension in a suture which extends across a fracture to a suture anchor;



FIG. 4 is a schematic illustration, generally similar to FIGS. 2 and 3, illustrating the manner in which body tissue is connected with a bone using a suture and suture anchors;



FIG. 5 is a schematic illustration, generally similar to FIGS. 2-4, illustrating the manner in which a suture extends between suture anchors through a nonlinear passage;



FIG. 6 is a schematic illustration, generally similar to FIG. 5, illustrating the manner in which a suture extends between a suture anchor and a suture retainer through a nonlinear passage;



FIG. 7 is a schematic illustration depicting a bone which has been fractured in such a manner as to have a bone fragment connected with the bone by muscle or other fibrous tissue;



FIG. 8 is a schematic illustration depicting the manner in which the bone fragment of FIG. 7 is connected to the bone by a suture and a pair of suture anchors;



FIG. 9 is a schematic illustration depicting the manner in which a bone fragment is connected with a bone by a suture which extends between an anchor within the bone and an anchor which engages the bone fragment;



FIG. 10 is a schematic illustration, generally similar to FIGS. 2-4, illustrating in the manner in which plates and rigid fasteners are used in association with a suture and anchors to treat a bone fracture;



FIG. 11 is a schematic illustration depicting the manner in which a thin elongated member is moved through bone and the manner in which a drill is moved along the thin elongated member to enlarge a passage formed in the bone by the thin elongated member;



FIG. 12 is a schematic illustration depicting the manner in which an anchor is moved through a passage in the drill of FIG. 11 after the thin elongated member has been removed from the passage in the drill;



FIG. 13 is a schematic illustration, generally similar to FIG. 2, illustrating the manner in which a tubular member is positioned in a passage in the bone;



FIG. 14 is a schematic illustration, generally similar to FIG. 5, illustrating the manner in which tubular members are positioned in a nonlinear passage in a bone; and



FIG. 15 is a schematic illustration, generally similar to FIG. 3, illustrating the manner in which a suture retainer is used with a tubular member which is positioned in a passage in a bone.





DETAILED DESCRIPTION OF THE INVENTION

A bone 20 which has been fractured is illustrated in FIG. 1. The bone 20 is divided into two sections 22 and 24 by a fracture 26. Opposite side surfaces 28 and 30 of the fracture 26 are pressed together by bone suture assemblies 32.


It should be understood that the bone suture assemblies 32 may be utilized in the treatment of any one of many different types of fractures. The fractures may or may not result in the formation of one or more bone fragments. In FIG. 1, the bone suture assemblies 32 have been illustrated as interconnecting sections 22 and 24 of a complete bone fracture of the spiral type. However, the bone suture assemblies 32 could be utilized to connect a fragment of a bone to the main portion of the bone from which the fragment was broken off. Each of the bone suture assemblies 32 has the same construction. However, the bone suture assemblies 32 could have different constructions if desired. The construction of one of the identical bone suture assemblies 32 is illustrated in FIG. 2.


The bone suture assembly 32 (FIG. 2) includes a flexible suture 38 which extends across the fracture 26. The suture 38 is disposed in a straight cylindrical passage 40 which extends diametrically across a generally cylindrical portion of the bone 20. The passage 40 extends through hard compact tissue of an outer layer 42 of the bone and through spongy or cancellous bone tissue 44 which is enclosed by the hard outer layer. Although the passage 40 has a linear configuration, the passage could have a nonlinear configuration if desired.


The suture 38 extends between a first suture anchor 50 disposed on one side of the fracture 26 and a second suture anchor 52 disposed on the opposite side of the fracture. Tension is maintained in the suture 38 to press the suture anchors 50 and 52 against opposite sides of the bone 20 with a predetermined force. This force presses the side surfaces 28 and 30 of the fracture 26 firmly together to promote healing of the fracture. If desired, buttons or other force distributing members could be provided between the anchors 50 and 52 and the bone 20. Body tissue could be disposed between the anchors 50 and 52 and the bone 20.


The suture 38 and/or suture anchors 50 and 52 may be formed of any desired natural or artificial material. For example, the suture 38 may formed of either a polymeric material or a metal. The suture 38 may be biodegradable. Any known suture material may be utilized to form the suture 38.


The suture anchors 50 and 52 have the same construction. However, the anchor 50 could have a construction which is different than the construction of the anchor 52. The anchor 50 has a cylindrical outer side surface 56 which extends between smooth rounded end portions 58 and 60. A pair of parallel cylindrical openings 64 and 66 extend diametrically through the anchor 50. The anchor 50 is free of sharp corners or projections to avoid cutting or abrading of body tissue disposed adjacent to the anchor.


The suture anchor 50 is made of a biocompatible material. Suitable materials include stainless steel or titanium, cobalt chrome and other biocompatible metals. Polymeric material may also be used, suitable polymeric materials includes polyethylene, polypropylene, and biodegradable material such as PLA and PGA. It is believed that it may be preferred to form the suture anchors 50 and 52 from biodegradable or bioerodible copolymers. If desired, the anchor 50 could be formed of body material or hydrophilic materials.


It is contemplated that the anchor 50 may have any desired configuration. For example, the anchor 50 could have any one of the configurations disclosed in U.S. Pat. No. 5,522,846 issued Jun. 4, 1996 and entitled “Suture Anchor”. Alternatively, the suture anchor 50 could have the configuration disclosed in U.S. Pat. No. 5,534,012 issued Jul. 9, 1996 and entitled “Method and Apparatus for Anchoring a Suture”.


Although the anchor 50 may have any desired configuration, the cross-sectional size of the anchor is such as to enable the anchor to be moved through the passage 40. In addition, the length of the anchor 50 is such as to enable it to span an opening at an end of the passage 40 and transmit force from the suture 38 to a substantial area on the outer layer 42 of the bone 20. It is believed that it will be preferred to form the anchor 50 in such a manner as to eliminate any sharp corners or projections.


In the illustrated embodiment of the invention, the anchor 50 has a cylindrical configuration. This particular anchor has an axial length of about two millimeters and a diameter of about one millimeter. The length of the anchor 50 may be approximately three times the diameter of the anchor. The openings 64 and 66 have a diameter of about one-half millimeter.


It should be understood that the foregoing dimensions have been set forth herein for purposes of clarity of description and it is contemplated that the size of the anchor 50 may vary as a function of the size of the bone being treated. Thus, relatively small anchors may be used in association with treatment of small bones in a wrist, hand, foot or ankle of a patient. Relatively large anchors may be used in association with treatment of larger bones in an arm, shoulder, leg or hip of a patient. It should be understood that the bone suture assembly 32 may be used in conjunction with many different bones other than the specific bones previously mentioned.


Only a single anchor 50 or 52 has been shown at opposite ends of the passage 40. It is contemplated that a plurality of anchors could be provided at each end of the passage 40. For example, a pair of separate or interconnected anchors could be provided in a manner similar to that disclosed in the aforementioned U.S. Pat. No. 5,534,012.


In the embodiment of the invention illustrated in FIG. 2, the suture 38 has a pair of limbs or sections 72 and 74 which extend through the openings 64 and 66 in the suture anchors 50 and 52. A connector section 76 interconnects the two limbs 72 and 74 of the suture 38 and engages a portion of the anchor 50. A knot 78 is formed in the opposite ends of the limbs 72 and 74 to interconnect the two limbs of the suture 38.


When the knot 78 is formed, a predetermined tension is present in the limbs 72 and 74 of the suture 38. This results in the suture anchors 50 and 52 being pressed firmly against the bone 20 with a predetermined force. This predetermined force is maintained during and after tying of the knot 78.


When the bone suture assembly 32 is to be used to treat the fracture 26 in the bone 20, the two sections 22 and 24 of the bone are pressed together at the fracture 26 to align the side surfaces 28 and 30 of the fracture. A drill is then used to form the passage 40 which extends diametrically through the generally cylindrical bone 20. Of course, the passage 40 could be formed by the use of a tool other than a drill. If desired, the passage 40 could have a noncircular cross-sectional configuration.


Once the passage 40 has been formed in the two sections 22 and 24 of the bone 20, a tubular cylindrical member is inserted into the passage 40 and extends diametrically through the bone 20. The leading end of the tubular cylindrical member is aligned with a circular outlet 84 from the passage 40. The opposite end of the tubular member is aligned with a circular inlet 86 to the passage 40. The tubular member has a thin cylindrical wall which engages the sections 22 and 24 of the bone 20. A cylindrical inner side surface of the tubular member defines a passage having a diameter which is only slightly less than the diameter of the passage 40.


By inserting the tubular member into the passage 40, the portions of the passage disposed on opposite sides of the fracture 26 are maintained in alignment. The tubular member may be flexible to enable the tubular member to be inserted into a nonlinear passage 40 through the bone 20. The tubular member may be formed of metal or a polymeric material. If the tubular member is formed of a polymeric material, it may be preferred to form the tubular member from a biodegradable or bioerodible copolymer.


The suture 38 is formed into a loop which extends through the openings 64 and 66 in the anchor 50. At this time, the suture 38 has a length which is substantially greater than the length illustrated in FIG. 2. The cylindrical anchor 50, with the suture 38 connected thereto, is then positioned in axial alignment with the tubular member which extends through the passage 40. Thus, the anchor 50 is moved to an orientation in which a longitudinal central axis of the anchor is coincident with the longitudinal central axis of the cylindrical passage in the tubular member which extends through the passage 40 in the bone 20.


The leading end 58 of the anchor 50 is then moved into the cylindrical tubular member which forms a liner for the passage 40. A pusher member pushes the anchor 50 from an upper (as viewed in FIG. 2) end of the tubular member along the passage 40 in the bone 20 and through the outlet 84 from the passage. As the anchor 50 moves through the passage 40, the suture 38 is pulled through the passage 40 by the anchor.


The orientation of the anchor 50 is then changed from an orientation in which the longitudinal central axis of the anchor 50 is aligned with the longitudinal central axis of the passage 40 to an orientation in which the longitudinal central axis of the anchor 50 extends generally perpendicular to the longitudinal central axis of the passage 40, i.e., the orientation shown in FIG. 2. To pivot the anchor 50 to the orientation shown in FIG. 2, as the anchor emerges from the outlet 84, the suture 38 is tensioned. The combination of the tension in the suture 38 and force applied against the trailing end 60 of the anchor by the pusher member causes the anchor to pivot about the trailing end 60 of the anchor. The pusher member is then withdrawn and the suture tensioned to move the anchor to the position shown in FIG. 2 in a manner similar to that described in the aforementioned U.S. Pat. Nos. 5,527,343 and 5,534,012.


Although it is believed that it may be preferred to change the orientation of the anchor 50 after it has emerged from the passage 40, the anchor could be blocked from reentering the passage in other ways if desired. Thus, the anchor could expand after emerging from the passage 40. This could be accomplished by having spring biased arms held in a retracted position by engagement of spring biased arms with the inner side surface of the tubular cylindrical member which lines the passage 40. Upon emerging from the passage, the arms would move outward under the influence of spring forces and extend radially outward beyond the edge of the exit from the passage 40. If desired, the anchor 50 could be constructed so as to expand in a manner similar to that disclosed in U.S. Pat. No. 5,397,331 and/or U.S. Pat. No. 4,409,974.


Rather than expanding under the influence of stored energy, such as spring force, the anchor 50 could expand by absorbing body fluids. Thus, the anchor 50 may be compressed when it moves through the passage 40 and will expand and absorb body fluids after emerging from the passage 40. It is contemplated that the anchor 50 could be constructed so as to expand in any one of the ways disclosed in U.S. patent application Ser. No. 08/699,553 filed Aug. 19, 1996 by Peter M. Bonutti and entitled “Suture Anchor”.


The cylindrical tubular member is then withdrawn from the passage 40. It should be understood that the cylindrical tubular member is used to line the passage 40 in the bone 20 during movement of the anchor 50 through the passage. The use of the tubular member to line the passage 40 may be omitted if desired. However, if the use of the tubular member to line the passage 40 is omitted, the anchor 50 and pusher member would be exposed to the cancellous bone tissue 44 during movement of the anchor through the passage.


The limbs 72 and 74 of the suture 38 are then threaded through openings 64 and 66 in the second suture anchor 52. The limbs 72 and 74 of the suture 38 are tensioned and the second anchor 52 is pressed against the outer side surface of the bone 20. While a predetermined tension force is maintained in the limbs 72 and 74 of the suture 38, the knot 78 is tied in the suture to interconnect the two suture anchors 50 and 52 with the suture 38. The suture 38 is then trimmed to the desired length.


Once the knot 78 has been tied between the limbs 72 and 74 of the suture 38, the tension in the suture 38 presses the side surfaces 28 and 30 of the fracture 26 together. This pressure between the side surfaces 28 and 30 of the fracture 26 is maintained by the suture 38 and suture anchors 50 and 52 until the fracture heals. It is believed that it may be preferred to form the suture 38 and suture anchors 50 and 52 of a biodegradable material which, after the fracture 26 has healed, will dissolve in the patient's body.


The cylindrical tubular member which is inserted into the passage 40 through the bone 20 performs the dual functions of lining the inside of the passage 40 and maintaining the two sections 22 and 24 of the bone in alignment. The cylindrical tubular member could have a slot formed in a side wall of the tubular member to facilitate insertion of the tubular member into the passage 40. It is contemplated that the cylindrical tubular member could be left in the passage 40 after the bone suture assembly 32 has been installed. If the slotted or unslotted cylindrical tubular member is to be left in the passage 40, the cylindrical tubular member may be formed of a biodegradable or bioerodible copolymer. When the cylindrical tubular member remains in the passage 40, the suture 38 extends through the tubular member.


Although only a knot 78 has been shown in FIG. 2 adjacent to the second anchor 52, a suture retainer could be provided to further hold the limbs 72 and 74 of the suture 38. If a suture retainer is to be used in association with the knot 78, the suture retainer will be moved along the limbs of the suture 38 toward the knot before the limbs 72 and 74 of the suture are trimmed to the short length shown in FIG. 2. The suture retainer would then be plastically deformed to grip the limbs 72 and 74 of the suture 38. Thereafter, the suture limbs 72 and 74 would be trimmed to a desired length.


Bone Suture Assembly
Second Embodiment

In the embodiment of the invention illustrated in FIG. 2, a pair of suture anchors 50 and 52 are connected with the suture 38 to maintain tension in the suture and pressure against opposite side surfaces 28 and 30 of the fracture 26. In the embodiment of the invention illustrated in FIG. 3, a suture retainer is used in place of one of the suture anchors. Since the embodiment of the invention illustrated in FIG. 3 is generally similar to the embodiment of the invention illustrated in FIG. 2, similar numerals will be utilized to designate similar components, the suffix letter “a” being associated with the embodiment of the invention illustrated in FIG. 3 to avoid confusion.


A bone 20a has sections 22a and 24a which are separated by a fracture 26a. The fracture 26a has side surfaces 28a and 30a which are pressed together by a bone suture assembly 32a. A suture 38a extends through a cylindrical passage 40a which extends diametrically through the generally cylindrical bone 20a. The suture 38a has a pair of limbs or sections 72a and 74a which are connected with a suture anchor 50a. The suture anchor 50a has the same construction as the suture anchor 50 of FIG. 2.


In accordance with a feature of this embodiment of the invention, a suture retainer 92 is used in place of the suture anchor 52 of FIG. 2. The suture retainer 92 has a spherical configuration. A cylindrical passage 94 extends through the center of the spherical suture retainer 92. The sections 72a and 74a of the suture 38a extend around the spherical outer side surface of the suture retainer 92. Thus, a loop is formed in each of the sections 72a and 74a around portions of the suture retainer 92.


If desired, the suture retainer 92 could have a different configuration. For example, the suture retainer 92 could have an oval or elliptical configuration. Although the passage 94 has a linear central axis, the passage could have a nonlinear central axis. If desired, a plurality of passages having the same or different configurations could be provided in the suture retainer 92.


After the suture 38a has been inserted through the suture retainer 92, in the manner illustrated schematically in FIG. 3, the suture retainer 92 is moved along the sections 72a and 74a of the suture 38a toward the bone 20a. The suture retainer 92 is formed as one piece of a polymeric material having a relatively low coefficient friction. Therefore, the two sections 72a and 74a of the suture 30a can readily slide along the surfaces of the suture retainer 52a while the suture retainer moves toward the bone 20a.


A predetermined tension is maintained in the sections 72a and 74a of the suture 38a while the suture retainer 92 is pressed against the bone 20a. This results in the suture 38a being pulled tightly against the suture anchor 50a. The tension in the suture 38a is effective to press the suture anchor 50a and retainer 92 against opposite sides of the bone 20a with a predetermined force.


Once the suture retainer 92 has been moved along the suture 38a and is being pressed against the bone 20a with a predetermined force, the suture retainer is plastically deformed to grip the sections 72a and 74a of the suture 38a. An apparatus 98 for pressing the suture retainer 92 against the bone 20a includes a tubular cylindrical plunger 102 (FIG. 3) having a cylindrical central passage through which the sections 72a and 74a of the suture 38a extend. The plunger 102 is enclosed by a tubular cylindrical housing 106. The plunger 102 is pressed downward, relative to the housing 106 with a predetermined force, indicated by arrows 108 and 110 in FIG. 3. An annular transducer or load cell 114 provides an output indicative of the magnitude of the force 108 and 110 with which the suture retainer 92 is pressed against the bone 20a by the plunger 102.


While the sections 72a and 74a of the suture 38a are being tensioned with a predetermined force and while the plunger 102 is being pressed against the suture retainer 92 with a predetermined force, the suture retainer 92 is plastically deformed. To plastically deform the suture retainer 92, a plurality of force applying or clamp members 120 and 122 are pressed against the suture retainer 92 with a predetermined minimum force, indicated schematically by arrows 126 in FIG. 3. The force application members 120 and 122 may have an arcuate configuration to conform to the spherical configuration of the suture retainer 92 or may have a flat configuration. The force applied against the suture retainer 92 by the force applying members 120 and 122 is sufficient to cause plastic deformation of the material of the suture retainer.


The force 126 is applied against the suture retainer 92 while the suture retainer is at a temperature which is below the transition temperature of the biodegradable polymer which forms the suture retainer 92. Thus, the suture retainer 92 is at approximately the same temperature as the bone 20a when the force 126 is applied against the suture retainer. The force 126 causes the material of the suture retainer 92 to flow and grip the sections 72a and 74a of the suture 38a.


Upon disengagement of the force application members 120 and 122 from the suture retainer 92, the application of downward (as viewed in FIG. 3) force against the suture retainer 92 is interrupted. The upward tensioning of the sections 72a and 74a of the suture 38a is also interrupted. At this time, the plastically deformed suture retainer 92 securely grips the two sections 72a and 74a of the suture 38a to maintain the tension in the suture 38a. If desired, a knot may be formed between the sections 72a and 74a of the suture as additional protection against the suture working loose over an extended period of time.


The suture retainer 92 may be formed of many different materials. However, it is believed that it will be preferred to form the suture retainer 92 of a biodegradable polymer. One biodegradable polymer which may be utilized is polycaperlactone. Alternatively, the suture retainer 92 could be formed of polyethylene oxide terephthalate or polybutylene terephthalate. It is also contemplated that other biodegradable or bioerodible copolymers could be utilized.


Although it is preferred to form the suture retainer 92 of a biodegradable material, the suture retainer could be formed of a material which is not biodegradable. For example, the suture retainer 92 could be formed of an acetyl resin, such as “DELRIN” (trademark). Alternatively, the suture retainer 92 could be formed of para-dimethylamino-benzenediazo sodium sulfonate, such as “DEXON” (trademark). The construction of the suture retainer 92 and the manner in which is cooperates with the suture 38a is the same as is disclosed in U.S. patent application Ser. No. 08/905,084 filed Aug. 1, 1997 by Peter M. Bonutti et al. and entitled “Method and Apparatus for Securing a Suture”.


The suture retainer 92 is plastically deformed to grip the limbs 72a and 74a of the suture 38a. However, the suture retainer 92 could be constructed so as to be mechanically actuated to grip the suture 38a. If desired, a combination of a mechanical gripping action and plastic deformation could be utilized by a retainer to grip the suture 38a.


Retaining Body Tissue Against Bone


In the embodiment of the invention illustrated in FIG. 2, a bone suture assembly 32 is utilized to press surfaces 28 and 30 of a fracture 26 together. In the embodiment of the invention illustrated in FIG. 4, the suture anchor assembly is utilized to hold body tissue against movement relative to a bone. Since the embodiment of the invention illustrated in FIG. 4 is generally similar to the embodiments of the invention illustrated in FIGS. 2 and 3, similar numerals will be utilized in association with similar components, the suffix letter “b” being associated with the numerals of FIG. 4 to avoid confusion.


A cylindrical passage 40b extends diametrically through a generally cylindrical bone 20b. A bone suture assembly 32b is utilized to retain body tissue 132 against movement relative to the bone 20b. The body tissue 132 may be a muscle, ligament, cartilage or other tissue which is to be held against movement relative to the bone 20b.


The bone suture assembly 32b includes a first suture anchor 50b and a second suture anchor 52b. A suture 38b extends through the passage 40b and interconnects the suture anchors 50b and 52b. Tension in the suture 38b presses the body tissue 132 against a side surface area on the bone 20b. The suture 38b has sections or limbs 72b and 74b which extends through openings in the suture anchors 50b and 52b in the manner previously explained. A knot 78b interconnects the sections 72b and 74b of the suture 38b to press the suture anchor 52b firmly against the body tissue 132. Although the illustrated suture has a pair of sections 72b and 74b, the suture could have a single section if desired.


The suture anchor assembly 32b is installed in association with the bone 20b and body tissue 132 in the same manner as previously explained in conjunction with the embodiment of the invention illustrated in FIG. 2. Thus, the passage 40 (FIG. 4) is formed in the bone 20b by drilling or other methods. The body tissue 132 may be offset to one side of the location where the passage 40b is formed during formation of the passage. This enables the passage 40b to be formed in the bone 20b without damaging the body tissue 132.


The suture anchor 50b is moved through the passage 40b with a longitudinal central axis of the suture anchor aligned with the longitudinal central axis of the passage 40b. When the suture anchor 50b emerges from the passage 40b, the anchor is pivoted to the orientation shown in FIG. 4. Alternatively, the anchor 50b may be mechanically expanded after emerging from the passage 40b. A cylindrical tubular member may be used to line the passage 40a during movement of the anchor 50b through the passage in the manner previously described in connection with the embodiment of FIG. 2.


After the anchor 50b has been moved to the position shown in FIG. 4, the body tissue 132 is positioned between the limbs 72b and 74b of the suture 38b. The limbs 72b and 74b of the suture 38b are then inserted through the openings in the suture anchor 52b. While a predetermined tension is maintained in the suture 38b, the knot 78b is tied between the limbs 72b and 74b of the suture. This results in the body tissue 132 being pressed against the bone 20b with a predetermined force. A button or other force distributing member may be provided between the suture anchor 52b and body tissue 132 if desired.


In the embodiment of the invention illustrated in FIG. 4, two suture anchors 50b and 52b are utilized to press the body tissue 132 against the bone 20b. However, a suture retainer could be substituted for one or more of the suture anchors 50b or 52b. For example, a suture retainer having the same construction and installed in the same manner as the suture retainer 92 of FIG. 3 could be substituted for the anchor 52b of FIG. 4. It should be understood that the suture retainer substituted for the anchor 52b of FIG. 4 could have any desired construction. Thus, a suture retainer having the construction of any one of the suture retainers disclosed in the aforementioned U.S. patent application Ser. No. 08/905,084 filed Aug. 1, 1997 by Peter M. Bonutti et al. and entitled “Method and Apparatus for Securing a Suture” could be utilized in place of the anchor 52b and/or the anchor 50b.


When a suture retainer is used in place of the anchor 52b, the suture retainer applies force against the body tissue 132 to press the body tissue against the bone 20b. If desired, a force distribution member could be provided between the suture retainer and the body tissue 132.


Although the passage 40b has been illustrated in FIG. 4 as having a linear configuration, the passage could have a nonlinear configuration if desired.


In the embodiment of the invention illustrated in FIG. 4, body tissue 132 is disposed adjacent to only one side of the bone 20b. However, if desired, body tissue could be disposed adjacent to opposite sides of the bone 20b. The body tissue could be connected with the anchor 50b in many different ways. For example, a separate length of suture could be connected with the body tissue and anchor 50b or with the suture 38b adjacent to the anchor 50b.


An alternative manner of connecting body tissue with the side of the bone adjacent to the anchor 50b would be to insert the body tissue between the limbs 72b and 74b of the suture 36b in the same manner as shown with the anchor 52b. If this is to be done, an end portion of the body tissue may be manually inserted between the limbs 72b and 74b of the suture 38b. If a central portion of the body tissue is to be disposed between the anchor 50b and the bone 20b, the connector section 76b of the suture could be cut. One of the limbs 72b or 74b of the suture would then be separated from the anchor 50b. The body tissue would be inserted between the limbs of the suture 38. The separated end of the suture would then be inserted through the anchor 50b and connected with the other limb of the suture 38b.


In the embodiment of the invention illustrated in FIG. 4, the body tissue 132 is pressed against a bone 20b which has not been fractured. However, it is contemplated that the bone suture assembly 32 could be utilized to perform the dual functions of pressing body tissue against a bone and of pressing opposite side surfaces of a fracture together. This would result in the body tissue being pressed against the bone 20b in the manner illustrated in FIG. 4 and in opposite side surfaces of a fracture being pressed together in the manner illustrated in FIG. 2 for the opposite side surfaces 28 and 30 of the fracture 26.


Nonlinear Suture Passage


In the embodiment of the invention illustrated in FIG. 2, the passage 40 through which the suture 38 extends has a linear configuration. In the embodiment of the invention illustrated in FIG. 5, the passage through which the suture extends has a nonlinear configuration. Since the embodiment of the invention illustrated in FIG. 5 is generally similar to the embodiment of the invention illustrated in FIGS. 2-4, similar numerals will be utilized to identify similar components, the suffix letter “c” being associated with the components of the embodiment of the invention illustrated in FIG. 5 to avoid confusion.


A bone 20c as a fracture 26c which divides the bone into two sections 22c and 24c. Opposite side surfaces 28c and 30c of the fracture 26c are pressed together by a bone suture assembly 32c. The bone suture assembly 32c includes a suture 38c which extends between first and second suture anchors 50c and 52c.


In accordance with a feature of this embodiment of the invention, the suture 38c is disposed in a passage 40c having a nonlinear configuration. Thus, the passage 40c includes a first section 140 which is skewed relative to a second section 142 of the passage 40c. A bend 144 is formed in the passage 40c at an intersection 146 of the first and second sections 140 and 142 of the passage 40c. The flexible suture 38c extends around the bend 144 along a nonlinear path between the suture anchors 50c and 52c. At the bend 144, the suture 38c applies force against the section 24c of the bone 20c urging the section 24c toward the left (as viewed in FIG. 5). This force presses the sections 22c and 24c of the bone 20c firmly together at the fracture 26c.


The suture anchors 50c and 52c have the same cylindrical construction as the suture anchors 50 and 52 in the embodiment of the invention illustrated in FIG. 2. A knot 78c (FIG. 5) is provided between limbs of the suture 38c to maintain a desired tension in the suture 38c. This tension pulls the suture anchors 50c and 52c toward each other. In addition, this tension presses the section 24c of the bone 20c firmly against the section 22c of the bone at the fracture 26c.


The first section 140 of the passage 40c is formed at an angle to and extends through a longitudinal central axis of the generally cylindrical bone 20c. The second section 142 of the passage 40c is formed in a direction perpendicular, i.e., along a radius, of the generally cylindrical bone 20c. The two sections 140 and 142 of the passage 40c terminate in the spongy cancellous bone tissue 44c.


When the suture assembly 32c is to be used to treat the fracture 26c in the bone 20c, the two sections 22c and 24c of the bone are pressed together at the fracture 26c to align the side surfaces 28c and 30c of the fracture. A drill or other hole forming apparatus is then used to form the first section 140 of the passage 40c. The drill or other hole forming apparatus is then used to form the second section 142 of the passage 40c. When the second section 142 of the passage 40c intersects the first section 140 of the passage 40c, formation of the section 142 of the passage 40c is interrupted.


Once the nonlinear passage 40c has been formed in the two sections 22c and 24c of the bone 20c, a tubular cylindrical liner (not shown) is inserted into the passage 40c. The tubular cylindrical liner may be formed by two separate tubular members which are inserted at opposite ends of the passage 40c. Alternatively, the tubular cylindrical liner may be formed by a single flexible tubular member which is inserted into the section 140 of the passage 40c and then moved around the bend 144 into the section 142 of the passage 40c. It should be understood that the tubular cylindrical liner for the passage 40c could be omitted if desired.


The cylindrical anchor 50c, with the suture 38c connected thereto, is then positioned in axial alignment with the section 142 of the passage 40c. The leading end 58c of the anchor 50c is then moved into the lined section 142 of the passage 40c. A flexible pusher member applies force against the trailing end 60c of the anchor 50c and pushes the anchor around the bend 144 and through the section 140 of the passage 40c.


Alternatively, a flexible wire or other member could be inserted into the section 140 of the passage 40c. The wire would move around the bend 144 and extend outward from the section 142 of the passage. The wire would then be connected with the anchor 50c and suture 38c. The leading end 58c of the anchor 50c would then be inserted into the section 142 of the passage 40c. Tension on the wire would pull the anchor 50c around the bend 144 and out of the section 140 of the passage 40c.


Once the anchor 50c has been moved out of the passage 40c, the tubular liner for the passage may be withdrawn. If a one-piece tubular liner is used, it may be withdrawn from the open end of the section 142 of the passage 40c. If a two-piece liner is used, one of the pieces may be withdrawn from the open end of the passage section 140 and slit to clear the suture 38c. Alternatively, the slit could be formed in the piece of the liner before it is inserted into the passage section 140. The other piece of the liner would be withdrawn from the open end of the passage section 142. Alternatively, the tubular liner for the passage 40c may be left in place. Of course, the use of a tubular liner for the passage 40c may be omitted.


The suture 38c is then threaded through openings in the suture anchor 52c. The suture 38c is then tensioned and the second anchor 52c is pressed against the outer side surface of the bone 20c. While a predetermined tension force is maintained in the suture 38c, the knot 78c is tied.


In the illustrated embodiment of the invention, the two sections 140 and 142 of the passage 40c have a straight cylindrical configuration. However, it is contemplated that the sections 140 and 142 of the passage 40c could have a different configuration if desired. For example, the section 140 and/or 142 of the passage 40c could have a nonlinear central axis and could have a noncircular cross-sectional configuration of desired.


Body tissue, corresponding to the body tissue 132 of FIG. 4 could be disposed between the anchor 50c and/or 52c and the bone 20c. Although the suture 38c has been illustrated as having a pair of limbs or sections which extend between the anchors 50c and 52c, the suture 38c could have a single limb or section if desired. The anchor 50c could mechanically expand, by absorbing body liquid or under the influence of expansion springs, after the anchor has emerged from the passage 40c to prevent the anchor from being pulled back through the passage.


Nonlinear Passage
Second Embodiment

In the embodiment of the invention illustrated in FIG. 5, the bone suture assembly 32c associated with the nonlinear passage 40c includes a pair of suture anchors 50c and 52c. In the embodiment of the invention illustrated in FIG. 6, a suture retainer in substituted for one of the suture anchors in much the same manner as previously described in conjunction with the embodiment of the invention illustrated in FIG. 3. Since the embodiment of the invention illustrated in FIG. 6 is generally similar to the embodiment of the invention illustrated in FIGS. 2-5, similar numerals will be utilized to designate similar components, the suffix letter “d” being associated with the numerals of FIG. 6 in order to avoid confusion.


A bone 20d has a fracture 26d which divides the bone into two sections 22d and 24d. The fracture 26d has side surfaces 28d and 30d which are pressed together by a bone suture assembly 32d. The bone suture assembly 32d includes a suture 38d which extends through a nonlinear passage 40d having the same construction as the nonlinear passage 40c of FIG. 5.


In accordance with a feature of this embodiment of the invention, the bone suture assembly 32d includes a suture anchor 50d having the same construction as the suture anchor 50 of FIG. 2, and a suture retainer 92d having the same construction as the suture retainer 92 of FIG. 3. The suture anchor 50d and suture retainer 92d maintain a predetermined tension in the suture 38d. This results in the suture anchor 50d being firmly pressed against the section 24d of the bone 20d. The suture retainer 92d is firmly pressed against the section 22d of the bone 20d by the tension in the suture 38d.


Since the passage 40d has a nonlinear configuration, the suture 38d is effective to apply a force component to the section 24d of the bone 20d urging the section 24d of the bone toward the left (as viewed in FIG. 6). This results in the surface 30d of the fracture 26d being pressed firmly against the surface 28d of the fracture.


The suture retainer 92d is plastically deformed to grip the suture 38d in the same manner as previously described herein in conjunction with the suture retainer 92 of FIG. 3. However, the suture retainer 92d could be constructed so as to form a mechanical connection with the suture 38d. If desired, a suture retainer could be substituted for the anchor 50d.


Although both the suture retainer 92d and anchor 50d have been illustrated in FIG. 6 as being disposed in engagement with the bone 20d, a force distributing member could be provided between the anchor and/or suture retainer and the bone. It is contemplated that body tissue, similar to the body tissue 132 of FIG. 4, could be disposed between the anchor 50d and/or the suture retainer 92d and the bone 20d.


Tissue Tensioning with Bone Fragment Retaining


In the embodiment of the invention illustrated in FIG. 2, the fracture in a portion of a bone is treated. In the embodiment of the invention illustrated in FIGS. 7 and 8, a fracture results in a fragment of a bone being separated from a main portion of the bone. The bone fragment is connected with the main portion of the bone by muscle, tendon, ligament, cartilage or other fibrous body tissue. In the embodiment of the invention illustrated in FIGS. 7 and 8, the fibrous body tissue is tensioned as the bone fragment is positioned relative to the main portion of the bone. Since the embodiment of the invention illustrated in FIGS. 7 and 8 is generally similar to the embodiment of the invention illustrated in FIGS. 2-6, similar numerals will be utilized to designate similar components, the suffix “e” being associated with the numerals of FIGS. 7 and 8 in order to avoid confusion.


A bone fragment 154 is separate from a main bone 20e (FIG. 7). The fragment 154 is connected with the main bone 20e by fibrous body tissue 158, i.e., muscle, tendon, ligament, cartilage, etc. The fibrous body tissue 158 extends between the bone fragment 154 and a portion 160 of the main bone 20e. The bone fragment 154 has a side surface 28e with a configuration which matches the configuration of a side surface 30e of a fracture 26e which occurred in the main bone 20e.


In order to promote healing of the main bone 20e, a bone suture assembly 32e (FIG. 8) is utilized to pull the bone fragment 154 toward the main bone 20e. As this occurs, the fibrous body tissue 158 is tensioned and the side surface 28e on the bone fragment 154 is pressed against the side surface 30e on the main bone 20e. The bone fragment 154 is pressed firmly against the main bone 20e by the bone suture assembly 32e. Thus, the gap illustrated schematically in FIG. 8, between the side surfaces 28e and 30e of the fracture 26e, is eliminated and the side surfaces of the fracture are pressed firmly together by the bone suture assembly 32e. If desired, the bone fragment 154 may be manually pressed against the main bone 20e before the bone suture assembly is pulled tight.


The bone suture assembly 32e includes a suture 38e having limbs or sections 72e and 74e. The suture 38e extends through openings in a first suture anchor 50e. The suture then extends into a passage 40e formed in the bone fragment 154 and the main bone 20e.


The passage 40e includes a first section 140e which extends through the bone fragment 154. In addition, the passage 40e includes a second section 142e which extend through the main bone 20e. The limbs or section 72e and 74e of the suture 38e extends through a second anchor 52e.


During installation of the bone suture assembly 32e, the limbs 72e and 74e of the suture 38e are gripped by a force or tension measurement device 98e. The tension measurement device 98e includes a load cell which measures the amount of tension applied to the limbs 72e and 74e of the suture 38e.


As tension is applied to the limbs 72e and 74e of the suture 38e, the bone fragment 154 is pulled toward the right (as viewed in FIG. 8) to move the side surface 28e on the bone fragment into alignment with the side surface 30e on the main bone 20e. As this occurs, the fibrous body tissue 158 is stretched or tensioned. While a predetermined force is transmitted through the limbs 72e and 74e to the suture anchor 50e and the bone fragment 154 to firmly press the bone fragment against the main bone 20e, a knot 78e is tied to interconnect the limbs 72e and 74e. While the predetermined tension is maintained and the knot 78e tied, the second anchor 52e is firmly pressed against the side surface of the main bone 20e.


Although the passage 40e could have a linear configuration if desired, in the embodiment of the invention illustrated in FIG. 8, the passage 40e has a nonlinear configuration. Thus, the first section 140e of the passage 40e has a central axis which is skewed relative to a central axis of the second section 142e of the passage 40e. This enables the flexible suture 38e to apply force to the bone fragment 154 having components urging the bone fragment rightward (as viewed in FIG. 8) against the surface 30e on the main bone 20e and downward (as viewed in FIG. 8) to maintain the tension in the fibrous body tissue 158.


When the passage 40e is to be formed in the bone fragment 154 and main bone section 20e, a hole is drilled through the bone fragment 154 to form the first section 140e of the passage. The second portion 142e of the passage 40e is drilled in the main bone 20e. It should be understood that the passage 40e could be formed in many different ways other than drilling. For example, a cutting tool or laser could be used to form the passage 40e.


The second section 142e of the passage 40e has a longitudinal central axis which is skewed at an acute angle relative to the longitudinal central axis of the first section 140e of the passage in the bone fragment 154. Thus, the first portion 140e of the passage 40e in the bone fragment 154 has a central axis which is close to being perpendicular to a longitudinal central axis of the main bone 20e. The second portion 142e of the passage 40e has a longitudinal central axis which is angularly offset to a substantial arc relative to the longitudinal central axis of the main bone 20e.


The anchor 50e is moved through the first section 140e of the passage 40e and positioned in engagement with an outer side surface of the bone fragment. The free ends of the limbs 72e and 74e of the suture 38e are then moved rightward (as viewed in FIG. 8) through the second portion 142e of the passage 40e. The free ends of the suture 38e are then threaded through openings in the second anchor 52e.


After the suture 38e has been inserted through openings in the second anchor 52e, the force or tension measuring device 98e is utilized to pull the free ends of the suture 38e toward the right (as viewed in FIG. 8). This tension pulls the bone fragment 154 into engagement with the main bone 20e. The knot 78e is tied in the free ends of the suture 38e while the tension is maintained in the suture.


If desired, the bone suture assembly 32e could be positioned relative to the bone 20e and the bone fragment 154 by moving the anchor 50e first through the second section 142e of the passage disposed in the main bone 20e and then through the first section 140e of the passage disposed in the fragment 154. The free ends of the suture would then be inserted through the second anchor 52e. The suture 38e would be tensioned to pull the bone fragment 154 into place with the side surface 28e in aligned engagement with the surface 30e on the main bone 20e. The knot 78e would then be tied while maintaining the desired tension in the suture 38e.


It should be understood that the anchor 52e and knot 78e could be positioned adjacent to the bone fragment 154 and the anchor 50e positioned adjacent to the bone 20e. Although only a single bone suture assembly 32e has been illustrated in FIG. 8, multiple bone suture assemblies could be used to position the bone fragment 154 relative to the bone 20e.


In the embodiment of the invention illustrated in FIGS. 7 and 8, the bone suture assembly 32e includes a pair of anchors 50e and 52e. If desired, a suture retainer could be substituted for either or both of the anchors 50e and 52e. Thus, a suture retainer having a construction similar to the construction of the suture retainer 92 of FIG. 3 could be used in place of the second anchor 52e. It should be understood that the suture retainer 92 could have the same construction as any one of the suture retainers disclosed in the aforementioned U.S. patent application Ser. No. 08/905,084 filed Aug. 1, 1997 by Peter M. Bonutti et al. and entitled “Method and Apparatus for Securing a Suture”.


In the embodiment of the invention illustrated in FIG. 8, the anchors 50e and 52e are placed in engagement with the bone of fragment 154 and main bone 20e. However, it is contemplated that the anchor 50e and/or 52e could be positioned in engagement with body tissue other than bone. For example, the anchor 50e could be positioned in engagement with a portion of the fibrous body tissue 158 to position the fibrous body tissue 158 relative to the bone fragment 154 and to more securely interconnect the fibrous body tissue and the bone fragment. If desired, body tissue could be positioned between the anchor 52e and the main bone 20e.


In FIG. 8, there is a single bone fragment 154. However, fractures may occur in such a manner as to have a plurality of bone fragments. A plurality of bone suture assemblies 32e could be utilized to interconnect the plurality of bone fragments and the main bone.


When a fracture occurs in such a manner as to form a plurality of bone fragments, it may be desired to use bone suture assemblies 32e in association with only the larger bone fragments. If desired, a bridge or cover member could extend across the bone fragments to position the bone fragments relative to each other. One or more bone suture assemblies 32e would extend through one or more of the larger bone fragments and through the bridge or cover member. Force applied against the bridge or cover member by an anchor or anchors in a bone suture assembly or assemblies 32e would urge the bridge or cover member toward the main bone 20e to position the smaller bone fragments relative to the larger bone fragments and main bone 20e and to press the bone fragments against each other and against the main bone.


One or more of the anchors 50e and 52e could be formed of body tissue or of material which absorbs body fluid and expands. Alternatively, one or more of the anchors 50e or 52e could be mechanically expanded to block movement into the passage 50e.


Bone Fragment Retention


In the embodiment of the invention illustrated in FIG. 2, the bone suture assembly 32 extends between diametrically opposite outer side surface areas on the bone 20. This results in the first suture anchor 50 being disposed against an outer side surface of the hard outer layer 42 of the bone 20 (FIG. 1) and the suture anchor 52 being disposed against the outer side surface of the hard outer layer 42 on the opposite side of the bone. In the embodiment of the invention illustrated in FIG. 9, one of the anchors is disposed within the bone and the other anchor is disposed outside of the bone. Since the embodiment of the invention illustrated in FIG. 9 is generally similar to the embodiment of the invention illustrated in FIGS. 2-8, similar numerals will be utilized to identify similar components, the suffix letter “f” being associated with the numerals of FIG. 9 in order to avoid confusion.


A bone 20f has a hard outer layer 42f which encloses spongy cancellous bone tissue 44f. A fragment 164 has broken away from the hard outer layer 42f. A bone suture assembly 32f is used to position and hold the fragment 164 in engagement with the bone 20f. The bone suture assembly 32f includes a first suture anchor 50f which is disposed in engagement with an inner side surface 166 of the outer layer 42f of bone. A second anchor 50f is disposed in engagement with an outer side surface 168 of the fragment 164. A suture 38f extends between the first and second anchors 50 and 52f. The suture 38f extends through a passage 40f which extends across a fracture 26f.


When the bone suture assembly 32f is used to position the fragment 164 against the outer layer 42f of the bone 20f, the fragment 164 is aligned with the outer layer 42f of the bone 20f. At this time, a side surface 172 on the fragment 164 is disposed in aligned engagement with a side surface 174 on the bone 20f. The two side surfaces 172 and 174 were formed by breaking away of the fragment 164 from the outer layer 42f of the bone.


Once the fragment 164 has been aligned with the bone 20f, the linear passage 40f is formed by drilling or other methods through the fragment 164 and the outer layer 42f of bone. A cylindrical tubular member (not shown) having a thin cylindrical side wall is then inserted through the passage 40f. The first anchor 50f is moved to an orientation in which a longitudinal central axis of the first anchor is aligned with a longitudinal central axis of the cylindrical tubular member.


The first anchor 50f is then moved through the cylindrical tubular member, across the fracture 26f and into the spongy cancellous bone tissue 44. A pusher member applies force against a trailing end of a first anchor 50f to push the anchor through the tubular member. When the leading end of the first anchor 50f emerges from the passage 40f, the longitudinal central axis of the first anchor is aligned with the longitudinal central axis of the passage 40f.


The first anchor 50f is then pivoted through 90 degrees to change its orientation to the orientation shown in FIG. 9. The tubular member is then withdrawn from the passage 40f. The free ends of the suture 38f are then inserted through openings in the anchor 52f. The suture is tensioned to press the anchor 50f against the inner side surface 166 on the outer layer 42f of the bone 20f. The second anchor 52f is pressed against the outer side surface 168 or the fragment 164 with a predetermined force by the tension in the suture 38f. A knot 78f is then tied in the free ends of the suture 38f to maintain the desired tension in the suture.


Although it is believed that it may be desired to remove the tubular member from the passage 40f, the tubular member could be left in the passage if desired. If the tubular member is to be left in the passage 40f, the tubular member may be formed of a biodegradable or bioerodible copolymer. Of course, the use of the tubular member could be eliminated if desired.


It should be understood that a suture retainer, having a construction similar to the construction of the suture retainer 92 of FIG. 3, could be used in place of the second anchor 52f if desired. Although the suture anchor 52f has been shown in FIG. 9 as being disposed in direct abutting engagement with the outer side surface 168 of the bone fragment 164, a layer of body tissue could be provided between the suture anchor 52f and the outer side surface 168 of the bone fragment 164 to hold the body tissue against movement relative to the bone 20f. If desired, a plurality of bone suture assemblies 32f could be utilized to hold the bone fragment 164.


Use of Plates with Bone Suture Assembly


In the embodiment of the invention illustrated in FIG. 2, the suture anchors 50 and 52 are disposed in abutting engagement with an outer side surface of a bone. In the embodiment of the invention illustrated in FIG. 10, a pair of bone plates and rigid fasteners are used in association with a bone suture assembly. Since the embodiment of the invention illustrated in FIG. 10 is generally similar to the embodiment of the invention illustrated in FIGS. 2-9, similar numerals will be utilized to designated similar components, the suffix “g” being associated with the numerals of FIG. 10 to avoid confusion.


A bone 20g has sections 22g and 24g which are separated by a fracture 26g. In accordance with a feature of this embodiment of the invention, a pair of plate members 184 and 186 are used in association with a bone suture assembly 32g. The plate members 184 and 186 may be formed of any desired biocompatible material. Thus, the plate members may be formed of metal or a polymeric material. If the plate members 184 and 186 are formed of polymeric material, biodegradable or bioerodible copolymers could be utilized.


In the illustrated embodiment of the invention, the plate members 184 and 186 are rigid and are shaped to engage the bone 20g. If desired, the plate members 184 and 186 could have sufficient flexibility to enable the plate members to be plastically deformed to the configuration of the bone 20g after having been positioned in engagement with the bone.


A first suture anchor 50g is pressed against the plate member 184 by tension in a suture 38g. The suture 38g extends through a passage 40g in the bone 20g. A second anchor 52g is pressed against the plate member 186 by the tension in the suture 38g. A knot 78g is provided in the suture 38g.


A pair of screws 190 and 192 extend diametrically through the bone 20g between the plate members 184 and 186. The screws 190 and 192 are engaged by nuts 196 and 198 which engage the plate member 184. The screws 190 and 192 and nuts 196 and 198 cooperate to press the plate members 184 and 186 against the bone 20g. If desired, bone suture assemblies having the same construction as the bone suture assembly 32g could be substituted for the screws 190 and 192 and nuts 196 and 198 so that the plates 184 and 186 would be held in position against the bone 20g by only the plurality of bone suture assemblies 32g.


The screws 190 and 192 and nuts 196 and 198 may be formed of any desired biocompatible material. Thus, the screws 190 and 192 and nuts 196 and 198 may be formed of metal or a polymeric material. If the screws 190 and 192 and nuts 196 and 198 are formed of polymeric material, biodegradable or bioerodible copolymers could be utilized.


In the illustrated embodiment of the invention, the screws 190 and 192 extend through the bone 20g. It is contemplated that shorter screws could be utilized if desired. These shorter screws would have relatively coarse bone engaging thread convolutions to hold the short screws and plate members 184 and 186 in place. The shorter screws would have a length which is less than diameter of the bone 20g.


In the illustrated embodiment of the invention, the bone suture assembly 32g extends through a linear passage 40g. If desired, the passage 40g could have a nonlinear configuration. If bone suture assemblies 32g are substituted for the screws 190 and 192 and nuts 196 and 198, some of the bone suture assemblies could extend through linear passages while other bone suture assemblies extend through nonlinear passages.


Installation Method


In the embodiment of the invention illustrated in FIG. 2, the passage 40 is formed in the bone 20 by any desired method. A thin walled cylindrical tubular member is then inserted into the passage and the first suture anchor 50 moved through the thin walled member. In the embodiment of the invention illustrated in FIGS. 11 and 12, a cannulated drill is used to drill a passage through a bone and to guide movement of the first anchor through the bone. Since the embodiment of the invention illustrated in FIGS. 11 and 12 is generally similar to the embodiments of the invention illustrated in FIGS. 2-10, similar numerals will be utilized to identify similar components, the suffix “h” being associated with the numerals in FIGS. 11 and 12 to avoid confusion.


A bone 20h has a fracture (not shown). When the fracture is to be treated with a bone suture assembly 32h (FIG. 12), a thin elongated cylindrical member or K-wire 204 is first inserted through the bone 20h. This may be done by rotating the thin elongated member 204 with a drill drive mechanism in the manner indicated by an arrow 206 in FIG. 11. The drill drive mechanism is provided with a passage which extends through a drive shaft for the mechanism. While the thin elongated member 204 is being rotated by the drill drive mechanism, the K-wire extends through the passage in the drill drive mechanism.


As the thin elongated member 204 is rotated by the drill drive mechanism, it is pressed against the bone 20h. As the thin elongated member 204 is rotated, in the manner indicated by the arrow 206 in FIG. 11, the thin elongated member is moved diametrically through the generally cylindrical bone 20h until the leading end of the thin elongated member 204 extends from the opposite side of the bone. Thus, the thin elongated member 204 is moved through the hard outer layer 42h (FIG. 12) at one side of the bone 20h, through the spongy or cancellous bone tissue 44h, and through the hard outer layer at the diametrically opposite side of the bone. When this has been done, the thin elongated member 204 will extend across the fracture in the bone.


The drill drive mechanism is then disengaged from the thin elongated member 204. A cannulated drill 210 is moved axially along the thin elongated member until the leading end portion 212 of the drill 210 engages the bone 20h (FIG. 11). The drill 210 is then gripped by the drill drive mechanism.


While the thin elongated member 204 remains stationary, the drill 210 is rotated about the thin elongated member in the manner indicated by an arrow 214 in FIG. 11. As the drill 210 is rotated about the stationary thin elongated member 204, the drill is moved axially into the bone 20h. As this occurs, the leading end 212 of the drill enlarges the hole or passage formed in the bone 20h by the thin elongated member 204. The drill 210 is moved along the thin elongated member 204 until the drill extends diametrically across the bone 20h. This movement of the drill 210 is guided by engagement of the thin elongated member 204 with a side wall of a cylindrical passage 218 which extends axially through the drill 210. Movement of the drill 210 through the bone 20h forms a passage 40h which extends through a fracture in the bone.


Once the drill 210 has been moved diametrically through the generally cylindrical bone 20h (FIG. 12), the thin elongated member 204 is withdrawn from the drill. This leaves an open cylindrical passage 218 extending through the drill 210 and across the bone 20h. The passage 218 has a diameter which is just slightly greater than the diameter of a cylindrical first anchor 50h of the bone suture assembly 32h. The cylindrical first anchor 50h is axially aligned with the passage 218 in the drill 210, in the manner shown in FIG. 12. At this time, the suture 38h has been inserted through openings in the first anchor 50h and suture limbs or sections 72h and 74h extend away from the first anchor 50h, in the manner indicated schematically in FIG. 12.


A cylindrical pusher member 222 is axially aligned with the first anchor 50h and the passage 218 through the drill 210. The pusher member 222 is utilized to push the first anchor 50h through the drill 210 to the far side of the bone 20h.


As the first suture anchor 50h emerges from the passage 28 in the drill 210, the anchor is pivoted through ninety degrees. This pivotal movement changes the orientation of the anchor 50h from an orientation in which the longitudinal central axis of the anchor 50h is aligned with the longitudinal central axis of the passage 218 and drill 210 to an orientation in which a longitudinal central axis of the cylindrical anchor 50h extends perpendicular to the longitudinal central axis of the passage and drill. The manner in which the anchor 50h is pivoted is the same as is described in the aforementioned U.S. Pat. Nos. 5,527,343 and 5,534,012.


The pusher member 222 is then withdrawn from the drill 10 and the drill is withdrawn from the passage formed through the bone 20h. As this occurs, the suture 38h is tensioned to hold the anchor 50h in place against the bone 20h. The drill 210 is then disengaged from the suture 38h. The free limbs 72 and 74 of the suture 38h are then inserted through a second anchor corresponding to the anchor 52 in FIG. 2. While a predetermined tension is maintained in the suture 38h, the suture is tied to hold the second suture anchor, corresponding to the suture anchor 52 in FIG. 2, against the bone 20h on a side of the bone opposite from the anchor 50h.


In the foregoing description, the drill 210 has been a rigid drill which has been used to form a linear passage to the bone 20h. However, it is contemplated that a flexible drill could be utilized to drill a passage through the bone. If this was done, the drill could be guided in such a manner as to form a nonlinear passage in the bone.


The foregoing description of how the passage 40h is formed has been in conjunction with a bone 20h having a fracture similar to the fracture 26 of FIG. 2. However, it is contemplated that the thin elongated member 204 and drill 210 could be used to form a passage in a bone which has not been fractured (FIG. 4). The thin elongated member 204 and 210 could be used to form a passage which extends only part way through a bone (FIG. 9).


In the description of the embodiments of the invention illustrated in FIGS. 1-12, the suture 38 (FIG. 2) has a pair of limbs or sections 72 and 74. It is contemplated that the suture 38 could have only a single limb which would be connected at one end with the first anchor 50 and at the opposite end with the second anchor 52. This single limb could either be tied off at the second anchor 52 or gripped by a suture retainer, similar to the suture retainer 92 of FIG. 3.


In the embodiments of the invention illustrated in FIGS. 1-12, the suture 38 has been formed separately from the first suture anchor 50. It is contemplated that the first suture anchor 50 could be formed as one piece with the suture 38. For example, the suture and anchor could be formed as one piece in a manner similar to that disclosed in U.S. Pat. No. 4,669,473 or in U.S. Pat. No. 4,741,330.


The anchors 50 and 52 in the embodiment of FIGS. 2-12 could have any one of many different constructions. For example, the anchors could expand by absorbing body fluid. The anchor 50, which is moved through a passage 40 in the embodiments of FIGS. 2-12, could mechanically expand upon exiting from the passage.


Positioning of Tubular Member


In the embodiment of the invention illustrated in FIG. 13, a tubular member is positioned in the passage which extends through the bone. Since the embodiment of the invention illustrated in FIG. 13 is generally similar to the embodiments of the invention illustrated in FIGS. 1-12, similar numerals will be utilized to designate similar components, the suffix letter “j” being associated with the numerals of FIG. 13 to avoid confusion.


A bone 20j which has been fractured is illustrated in FIG. 1. The bone 20j is divided into two sections 22j and 24j by a fracture 26j. Opposite side surfaces 28j and 30j of the fracture 26j are pressed together by bone securing assemblies 32j.


It should be understood that the bone securing assemblies 32j may be utilized in the treatment of any one of many different types of fractures. The fractures may or may not result in the formation of one or more bone fragments. In FIG. 13, the bone securing assembly 32j has been illustrated as interconnecting sections 22j and 24j of a complete bone fracture of the spiral type. However, the bone securing assemblies 32j could be utilized to connect a fragment of a bone to the main portion of the bone from which the fragment was broken off.


The bone securing assembly 32j (FIG. 13) includes a force transmitting member 38j which extends across the fracture 26j. The force transmitting member 38j may be any one of many different types of force transmitting members. The force transmitting member 38j may be formed of human or animal body tissue. However, it is presently preferred to use a suture as the force transmitting member 38j. Therefore, the force transmitting member 38j will be referred to herein as a suture.


The suture 38j, that is, the force transmitting member, is disposed in a straight cylindrical passage 40j which extends diametrically across a generally cylindrical portion of the bone 20j. The passage 40j extends through hard compact tissue of an outer layer 42j of the bone and through spongy or cancellous bone tissue 44j which is enclosed by the hard outer layer. Although the passage 40j has a linear configuration, the passage could have a nonlinear configuration if desired.


The suture 38j extends between a first suture anchor 50j disposed on one side of the fracture 26j and a second suture anchor 52j disposed on the opposite side of the fracture. Tension is maintained in the suture 38j to press the suture anchors 50j and 52j against opposite sides of the bone 20l with a predetermined force. This force presses the side surfaces 28j and 30j of the fracture 26j firmly together to promote healing of the fracture. If desired, buttons or other force distributing members could be provided between the anchors 50j and 52j and the bone 20j. Body tissue could be disposed between the anchors 50j and 52j and the bone 20j.


The suture 38j and/or suture anchors 50j and 52j may be formed of any desired natural or artificial material. For example, the suture 38j may be formed of either a polymeric material or a metal. The suture 38j may be biodegradable. Any known suture material may be utilized to form the suture 38j.


The suture anchors 50j and 52j have the same construction. However, the anchor 50j could have a construction which is different than the construction of the anchor 52j. The anchor 50j has a cylindrical outer side surface 56j which extends between smooth rounded end portions 581 and 60j. A pair of parallel cylindrical openings 64j and 66j extend diametrically through the anchor 50j. The anchor 50j is free of sharp corners or projections to avoid cutting or abrading of body tissue disposed adjacent to the anchor.


The suture anchor 50j is made of a biocompatible material. Suitable materials include stainless steel or titanium, cobalt chrome and other biocompatible metals. Polymeric material may also be used, suitable polymeric materials includes polyethylene, polypropylene, and biodegradable material such as PLA and PGA. It is believed that it may be preferred to form the suture anchors 50j and 52j from biodegradable or bioerodible copolymers. If desired, the anchor 50j could be formed of body material or hydrophilic materials.


It is contemplated that the anchor 50j may have any desired configuration. For example, the anchor 50j could have any one of the configurations disclosed in U.S. Pat. No. 5,522,846 issued Jun. 4, 1996 and entitled “Suture Anchor”. Alternatively, the suture anchor 50j could have the configuration disclosed in U.S. Pat. No. 5,534,012 issued Jul. 9, 1996 and entitled “Method and Apparatus for Anchoring a Suture”.


The cross-sectional size of the anchor 50j may be such as to enable the anchor to be moved through the passage 40j. However, the anchor 50j could have a size and configuration which would prevent movement of the anchor 50j through the passage 40j. For example, the anchors 50j and 52j could have the same construction as the retainer 92 of FIG. 3.


The length of the anchor 50j is such as to enable it to span an opening at an end of the passage 40j and transmit force from the suture 38j to a substantial area on the outer layer 42j of the bone 20j. The length of the anchor 50j may be approximately three times the diameter of the anchor. It is believed that it will be preferred to form the anchor 50j in such a manner as to eliminate any sharp corners or projections.


In the illustrated embodiment of the invention, the anchor 50j has a cylindrical configuration. This particular anchor has an axial length of about two millimeters and a diameter of about one millimeter. The openings 64j and 66j have a diameter of about one-half millimeter.


It should be understood that the foregoing dimensions have been set forth herein for purposes of clarity of description and it is contemplated that the size of the anchor 50j may vary as a function of the size of the bone being treated. Thus, relatively small anchors may be used in association with treatment of small bones in a wrist, hand, foot or ankle of a patient. Relatively large anchors may be used in association with treatment of larger bones in an arm, shoulder, leg or hip of a patient. It should be understood that the bone securing assembly 32j may be used in conjunction with many different bones other than the specific bones previously mentioned.


Only a single anchor 50j or 52j has been shown at opposite ends of the passage 40j. It is contemplated that a plurality of anchors could be provided at each end of the passage 40j. For example, a pair of separate or interconnected anchors could be provided in a manner similar to that disclosed in the aforementioned U.S. Pat. No. 5,534,012.


In the embodiment of the invention illustrated in FIG. 13, the suture 38j has a pair of limbs or sections 72j and 74j which extend through the openings 64j and 66j in the suture anchors 50j and 52j. A connector section 76j interconnects the two limbs 72j and 74j of the suture 38j and engages a portion of the anchor 50j. A knot 78j is formed in the opposite ends of the limbs 72j and 74j to interconnect the two limbs of the suture 38j.


When the knot 78j is formed, a predetermined tension is present in the limbs 72j and 74j of the suture 38j. This results in the suture anchors 50j and 52j being pressed firmly against the bone 20j with a predetermined force. This predetermined force is maintained during and after tying of the knot 78j.


When the bone securing assembly 32j is to be used to treat the fracture 26j in the bone 20j, the two sections 22j and 24j of the bone are pressed together at the fracture 26j to align the side surfaces 28j and 30j of the fracture. A drill is then used to form the passage 40j which extends diametrically through the generally cylindrical bone 20j. Of course, the passage 40j could be formed by the use of a tool other than a drill. If desired, the passage 40j could have a noncircular cross-sectional configuration.


Once the passage 40j has been formed in the two sections 22j and 24j of the bone 20j, a tubular cylindrical member 240 is inserted into the passage 40j and extends diametrically through the bone 20j. The leading end 242 of the tubular cylindrical member 240 is aligned with a circular outlet 84j from the passage 40j. The opposite or trailing end 244 of the tubular member is aligned with a circular inlet 86j to the passage 40j. The tubular member 240 has a thin cylindrical wall which engages the sections 22j and 24j of the bone 20l. A cylindrical inner side surface of the tubular member 240 defines a cylindrical passage having a diameter which is only slightly less than the diameter of the passage 40j.


The leading end 242 of the tubular member 240 is disposed in the compact outer layer 42j of the bone 20j. Similarly, the trailing end 244 of the tubular member 240 is disposed in the compact outer layer 42j of the bone 20j. The tubular member 240 extends across the fracture 26j and stabilizes the two sections 22j and 24j of the bone 20j. Since the opposite end portions of the tubular member 240 are disposed in the compact outer layer 42j of the bone 20j, the tubular member is solidly supported and holds the two sections 22j and 24j of the bone 20j in alignment at the fracture 26j.


The opposite ends 242 and 244 of the tubular member 240 are axially spaced from a generally cylindrical outer side surface 250 on the bone 20j. This enables the anchors 50j and 52j to be pressed against the outer side surface 250 of the bone 20j. Therefore, tension forces in the suture 38j are transmitted through the anchors 50j and 52j to the bone 20j.


By inserting the tubular member 240 into the passage 40j, the portions of the passage disposed on opposite sides of the fracture 26j are maintained in alignment. The tubular member 240 may be flexible to enable the tubular member to be inserted into a nonlinear passage 40j through the bone 20j. The tubular member 240 may be formed of metal or a polymeric material. If the tubular member 240 is formed of a polymeric material, it may be preferred to form the tubular member from a biodegradable or bioerodible copolymer.


In accordance with one of the features of this embodiment of the invention, the tubular member 240 is formed of bone. By forming the tubular member 240 of bone, tissue growth into the tubular member is promoted. The tubular member 240 may be packed with bone or bone graft. The tubular member 240 may contain bone osteoinductive protein (BMP). Bone growth inducing materials containing apatite compositions with collagen and/or other materials may be utilized. The tubular member 240 may be formed of either human or animal bone.


It is contemplated that it may be preferred to form the tubular member 240 of freeze dried human bone obtained from a cadaver. The freeze dried bone will absorb body fluids. As this occurs, the tubular member 240 will expand and grip the two sections 22j and 24j of the bone 20j. The body fluids will be conducted into bone growth promoting materials contained in the tubular member 240. If desired, antibiotics and/or other medicants may be provided in the bone or bone graft with which the tubular member 240 is packed. Of course, the tubular member 240 may be formed of other materials, such as biodegradable materials, if desired.


The suture 38j is formed into a loop which extends through the openings 64j and 66j in the anchor 50j. At this time, the suture 38j has a length which is substantially greater than the length illustrated in FIG. 2. The cylindrical anchor 50j, with the suture 38j connected thereto, is then positioned in axial alignment with the tubular member 240 which extends through the passage 40j. Thus, the anchor 50j is moved to an orientation in which a longitudinal central axis of the anchor is coincident with the longitudinal central axis of the cylindrical passage 246 in the tubular member 240 which extends through the passage 40j in the bone 20j.


The leading end 58j of the anchor 50j is then moved into the cylindrical tubular member 240 which forms a liner for the passage 40j. A pusher member pushes the anchor 50j from an upper (as viewed in FIG. 13) end 244 of the tubular member 240 along the passage 246 in the tubular member 240 and the passage 40j in the bone 20 and through the outlet 84j from the passage. As the anchor 50j moves through the passages 40j and 246, the suture 38j is pulled through the passages by the anchor.


The orientation of the anchor 50j is then changed from an orientation in which the longitudinal central axis of the anchor 50j is aligned with the coincident longitudinal central axes of the passages 40j and 246 to an orientation in which the longitudinal central axis of the anchor 50j extends generally perpendicular to the longitudinal central axis of the passages 40j and 246, i.e., the orientation shown in FIG. 13. To pivot the anchor 50j to the orientation shown in FIG. 13, as the anchor emerges from the outlet 84, the suture 38j is tensioned. The combination of the tension in the suture 38j and force applied against the trailing end 60j of the anchor 50j by the pusher member causes the anchor to pivot about the trailing end 60j of the anchor. The pusher member is then withdrawn and the suture 38j tensioned to move the anchor to the position shown in FIG. 13 in a manner similar to that described in the aforementioned U.S. Pat. Nos. 5,527,343 and 5,534,012.


Although it is believed that it may be preferred to change the orientation of the anchor 50j after it has emerged from the passages 40j and 246, the anchor could be blocked from reentering the passage in other ways if desired. Thus, the anchor could expand after emerging from the passages 40j and 246. This could be accomplished by having spring biased arms held in a retracted position by engagement of spring biased arms with the inner side surface of the tubular cylindrical member 240 which lines the passage 40j. Upon emerging from the passages 40j and 246, the arms would move outward under the influence of spring forces and extend radially outward beyond the edge of the exit from the passage 40j. If desired, the anchor 50j could be constructed so as to expand in a manner similar to that disclosed in U.S. Pat. No. 5,397,331 and/or U.S. Pat. No. 4,409,974.


Rather than expanding under the influence of stored energy, such as spring force, the anchor 50j could expand by absorbing body fluids. Thus, the anchor 50j may be compressed when it moves through the passages 40j and 246 and will expand and absorb body fluids after emerging from the passages 40j and 246. It is contemplated that the anchor 50j could be constructed so as to expand in any one of the ways disclosed in U.S. patent application Ser. No. 08/699,553 filed Aug. 19, 1996 by Peter M. Bonutti and entitled “Suture Anchor”.


Once the anchor 50j has been moved through the passage 246, the passage is packed with bone particles and/or bone graft. The bone particles and/or bone graft contains bone growth inducing materials. In addition, the bone particles and/or bone graft may contain medicinal substances along with osteoinductive protein.


The limbs 72j and 74j of the suture 38j are then threaded through openings 64j and 66j in the second suture anchor 52j. The limbs 72j and 74j of the suture 38j are tensioned and the second anchor 52j is pressed against the outer side surface 250 of the bone 20j. While a predetermined tension force is maintained in the limbs 72j and 74j of the suture 38j, the knot 78j is tied in the suture to interconnect the two suture anchors 50j and 52j with the suture 38j. The suture 38j is then trimmed to the desired length.


Once the knot 78j has been tied between the limbs 72j and 74j of the suture 38j, the tension in the suture 38j presses the side surfaces 28j and 30 of the fracture 26j together. This pressure between the side surfaces 28 and 30j of the fracture 26j is maintained by the suture 38 and suture anchors 50j and 52j until the fracture heals. It is believed that it may be preferred to form the suture 38j and suture anchors 50j and 52j of a biodegradable material which, after the fracture 26j has healed, will dissolve in the patient's body.


The cylindrical tubular member 240 which is inserted into the passage 40j through the bone 20j performs the dual functions of lining the inside of the passage 40j and maintaining the two sections 22j and 24j of the bone in alignment. The cylindrical tubular member 240 could have a slot formed in a side wall of the tubular member to facilitate insertion of the tubular member into the passage 40j. It is contemplated that the cylindrical tubular member 240 could be left in the passage 40j after the bone securing assembly 32j has been installed. If the slotted or unslotted cylindrical tubular member 240 is to be left in the passage 40j, the cylindrical tubular member 240 may be formed of a biodegradable or bioerodible copolymer. When the cylindrical tubular member remains in the passage 40j, the suture 38j extends through the tubular member.


Although only a knot 78j has been shown in FIG. 13 adjacent to the second anchor 52j, a suture retainer could be provided to further hold the limbs 72j and 74j of the suture 38j. If a suture retainer is to be used in association with the knot 78j, the suture retainer will be moved along the limbs of the suture 38j toward the knot before the limbs 72j and 74j of the suture are trimmed to the short length shown in FIG. 13. The suture retainer would then be plastically deformed to grip the limbs 72j and 74j of the suture 38j. Thereafter, the suture limbs 72j and 74j would be trimmed to a desired length.


Although it is preferred to use a suture as the force transmitting member 38j, it should be understood that the anchors 50j and 52j could be interconnected by other force transmitting members, such as a rod formed of bone. Although the anchors 50j and 52j have constructions which enable them to be used with a suture, the anchors could be constructed so as to be used with other types of force transmitting members. For example, the anchors 50j and 52j could have thread convolutions to engage thread convolutions on a force transmitting member formed by a rod.


In the embodiment of the invention illustrated in FIG. 13, the member 240 is tubular. However, it is contemplated that a solid member could be used to transmit force to bone on opposite sides of the fracture 26j. Thus, the member 240 could be a solid cylindrical member formed of bone. The cylindrical member may be formed of freeze dried bone.


When the member 240 is a solid member, the suture or other force transmitting member 38j is eliminated. The solid member formed of bone becomes the force transmitting member. Anchors, corresponding to the anchors 50j and 52j, are connected to opposite ends of the solid member 240 formed of bone. The anchors may have internal thread convolutions which engage external thread convolutions on the solid member 240 formed of bone. Of course, other known connectors could be utilized to connect anchors with opposite ends of the solid member 240 formed of bone.


Nonlinear Suture Passage—Tubular Member


In the embodiment of the invention illustrated in FIG. 13, the passage 40j through which the suture 38j extends has a linear configuration. In the embodiment of the invention illustrated in FIG. 14, the passage through which the suture extends has a nonlinear configuration. Since the embodiment of the invention illustrated in FIG. 14 is generally similar to the embodiment of the invention illustrated in FIGS. 1-13, similar numerals will be utilized to identify similar components, the suffix letter “k” being associated with the components of the embodiment of the invention illustrated in FIG. 14 to avoid confusion.


A bone 20k as a fracture 26k which divides the bone into two sections 22k and 24k. Opposite side surfaces 28k and 30k of the fracture 26k are pressed together by a bone suture assembly 32k. The bone suture assembly 32k includes a suture 38k which extends between first and second suture anchors 50k and 52k.


The suture 38k is disposed in a passage 40k having a nonlinear configuration. Thus, the passage 40k includes a first section 140k which is skewed relative to a second section 142k of the passage 40k. A bend 144k is formed in the passage 40k at an intersection 146k of the first and second sections 140k and 142k of the passage 40k. The flexible suture 38k extends around the bend 144k along a nonlinear path between the suture anchors 50k and 52k. At the bend 144k, the suture 38k applies force against the section 24k of the bone 20k urging the section 24k toward the left (as viewed in FIG. 5). This force presses the sections 22k and 24k of the bone 20k firmly together at the fracture 26k.


The suture anchors 50k and 52k have the same cylindrical construction as the suture anchors 50, 52, 50j and 52j in the embodiment of the invention illustrated in FIGS. 2 and 13. A knot 78k (FIG. 14) is provided between limbs of the suture 38k to maintain a desired tension in the suture 38k. This tension pulls the suture anchors 50k and 52k toward each other. In addition, this tension presses the section 24k of the bone 20k firmly against the section 22k of the bone at the fracture 26k.


The first section 140k of the passage 40k is formed at an angle to and extends through a longitudinal central axis of the generally cylindrical bone 20k. The second section 142k of the passage 40k is formed in a direction perpendicular, i.e., along a radius, of the generally cylindrical bone 20k. The two sections 140k and 142k of the passage 40k terminate in the spongy cancellous bone tissue 44k.


When the suture assembly 32k is to be used to treat the fracture 26k in the bone 20k, the two sections 22k and 24k of the bone are pressed together at the fracture 26k to align the side surfaces 28k and 30k of the fracture. A drill or other hole forming apparatus is then used to form the first section 140k of the passage 40k. The drill or other hole forming apparatus is then used to form the second section 142k of the passage 40k. When the second section 142k of the passage 40k intersects the first section 140k of the passage 40k, formation of the section 142k of the passage 40k is interrupted.


Once the nonlinear passage 40k has been formed in the two sections 22k and 24k of the bone 20k, a tubular cylindrical liner 240k is inserted into the passage 40k. The tubular cylindrical liner 240k is formed by two separate cylindrical tubular members 252 and 254 which are inserted at opposite ends of the passage 40k. Alternatively, the tubular cylindrical liner 240k may be formed by a single flexible tubular member which is inserted into the section 140k of the passage 40k and then moved around the bend 144k into the section 142k of the passage 40k.


It is believed that it may be preferred to form the tubular members 252 and 254 of bone. The bone forming the tubular members 252 and 254 may be either human or animal bone. The tubular members 252 and 254 may be formed of freeze dried human bone.


The leading end 242k of the tubular member 252 is disposed in the compact outer layer 42k of the bone 20k. Similarly, the trailing end 244k of the tubular member 254 is disposed in the compact outer layer 42k of the bone 20k. The tubular member 252 extends across the fracture 26k and stabilizes the two sections 22k and 24k of the bone 20k. Since the end portions 242k and 244k of the tubular members 252 and 254 are disposed in the compact outer layer 42k of the bone 20k, the tubular members are solidly supported and hold the two sections 22k and 24k of the bone 20k in alignment at the fracture 26k.


The opposite ends 242k and 244k of the tubular members 252 and 254 are axially spaced from a generally cylindrical outer side surface 250k on the bone 20k. This enables the anchors 50k and 52k to be pressed against the outer side surface 250k of the bone 20k. Therefore, tension forces in the suture 38k are transmitted through the anchors 50k and 52k to the bone 20k.


The cylindrical anchor 50k, with the suture 38k connected thereto, is then positioned in axial alignment with the section 142k of the passage 40k. The leading end 58k of the anchor 50k is then moved into the section 142k of the passage 40k lined by the tubular member 254. A flexible pusher member applies force against the trailing end 60k of the anchor 50k and pushes the anchor around the bend 144k and through the section 140k of the passage 40k lined by the tubular member 252.


Alternatively, a flexible wire or other member could be inserted into the section 140k of the passage 40k. The wire would move around the bend 144k and extend outward from the section 142k of the passage. The wire would then be connected with the anchor 50k and suture 38k. The leading end 58k of the anchor 50k would then be inserted into the section 142k of the passage 40k. Tension on the wire would pull the anchor 50k around the bend 144k and out of the section 140k of the passage 40k.


The passages in the tubular members 252 and 254 may be packed with bone particles and/or bone graft. Bone osteoinductive protein (BMP) may be provided in the tubular members. Antibiotics and/or other medicants may be included along with collagen.


The suture 38k is then threaded through openings in the suture anchor 52k. The suture 38k is then tensioned and the second anchor 52k is pressed against the outer side surface of the bone 20k. While a predetermined tension force is maintained in the suture 38k, the knot 78k is tied.


In the illustrated embodiment of the invention, the two sections 140k and 142k of the passage 40k have a straight cylindrical configuration. However, it is contemplated that the sections 140k and 142k of the passage 40k could have a different configuration if desired. For example, the section 140k and/or 142k of the passage 40k could have a nonlinear central axis and could have a noncircular cross-sectional configuration of desired.


Body tissue, corresponding to the body tissue 132 of FIG. 4 could be disposed between the anchor 50k and/or 52k and the bone 20k. Although the suture 38k has been illustrated as having a pair of limbs or sections which extend between the anchors 50k and 52k, the suture 38k could have a single limb or section if desired. The anchor 50c could mechanically expand, by absorbing body liquid or under the influence of expansion springs, after the anchor has emerged from the passage 40k to prevent the anchor from being pulled back through the passage.


Retainer and Tubular Member


In the embodiment of the invention illustrated in FIG. 13, a pair of suture anchors 50j and 52j are connected with the suture 38j to maintain tension in the suture and pressure against opposite side surfaces 28j and 30j of the fracture 26j. In the embodiment of the invention illustrated in FIG. 15, a suture retainer is used in place of one of the suture anchors. Since the embodiment of the invention illustrated in FIG. 15 is generally similar to the embodiment of the invention illustrated in FIG. 13, similar numerals will be utilized to designate similar components, the suffix letter “m” being associated with the embodiment of the invention illustrated in FIG. 15 to avoid confusion.


A bone 20m has sections 22m and 24m which are separated by a fracture 26m. The fracture 26m has side surfaces 28m and 30m which are pressed together by a bone suture assembly 32m. A suture 38m extends through a cylindrical passage 40m which extends diametrically through the generally cylindrical bone 20m. The suture 38m has a pair of limbs or sections 72m and 74m which are connected with a suture anchor 50m. The suture anchor 50m has the same construction as the suture anchor 50 of FIG. 2.


Once the passage 40 has been formed in the two tubular sections 22m and 24m of the bone 20m, a tubular cylindrical member 240m is installed into the passage 40m and extends diametrically through the bone 20m. The leading end 242m of the cylindrical member 240m is aligned with a circular outlet 84m from the passage 40m. The opposite or trailing end 244m of the tubular member 240m is aligned with a circular inlet 86m to the passage 40m.


The tubular member 240m has a thin cylindrical wall which engages the sections 22m and 24m of the bone 20m. A cylindrical inner side surface of the tubular member 240m defines a cylindrical passage 246m having a diameter which is only slightly less than the diameter of the passage 40m. The tubular member 240m is formed of bone. Alternatively, the tubular member 240m could be formed of a biodegradable material.


The leading end 242m of the tubular member 240m is disposed in the compact outer layer 42m of the bone 20m. Similarly, the trailing end 244m of the tubular member 240m is disposed in the compact outer layer 42m of the bone 20m. The tubular member 240m extends across the fracture 26m and stabilizes the two sections 22m and 24m of the bone 20m. Since the opposite end portions of the tubular member 240m are disposed in the compact outer layer 42m of the bone 20m, the tubular member is solidly supported and holds the two sections 22m and 24m of the bone 20m in alignment at the fracture 26m.


The opposite ends 242m and 244m of the tubular member 240m are axially spaced from a generally cylindrical outer side surface 250m on the bone 20m. This enables the anchors 50m and 92m to be pressed against the outer side surface 250m of the bone 20m. Therefore, tension forces in the suture 38m are transmitted through the anchors 50m and 92m to the bone 20m.


The tubular member 240m is formed of freeze dried human bone. The tubular member 240m is packed with bone and/or bone graft. The tubular member 240m also contains bone osteoinductive protein (BMP). Suitable medicants may be provided in the tubular member 240m.


A suture retainer 92m is used in place of the suture anchor 52 of FIG. 2. The suture retainer 92m (FIG. 15) has a spherical configuration. A cylindrical passage 94m extends through the center of the spherical suture retainer 92m. The sections 72m and 74m of the suture 38m extend around the spherical outer side surface of the suture retainer 92m. Thus, a loop is formed in each of the sections 72m and 74m around portions of the suture retainer 92m.


If desired, the suture retainer 92m could have a different configuration. For example, the suture retainer 92m could have an oval or elliptical configuration. Although the passage 94m has a linear central axis, the passage could have a nonlinear central axis. If desired, a plurality of passages having the same or different configurations could be provided in the suture retainer 92m.


After the suture 38m has been inserted through the suture retainer 92m, the suture retainer 92m is moved along the sections 72m and 74m of the suture 38m toward the bone 20m. The suture retainer 92m is formed as one piece of a polymeric material having a relatively low coefficient friction. Therefore, the two sections 72m and 74m of the suture 30m can readily slide along the surfaces of the suture retainer 52m while the suture retainer moves toward the bone 20m.


A predetermined tension is maintained in the sections 72m and 74m of the suture 38m while the suture retainer 92m is pressed against the bone 20m. This results in the suture 38m being pulled tightly against the suture anchor 50m. The tension in the suture 38m is effective to press the suture anchor 50m and retainer 92m against opposite sides of the bone 20m with a predetermined force.


While the sections 72m and 74m of the suture 38m are being tensioned with a predetermined force, the suture retainer 92m is plastically deformed in the same manner as previously described in conjunction with the embodiment of the invention illustrated in FIG. 3. To plastically deform the suture retainer 92m, a plurality of force applying or clamp members are pressed against the suture retainer with a predetermined minimum force. The force applied against the suture retainer 92m by the force applying members is sufficient to cause plastic deformation of the material of the suture retainer.


The force is applied against the suture retainer 92m while the suture retainer is at a temperature which is below the transition temperature of the biodegradable polymer which forms the suture retainer 92m. Thus, the suture retainer 92m is at approximately the same temperature as the bone 20m when the force is applied against the suture retainer. The force causes the material of the suture retainer 92m to flow and grip the sections 72m and 74m of the suture 38m.


The suture retainer 92m may be formed of many different materials. However, it is believed that it will be preferred to form the suture retainer 92m of a biodegradable polymer. One biodegradable polymer which may be utilized is polycaperlactone. Alternatively, the suture retainer 92m could be formed of polyethylene oxide terephthalate or polybutylene terephthalate. It is also contemplated that other biodegradable or bioerodible copolymers could be utilized.


Although it is preferred to form the suture retainer 92m of a biodegradable material, the suture retainer could be formed of a material which is not biodegradable. For example, the suture retainer 92m could be formed of an acetyl resin, such as “DELRIN” (trademark). Alternatively, the suture retainer 92m could be formed of para-dimethylamino-benzenediaz-o sodium sulfonate, such as “DEXON” (trademark). The construction of the suture retainer 92m and the manner in which is cooperates with the suture 38m is the same as is disclosed in U.S. patent application Ser. No. 08/905,084 filed Aug. 1, 1997 by Peter M. Bonutti et al. and entitled “Method and Apparatus for Securing a Suture”.


The suture retainer 92m is plastically deformed to grip the limbs 72m and 74m of the suture 38m. However, the suture retainer 92m could be constructed so as to be mechanically actuated to grip the suture 38m. If desired, a combination of a mechanical gripping action and plastic deformation could be utilized by a retainer to grip the suture 38m.


CONCLUSION

In view of the foregoing description, it is apparent that the present invention relates to a method of securing sections 22 and 24 of a fractured bone 20. Sections 22 and 24 of a fractured bone 20 are held against movement relative to each other by a force transmitting member, such as a suture 38, which extends through a passage 40 in the bone. The passage 40 in the bone may have a linear or nonlinear configuration. Tension is maintained in the force transmitting member 38 to press surfaces 28 and 30 on the fracture together by securing anchors 50 and 52 or suture retainers 92 to opposite ends of the force transmitting member 38. It is believed that a suture 38 may advantageously be used as the force transmitting member.


A tubular member 240 is positioned in a linear passage (FIGS. 13 and 15) or a nonlinear passage (FIG. 14) through the bone 20. The tubular member 240 extends into portions of the passage 40 on opposite sides of the fracture 26. End portions of the tubular member may be positioned in a compact outer layer 42 of the bone. The tubular member 240 may be formed of bone. The force transmitting member 38 may be formed of bone or other body tissue.

Claims
  • 1. A fixation system for securing a portion of a body of a patient, the body portion including an anchor-receiving hole extending between a first surface and a second surface of the body portion, the anchor-receiving hole including a first entrance in the first surface of the body portion and a second entrance in the second surface of the body portion, the system comprising: a plate having a bone contacting surface, a second surface opposite the bone contacting surface, and an opening extending between the bone contacting surface and the second surface of the plate, the opening having a central longitudinal axis and a maximum dimension transverse the central longitudinal axis of the opening, the plate being configured to be attached to the body portion with at least one fastener, the bone contacting surface, when the plate is attached to the body portion, being configured to contact the first surface of the body portion such that the opening is aligned with the first entrance of the anchor-receiving hole in the body portion;an anchor having a first end, a second end, and a length therebetween, the anchor having a width transverse to the length, the anchor having a depth transverse to the width and the length, the length of the anchor being greater than the width of the anchor and greater than the maximum dimension of the opening of the plate, the width and the depth of the anchor being less than the maximum dimension of the opening of the plate thereby permitting the anchor to pass through the opening of the plate and into the anchor-receiving hole in the body portion, the anchor having at least one passage extending therethrough, the at least one passage having a central longitudinal axis transverse to the length of the anchor;a securing member having a maximum dimension greater than the maximum dimension of the opening of the plate, the securing member having at least two apertures extending therethrough, the apertures each having a central longitudinal axis transverse to the maximum dimension of the securing member, the securing member being configured to be positioned adjacent to and extend across the opening of the plate; andan elongate member configured to be positioned through the anchor-receiving hole of the body portion, the at least one passage of the anchor, and the at least two apertures of the securing member to connect the anchor and the securing member.
  • 2. The system of claim 1, further including a second plate positioned proximate the second surface of the body portion, wherein the elongate member is positioned through the second plate.
  • 3. The system of claim 1, wherein the body portion includes bone.
  • 4. The system of claim 1, wherein the plate is configured to be positioned between the securing member and the body portion.
  • 5. The system of claim 1, wherein the elongate member comprises a polymeric material.
  • 6. The system of claim 1, wherein the anchor comprises one of stainless steel and titanium.
  • 7. The system of claim 1, wherein the securing member comprises one of stainless steel and titanium.
  • 8. The system of claim 1, wherein the anchor is configured to be positioned adjacent to and extend across the second entrance of the anchor-receiving hole.
  • 9. The system of claim 8, wherein tension in the elongate member serves in securing the position of the body portion between the anchor and the securing member.
  • 10. The system of claim 8, wherein the at least one passage of the anchor includes a first passage and a second passage, and the elongate member is positioned through the first passage and the second passage.
  • 11. The system of claim 8, wherein the anchor has a first surface and an opposite second surface, and the at least one passage extends between the first and second surfaces, the first surface of the anchor being configured to contact the second surface of the body portion.
  • 12. The system of claim 11, wherein the second surface of the anchor is disposed at least in part in a first plane, the first plane, when the first surface of the anchor is contacted to the second surface of the body portion, being transverse to a central longitudinal axis of the anchor-receiving hole.
  • 13. The system of claim 8, wherein the body portion is two bone pieces, the anchor-receiving hole extends through each of the two bone pieces, and the elongate member is configured to be tensioned with respect to the anchor and the securing member to clamp the two bone pieces in position with respect to one another.
  • 14. The system of claim 8, wherein the elongated member is a suture.
  • 15. The system of claim 14, wherein the suture is configured to be tensioned with respect to the anchor and the securing member, tension in the elongate member clamping the body portion and the plate between the anchor and the securing member.
  • 16. A fixation system for securing a portion of a body of a patient, the body portion having an anchor-receiving hole extending from a first surface to a second surface of the body portion, the anchor-receiving hole having a first entrance in the first surface of the body portion and a second entrance in the second surface of the body portion, and the anchor-receiving hole having a central longitudinal axis and a maximum dimension transverse to the central longitudinal axis thereof, the system comprising: a plate having a bone contacting surface, a second surface opposite the bone contacting surface, and an opening extending from the bone contacting surface to the second surface, the bone contacting surface being disposed at least in part in a first plane, the opening having a central longitudinal axis that is transverse to the first plane, the opening having a maximum dimension that is transverse to the central longitudinal axis of the opening, the bone contacting surface, when the plate is attached to the body portion, being configured to contact the first surface of the body portion such that the opening is aligned with the first entrance of the anchor-receiving hole in the body portion;an anchor being configured to be positioned adjacent to and extend across the second entrance to the anchor-receiving hole, the anchor having a first end, a second end, a length between the first and second ends, a width transverse to and being less than the length, and a depth transverse to and being less than the width and the length, the length of the anchor being greater than the maximum dimension of the anchor-receiving hole and the maximum dimension of the opening of the plate, the width and the depth of the anchor being less than the maximum dimension of the anchor-receiving hole and the maximum dimension of the opening of the plate such that the anchor can pass through the opening of the plate and the anchor-receiving hole in the body portion, the anchor having at least one passage therethrough, the passage having a central longitudinal axis transverse to the length of the anchor;a securing member configured to be positioned adjacent to and across the opening of the plate, the securing member having a maximum dimension greater than the maximum dimension of the opening of the plate, the securing member having at least two apertures extending therethrough, the apertures each having a central longitudinal axis transverse to the maximum dimension of the securing member; andan elongate member configured to extend through the anchor-receiving hole and be positioned through the at least one passage of the anchor and the at least two apertures of the securing member to connect the anchor and the securing member to one another.
  • 17. The system of claim 16, wherein the anchor has a first surface and an opposite second surface, and the at least one passage extends between the first and second surfaces, the first surface of the anchor being configured to contact the second surface of the body portion.
  • 18. The system of claim 17, wherein the second surface of the anchor is disposed at least in part in a first plane, the first plane, when the first surface of the anchor is contacted to the second surface of the body portion, being transverse to a central longitudinal axis of the anchor-receiving hole.
  • 19. The system of claim 16, wherein the body portion is two bone pieces, the anchor-receiving hole extends through each of the two bone pieces, and the elongate member is configured to be tensioned with respect to the anchor and the securing member to clamp the two bone pieces in position with respect to one another.
  • 20. The system of claim 16, wherein the elongated member is a suture, the suture being configured to be tensioned with respect to the anchor and the securing member, tension in the elongate member clamping the body portion and the plate between the anchor and the securing member.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/359,364 filed Jan. 26, 2009, now U.S. Pat. No. 8,147,514. The aforementioned application Ser. No. 12/359,364 is itself a continuation of U.S. patent application Ser. No. 10/685,117 filed Oct. 14, 2003, now U.S. Pat. No. 7,481,825. The aforementioned application Ser. No. 10/685,117 is itself a continuation of U.S. patent application Ser. No. 09/835,473 filed Apr. 16, 2001, now U.S. Pat. No. 6,638,279. The aforementioned application Ser. No. 09/835,473 is itself a continuation of U.S. patent application Ser. No. 09/532,942 filed Mar. 22, 2000, now U.S. Pat. No. 6,238,395. The aforementioned application Ser. No. 09/532,942 is itself a continuation of U.S. patent application Ser. No. 09/363,707 filed Jul. 29, 1999, now U.S. Pat. No. 6,045,551. The aforementioned application Ser. No. 09/363,707 is itself a continuation-in-part of U.S. patent application Ser. No. 09/323,488 filed Jun. 1, 1999, now U.S. Pat. No. 6,117,160. The aforementioned application Ser. No. 09/323,488 is itself a continuation of U.S. patent application Ser. No. 09/019,977 filed Feb. 6, 1998, now U.S. Pat. No. 5,921,986. The benefit of the earlier filing dates of the aforementioned applications and patents is claimed.

US Referenced Citations (1501)
Number Name Date Kind
157343 Molesworth Dec 1874 A
319296 Molesworth Jun 1885 A
668878 Jensen Feb 1901 A
668879 Miller Feb 1901 A
673783 Peters May 1901 A
702789 Gibson Jun 1902 A
832201 Kistler Oct 1906 A
862712 Collins Aug 1907 A
1213005 Pillsbury Jan 1917 A
1433031 Henri Oct 1922 A
1725670 Novack Aug 1929 A
1863057 Innes Jun 1932 A
1870942 Beatty Aug 1932 A
2121193 Hanicke Dec 1932 A
1909967 Jones May 1933 A
1959615 Derrah May 1934 A
2187852 Friddle Aug 1936 A
2178840 Lorenian Nov 1939 A
2199025 Conn Apr 1940 A
2235419 Callahan Mar 1941 A
2248054 Becker Jul 1941 A
2270188 Longfellow Jan 1942 A
2433815 Nicephore et al. Dec 1947 A
2518276 Braward Aug 1950 A
2526662 Hipps et al. Oct 1950 A
2557669 Lloyd Jun 1951 A
2566499 Richter Sep 1951 A
2589720 McMath Mar 1952 A
2621145 Sano Dec 1952 A
2621653 Briggs Dec 1952 A
2642874 Keeling Jun 1953 A
2687719 Hoyt Aug 1954 A
2701559 Cooper Feb 1955 A
2724326 Long Nov 1955 A
2725053 Bambara Nov 1955 A
2830587 Everett Apr 1958 A
2854983 Baskin Oct 1958 A
2936760 Gants May 1960 A
2955530 Nilo Oct 1960 A
3039468 Price Jun 1962 A
3048522 Velley Aug 1962 A
3081773 Boyd Mar 1963 A
3108357 Liebig Oct 1963 A
3108595 Overment Oct 1963 A
3367809 Soloff May 1964 A
3204635 Voss et al. Sep 1965 A
3229006 Nohl Jan 1966 A
3253594 Matthews et al. May 1966 A
3347234 Voss Oct 1967 A
3391690 Armao Jul 1968 A
3397699 Kohl Aug 1968 A
3417745 Emanuel Dec 1968 A
3459175 Miller Aug 1969 A
3469003 Hardy Sep 1969 A
3477429 Sampson Nov 1969 A
3495586 Regenbogen Feb 1970 A
3513848 Winston et al. May 1970 A
3514791 Sparks Jun 1970 A
3517128 Hines Jun 1970 A
3518993 Blake Jul 1970 A
3554192 Isberner Jan 1971 A
3557794 Patten Jan 1971 A
3577991 Wilkinson May 1971 A
3593709 Halloran Jul 1971 A
3596292 Erb et al. Aug 1971 A
3608539 Miller Sep 1971 A
3613497 Heldermann Oct 1971 A
3620218 Schmitt et al. Nov 1971 A
3624747 McKnight et al. Nov 1971 A
3625220 Engelsher Dec 1971 A
3626949 Shute Dec 1971 A
3635223 Klieman Jan 1972 A
3648705 Lary Mar 1972 A
3653388 Tenckhoff Apr 1972 A
3656476 Swinney Apr 1972 A
3657056 Winston et al. Apr 1972 A
3670732 Robinson Jun 1972 A
3678980 Gutshall Jul 1972 A
3698017 Scales et al. Oct 1972 A
3709218 Halloran Jan 1973 A
3711347 Wagner et al. Jan 1973 A
3716051 Fischer Feb 1973 A
3721244 Elmaleh Mar 1973 A
3739773 Schmitt et al. Jun 1973 A
3750652 Sherwin Aug 1973 A
3760808 Bleuer Sep 1973 A
3769980 Karman Nov 1973 A
3774244 Walker Nov 1973 A
3774596 Cook Nov 1973 A
3779239 Fischer et al. Dec 1973 A
3788318 Kim et al. Jan 1974 A
3789852 Kim et al. Feb 1974 A
3800788 White Apr 1974 A
3802438 Wolvek Apr 1974 A
3804089 Bridgman Apr 1974 A
3807393 McDonald Apr 1974 A
3807394 Attenborough Apr 1974 A
3809075 Matles May 1974 A
3811449 Gravlee et al. May 1974 A
3812855 Banko May 1974 A
3825010 McDonald Jul 1974 A
3833003 Taricco Sep 1974 A
3835849 McGuire Sep 1974 A
3841304 Jones Oct 1974 A
3842824 Neufeld Oct 1974 A
3845772 Smith Nov 1974 A
3850172 Cazalis Nov 1974 A
3850720 Collins Nov 1974 A
3852830 Marmor Dec 1974 A
3857396 Hardwick Dec 1974 A
3863639 Kleaveland Feb 1975 A
3867932 Huene Feb 1975 A
3869731 Waugh et al. Mar 1975 A
3874264 Polos Apr 1975 A
3875652 Arnold Apr 1975 A
3875946 Duncan Apr 1975 A
3882852 Sinnreich May 1975 A
3889686 Duturbure et al. Jun 1975 A
3894530 Dardik et al. Jul 1975 A
3898992 Balamuth Aug 1975 A
3903549 Deyerle Sep 1975 A
3911923 Yoon Oct 1975 A
3915171 Shermeta Oct 1975 A
3918442 Nikolaev et al. Nov 1975 A
3920022 Pastor Nov 1975 A
3939835 Bridgman Feb 1976 A
3945375 Banko Mar 1976 A
3960143 Terada Jun 1976 A
3961632 Moossun Jun 1976 A
3967625 Yoon Jul 1976 A
3968800 Vilasi Jul 1976 A
3970089 Saice Jul 1976 A
3973277 Semple et al. Aug 1976 A
3976079 Samuels et al. Aug 1976 A
3989049 Yoon Nov 1976 A
3991426 Flom et al. Nov 1976 A
3994287 Turp et al. Nov 1976 A
4000525 Klawitter et al. Jan 1977 A
4022216 Stevens May 1977 A
4023559 Gaskell May 1977 A
4040413 Ohshiro Aug 1977 A
4053953 Flom et al. Oct 1977 A
4055862 Farling Nov 1977 A
4064566 Fletcher et al. Dec 1977 A
4077412 Moossun Mar 1978 A
4081866 Upshaw et al. Apr 1978 A
4083369 Sinnreich Apr 1978 A
4085466 Goodfellow et al. Apr 1978 A
4085743 Yoon Apr 1978 A
4089071 Kainberz et al. May 1978 A
4092113 Hardy May 1978 A
4103680 Yoon Aug 1978 A
RE29757 Helfet Sep 1978 E
4122605 Hirabayashi et al. Oct 1978 A
4142517 Contreras et al. Mar 1979 A
4148307 Utsugi Apr 1979 A
4156574 Boden May 1979 A
4164794 Spector et al. Aug 1979 A
4169470 Ender et al. Oct 1979 A
4171544 Hench et al. Oct 1979 A
4177814 Knepshield et al. Dec 1979 A
4183102 Guiset Jan 1980 A
4186448 Brekke Feb 1980 A
4191747 Scheicher Mar 1980 A
4198981 Sinnreich Apr 1980 A
4199864 Ashman Apr 1980 A
4200939 Oser May 1980 A
4203444 Bonnell et al. May 1980 A
4209012 Smucker Jun 1980 A
4209861 Brozone et al. Jul 1980 A
4210148 Stivala Jul 1980 A
4210580 Amrani Jul 1980 A
4213209 Insall et al. Jul 1980 A
4213816 Morris Jul 1980 A
4224696 Murray et al. Sep 1980 A
4224929 Furihata Sep 1980 A
4228802 Trott Oct 1980 A
4230119 Blum Oct 1980 A
4235233 Mouwen Nov 1980 A
4235238 Ogiu et al. Nov 1980 A
4240433 Bordow Dec 1980 A
4243048 Griffin Jan 1981 A
4244370 Furlow et al. Jan 1981 A
4257411 Cho Mar 1981 A
4263900 Nicholson Apr 1981 A
4265231 Scheller, Jr. et al. May 1981 A
4265848 Ruesch May 1981 A
4274414 Johnson et al. Jun 1981 A
4281649 Derweduwen Aug 1981 A
4291698 Fuchs Sep 1981 A
4295464 Shihata Oct 1981 A
4298002 Ronel et al. Nov 1981 A
4298992 Burstein et al. Nov 1981 A
4298998 Naficy Nov 1981 A
4299224 Noiles Nov 1981 A
4299227 Lincoff Nov 1981 A
4304178 Haeberle Dec 1981 A
4309488 Heide et al. Jan 1982 A
4311145 Esty et al. Jan 1982 A
4312353 Shahbabian Jan 1982 A
4320762 Bentov Mar 1982 A
4344193 Kenny Aug 1982 A
4349029 Mott Sep 1982 A
4349921 Kuntz Sep 1982 A
4351069 Ballintyn et al. Sep 1982 A
4352883 Lim Oct 1982 A
4357940 Muller Nov 1982 A
4364381 Sher et al. Dec 1982 A
4365356 Broemer et al. Dec 1982 A
4369768 Vukovic Jan 1983 A
4373217 Draenert Feb 1983 A
4373709 Whitt Feb 1983 A
4374523 Yoon Feb 1983 A
4385404 Sully et al. May 1983 A
4388921 Sutter et al. Jun 1983 A
4391909 Lim Jul 1983 A
4395798 McVey Aug 1983 A
4400833 Kurland Aug 1983 A
4407273 Ouchi Oct 1983 A
4409974 Freedland Oct 1983 A
4414166 Charlson et al. Nov 1983 A
4421112 Mains et al. Dec 1983 A
4430760 Smestad Feb 1984 A
4434797 Silander Mar 1984 A
4437191 Van der Zet et al. Mar 1984 A
4437362 Hurst Mar 1984 A
4442655 Stroetmann et al. Apr 1984 A
4444180 Schneider et al. Apr 1984 A
4445509 Auth May 1984 A
4447227 Kotsanis May 1984 A
4448194 DiGiovanni et al. May 1984 A
4450591 Rappaport May 1984 A
4453421 Umano Jun 1984 A
4453539 Raftopoulos et al. Jun 1984 A
4456005 Lichty Jun 1984 A
4457302 Caspari et al. Jul 1984 A
4461281 Carson Jul 1984 A
4466429 Loscher et al. Aug 1984 A
4466888 Verkaart Aug 1984 A
4472840 Jefferies Sep 1984 A
4474177 Whiteside Oct 1984 A
4484579 Meno et al. Nov 1984 A
4485096 Bell Nov 1984 A
4487203 Androphy Dec 1984 A
4493317 Klaue Jan 1985 A
4495664 Blanquaert Jan 1985 A
4501031 McDaniel et al. Feb 1985 A
4501266 McDaniel Feb 1985 A
4501269 Bagby Feb 1985 A
4502159 Woodroof et al. Mar 1985 A
4502161 Wall Mar 1985 A
4504268 Herlitze Mar 1985 A
4505274 Speelman Mar 1985 A
4506681 Mundell Mar 1985 A
4509518 McGarry et al. Apr 1985 A
4514125 Stol Apr 1985 A
4516276 Mittelmeier et al. May 1985 A
4526173 Sheehan Jul 1985 A
4532926 O'Holla Aug 1985 A
4535757 Webster Aug 1985 A
4535772 Sheehan Aug 1985 A
4540404 Wolvek Sep 1985 A
4541423 Barber Sep 1985 A
4543375 Doebler et al. Sep 1985 A
4545374 Jacobson Oct 1985 A
4547327 Bruins et al. Oct 1985 A
4551135 Gorman et al. Nov 1985 A
4553272 Mears Nov 1985 A
4554686 Baker Nov 1985 A
4555242 Saudagar Nov 1985 A
4556059 Adamson, Jr. Dec 1985 A
4556350 Bernhardt et al. Dec 1985 A
4556391 Tardivel et al. Dec 1985 A
4562598 Kranz Jan 1986 A
4565192 Shapiro Jan 1986 A
4566138 Lewis et al. Jan 1986 A
4572186 Gould et al. Feb 1986 A
4573448 Kambin Mar 1986 A
4574794 Cooke et al. Mar 1986 A
4575371 Nordqvist et al. Mar 1986 A
4584722 Levy et al. Apr 1986 A
4585000 Hershenson Apr 1986 A
4589414 Yoshida et al. May 1986 A
4589686 McGrew May 1986 A
4589868 Dretler May 1986 A
4590928 Hunt et al. May 1986 A
4597379 Kihn et al. Jul 1986 A
4599085 Riess et al. Jul 1986 A
4601893 Cardinal Jul 1986 A
4603694 Wheeler Aug 1986 A
4606335 Wedeen Aug 1986 A
4608052 Van Kampen et al. Aug 1986 A
4608965 Anspach, Jr. et al. Sep 1986 A
4610662 Weikl et al. Sep 1986 A
4611593 Fogarty et al. Sep 1986 A
4615717 Neubauer et al. Oct 1986 A
4619391 Sharkany et al. Oct 1986 A
4621640 Mulhollan et al. Nov 1986 A
4623553 Ries et al. Nov 1986 A
4624254 McGarry et al. Nov 1986 A
4630609 Chin Dec 1986 A
4632101 Freedland Dec 1986 A
4641648 Shapiro Feb 1987 A
4642117 Nguyen et al. Feb 1987 A
4642120 Nevo et al. Feb 1987 A
4645503 Lin et al. Feb 1987 A
4646736 Auth Mar 1987 A
4646738 Trott Mar 1987 A
4649918 Pegg et al. Mar 1987 A
4651717 Jakubczak Mar 1987 A
4651752 Fuerst Mar 1987 A
4654464 Mittelmeier et al. Mar 1987 A
4657460 Bien Apr 1987 A
4657548 Nichols Apr 1987 A
4659268 Del Mundo et al. Apr 1987 A
4662063 Collins et al. May 1987 A
4662068 Polonsky May 1987 A
4662372 Sharkany et al. May 1987 A
4662887 Turner et al. May 1987 A
4669473 Richards et al. Jun 1987 A
4678470 Nashef et al. Jul 1987 A
4681106 Kensey et al. Jul 1987 A
4681107 Kees, Jr. Jul 1987 A
4682598 Beraha Jul 1987 A
4685458 Leckrone Aug 1987 A
4685460 Thornton Aug 1987 A
4691741 Affa et al. Sep 1987 A
4696667 Masch Sep 1987 A
4705040 Mueller et al. Nov 1987 A
4706659 Matthews et al. Nov 1987 A
4706670 Andersen et al. Nov 1987 A
4708139 Dunbar, IV Nov 1987 A
4711233 Brown Dec 1987 A
4712542 Daniel et al. Dec 1987 A
4713076 Draenert Dec 1987 A
4713077 Small Dec 1987 A
4714074 Rey et al. Dec 1987 A
4716893 Fischer et al. Jan 1988 A
4716901 Jackson et al. Jan 1988 A
4718909 Brown Jan 1988 A
4718916 Morscher Jan 1988 A
4719908 Averill et al. Jan 1988 A
4721096 Naughton et al. Jan 1988 A
4721103 Freedland Jan 1988 A
4721104 Kaufman et al. Jan 1988 A
4722331 Fox Feb 1988 A
4722948 Sanderson Feb 1988 A
4724584 Kasai Feb 1988 A
4738255 Goble et al. Apr 1988 A
4739751 Sapega et al. Apr 1988 A
4741330 Hayhurst May 1988 A
4743229 Chu May 1988 A
4743259 Bolander et al. May 1988 A
4744364 Kensey May 1988 A
4747405 Leckrone May 1988 A
4749585 Greco et al. Jun 1988 A
4750488 Wuchinich et al. Jun 1988 A
4750492 Jacobs Jun 1988 A
4751922 Dipietropolo Jun 1988 A
4755184 Silverberg Jul 1988 A
4759350 Dunn et al. Jul 1988 A
4768507 Fischell Sep 1988 A
4772286 Goble et al. Sep 1988 A
4776328 Frey et al. Oct 1988 A
4776738 Winston Oct 1988 A
4776851 Bruchman et al. Oct 1988 A
4779611 Grooters et al. Oct 1988 A
4781182 Purnell et al. Nov 1988 A
4781681 Sharrow et al. Nov 1988 A
4781922 Bone Nov 1988 A
4784133 Mackin Nov 1988 A
4789663 Wallace et al. Dec 1988 A
4790303 Steffee Dec 1988 A
4790819 Li et al. Dec 1988 A
4792336 Hiavacek et al. Dec 1988 A
4793359 Sharrow Dec 1988 A
4794854 Swaim Jan 1989 A
4795467 Piez et al. Jan 1989 A
4796629 Grayzel Jan 1989 A
4798205 Bonomo et al. Jan 1989 A
4798213 Doppelt Jan 1989 A
4800901 Rosenberg Jan 1989 A
4801299 Brendel et al. Jan 1989 A
4802479 Haber et al. Feb 1989 A
4817591 Klause Apr 1989 A
4817602 Beraha Apr 1989 A
4822224 Carl et al. Apr 1989 A
4823794 Pierce Apr 1989 A
4825857 Kenna May 1989 A
4828563 Muller-Lierheim et al. May 1989 A
4832025 Coates May 1989 A
4832026 Jones May 1989 A
4832683 Idemoto et al. May 1989 A
4834752 Van Kampen May 1989 A
4834757 Brantigan May 1989 A
4841960 Garner Jun 1989 A
4842517 Kawahara et al. Jun 1989 A
4843112 Gerhart Jun 1989 A
4844064 Thimsen et al. Jul 1989 A
4846791 Hattler et al. Jul 1989 A
4846812 Walker et al. Jul 1989 A
4846835 Grande Jul 1989 A
4857045 Rydell Aug 1989 A
4861334 Nawaz Aug 1989 A
4862874 Kellner Sep 1989 A
4862882 Venturi et al. Sep 1989 A
4862974 Warren et al. Sep 1989 A
4863472 Tormala et al. Sep 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4869242 Galluzzo Sep 1989 A
4870957 Goble et al. Oct 1989 A
4875468 Krauter et al. Oct 1989 A
4877020 Vich Oct 1989 A
4880429 Stone Nov 1989 A
4883048 Purnell et al. Nov 1989 A
4883666 Sabel et al. Nov 1989 A
4888022 Huebsch Dec 1989 A
4890612 Kensey Jan 1990 A
4892552 Ainsworth et al. Jan 1990 A
4895148 Bays et al. Jan 1990 A
4898156 Gatturna et al. Feb 1990 A
4899729 Gill et al. Feb 1990 A
4899743 Nicholson et al. Feb 1990 A
4899744 Fujitsuka et al. Feb 1990 A
4901721 Hakki Feb 1990 A
4902296 Bolander et al. Feb 1990 A
4904259 Itay Feb 1990 A
4904261 Dove Feb 1990 A
4909789 Taguchi Mar 1990 A
4911721 Aendergaten et al. Mar 1990 A
4919667 Richmond Apr 1990 A
4921478 Solano et al. May 1990 A
4921479 Grayzel May 1990 A
4922897 Sapega et al. May 1990 A
4923464 DiPisa, Jr. May 1990 A
4924865 Bays et al. May 1990 A
4924866 Yoon May 1990 A
4927412 Menasche May 1990 A
4927421 Goble et al. May 1990 A
4932956 Reddy et al. Jun 1990 A
4932959 Horzewski et al. Jun 1990 A
4932960 Green et al. Jun 1990 A
4932973 Gendler Jun 1990 A
4935023 Whiteside et al. Jun 1990 A
4935028 Drews Jun 1990 A
4936848 Bagby Jun 1990 A
4936852 Kent et al. Jun 1990 A
4944760 Kenna Jul 1990 A
4945625 Winston Aug 1990 A
4945896 Gade Aug 1990 A
4946468 Li Aug 1990 A
4950296 McIntyre Aug 1990 A
4950298 Gustilo et al. Aug 1990 A
4952213 Bowman et al. Aug 1990 A
4954126 Wallsten Sep 1990 A
4955910 Bolesky Sep 1990 A
4957498 Caspari et al. Sep 1990 A
4961740 Ray et al. Oct 1990 A
4961741 Hayhurst Oct 1990 A
4961954 Goldberg et al. Oct 1990 A
4963151 Ducheyne et al. Oct 1990 A
4963489 Naughton et al. Oct 1990 A
4964862 Arms Oct 1990 A
4964865 Burkhead et al. Oct 1990 A
4966583 Debbas Oct 1990 A
4968298 Michelson Nov 1990 A
4968315 Gatturna Nov 1990 A
4969888 Scholten et al. Nov 1990 A
4969892 Burton et al. Nov 1990 A
4969895 McLeod et al. Nov 1990 A
4979949 Matsen, III et al. Dec 1990 A
4979957 Hodorek Dec 1990 A
4983179 Sjostrom Jan 1991 A
4984563 Renaud Jan 1991 A
4984564 Yuen Jan 1991 A
4985038 Lyell Jan 1991 A
4990161 Kampner Feb 1991 A
4994047 Walker et al. Feb 1991 A
4994067 Summers Feb 1991 A
4994071 MacGregor Feb 1991 A
4995868 Brazier Feb 1991 A
4997445 Hodorek Mar 1991 A
4998539 Delsanti Mar 1991 A
5002550 Li Mar 1991 A
5002557 Hasson Mar 1991 A
5002563 Pyka et al. Mar 1991 A
5007912 Albrektsson et al. Apr 1991 A
5009652 Morgan et al. Apr 1991 A
5009662 Wallace et al. Apr 1991 A
5009663 Broome Apr 1991 A
5009664 Sievers Apr 1991 A
5013316 Goble et al. May 1991 A
5015247 Michelson May 1991 A
5015255 Kuslich May 1991 A
5019090 Pinchuk May 1991 A
5019104 Whiteside et al. May 1991 A
5021056 Hofmann et al. Jun 1991 A
5021059 Kensey et al. Jun 1991 A
5026373 Ray et al. Jun 1991 A
5027827 Cody et al. Jul 1991 A
5032132 Matsen, III et al. Jul 1991 A
5035699 Coates Jul 1991 A
5035713 Friis Jul 1991 A
5037404 Gold et al. Aug 1991 A
5037422 Hayhurst et al. Aug 1991 A
5037423 Kenna Aug 1991 A
5041093 Chu Aug 1991 A
5041114 Chapman et al. Aug 1991 A
5041125 Montano, Jr. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5042976 Ishitsu et al. Aug 1991 A
5046513 Gatturna et al. Sep 1991 A
5047055 Bao et al. Sep 1991 A
5051049 Wills Sep 1991 A
5053009 Herzberg Oct 1991 A
5053039 Hofmann et al. Oct 1991 A
5053046 Janese Oct 1991 A
5053047 Yoon Oct 1991 A
5059193 Kuslich Oct 1991 A
5059206 Winters Oct 1991 A
5060678 Bauman et al. Oct 1991 A
5061274 Kensey Oct 1991 A
5061281 Mares et al. Oct 1991 A
5061286 Lyle Oct 1991 A
5062843 Mahony, III Nov 1991 A
5069674 Fearnot et al. Dec 1991 A
5071411 Hillstead Dec 1991 A
5073373 O'Leary et al. Dec 1991 A
5078731 Hayhurst Jan 1992 A
5078744 Chvapil Jan 1992 A
5078745 Rhenter et al. Jan 1992 A
5082670 Gage et al. Jan 1992 A
5084050 Draenert Jan 1992 A
5084051 Tormala et al. Jan 1992 A
5085660 Lin Feb 1992 A
5085661 Moss Feb 1992 A
5092348 Dubrul et al. Mar 1992 A
5098433 Freedland Mar 1992 A
5098434 Serbousek Mar 1992 A
5098436 Ferrante et al. Mar 1992 A
5098437 Kashuba et al. Mar 1992 A
5099859 Bell Mar 1992 A
5100405 McLaren Mar 1992 A
5100409 Coates et al. Mar 1992 A
5100417 Cerier et al. Mar 1992 A
5100689 Goldberg et al. Mar 1992 A
5101720 Bianchi Apr 1992 A
5102417 Palmaz Apr 1992 A
5102421 Anspach, Jr. Apr 1992 A
5104383 Shichman Apr 1992 A
5108399 Eitenmuller et al. Apr 1992 A
5108433 May et al. Apr 1992 A
5108441 McDowell Apr 1992 A
5111987 Moeinzadeh et al. May 1992 A
5116374 Stone May 1992 A
5120175 Arbegast et al. Jun 1992 A
5122122 Allgood Jun 1992 A
5122144 Bert et al. Jun 1992 A
5123520 Schmid et al. Jun 1992 A
5123906 Kelman Jun 1992 A
5123914 Cope Jun 1992 A
5123941 Lauren et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
RE34021 Mueller Aug 1992 E
5135522 Fahrenkrug et al. Aug 1992 A
5139520 Rosenberg Aug 1992 A
5141520 Goble et al. Aug 1992 A
5143062 Peckham Sep 1992 A
5143093 Sahota Sep 1992 A
5147362 Goble Sep 1992 A
5152744 Krause et al. Oct 1992 A
5152765 Ross et al. Oct 1992 A
5152778 Bales, Jr. et al. Oct 1992 A
5154717 Matsen, III et al. Oct 1992 A
5154720 Trott et al. Oct 1992 A
5156613 Sawyer Oct 1992 A
5156616 Meadows et al. Oct 1992 A
5158553 Berry et al. Oct 1992 A
5158566 Pianetti Oct 1992 A
5158571 Picha Oct 1992 A
5158934 Ammann et al. Oct 1992 A
5159921 Hoover Nov 1992 A
5162506 Hadden Nov 1992 A
5163949 Bonutti Nov 1992 A
5163960 Bonutti Nov 1992 A
5170800 Smith et al. Dec 1992 A
5171243 Kashuba et al. Dec 1992 A
5171244 Caspari et al. Dec 1992 A
5171251 Bregen et al. Dec 1992 A
5171276 Caspari et al. Dec 1992 A
5174300 Bales et al. Dec 1992 A
1312518 Hayhurst Jan 1993 A
5176682 Chow Jan 1993 A
5176684 Ferrante et al. Jan 1993 A
5176702 Bales et al. Jan 1993 A
5178622 Lehner, II Jan 1993 A
5179964 Cook Jan 1993 A
5180388 DiCarlo Jan 1993 A
5183053 Yeh et al. Feb 1993 A
5183464 Dubrul et al. Feb 1993 A
5185001 Galanakis Feb 1993 A
5186178 Yeh et al. Feb 1993 A
5192287 Fournier et al. Mar 1993 A
5192326 Bao et al. Mar 1993 A
5192327 Brantigan Mar 1993 A
5195507 Bilweis Mar 1993 A
5195970 Gahara Mar 1993 A
5197166 Meier et al. Mar 1993 A
5197488 Kovacevic Mar 1993 A
5197955 Stephens et al. Mar 1993 A
5197968 Clement Mar 1993 A
5197971 Bonutti Mar 1993 A
5197987 Koch et al. Mar 1993 A
5201768 Caspari et al. Apr 1993 A
5203784 Ross et al. Apr 1993 A
5203787 Noblitt et al. Apr 1993 A
5204106 Schepers et al. Apr 1993 A
5207692 Kraus et al. May 1993 A
5208950 Merritt May 1993 A
5209776 Bass et al. May 1993 A
5211647 Schmieding May 1993 A
5217463 Mikhail Jun 1993 A
5217486 Rice et al. Jun 1993 A
5217493 Raad et al. Jun 1993 A
5219359 McQuilkin et al. Jun 1993 A
5224946 Hayhurst et al. Jul 1993 A
5226426 Yoon Jul 1993 A
5226877 Epstein Jul 1993 A
5226899 Lee et al. Jul 1993 A
5226915 Bertin Jul 1993 A
5228459 Caspari et al. Jul 1993 A
5234006 Eaton et al. Aug 1993 A
5234425 Fogarty et al. Aug 1993 A
5234433 Bert et al. Aug 1993 A
5236432 Matsen, III et al. Aug 1993 A
5236438 Wilk Aug 1993 A
5236445 Hayhurst et al. Aug 1993 A
5242902 Murphy et al. Sep 1993 A
5244946 Guest et al. Sep 1993 A
5246441 Ross et al. Sep 1993 A
5250026 Ehrlich et al. Oct 1993 A
5250055 Moore et al. Oct 1993 A
5250070 Parodi Oct 1993 A
5254091 Aliahmad et al. Oct 1993 A
5254113 Wilk Oct 1993 A
5258004 Bales et al. Nov 1993 A
5258007 Spetzler et al. Nov 1993 A
5258015 Li et al. Nov 1993 A
5258016 DiPoto et al. Nov 1993 A
5258031 Salib et al. Nov 1993 A
5258032 Bertin Nov 1993 A
5261914 Warren Nov 1993 A
5263498 Caspari et al. Nov 1993 A
5263987 Shah Nov 1993 A
5266325 Kuzma et al. Nov 1993 A
5268001 Nicholson et al. Dec 1993 A
5269783 Sander Dec 1993 A
5269785 Bonutti Dec 1993 A
5269809 Hayhurst et al. Dec 1993 A
5273524 Fox et al. Dec 1993 A
5275166 Vaitekunas et al. Jan 1994 A
5281235 Haber et al. Jan 1994 A
5282803 Lackey Feb 1994 A
5282832 Toso et al. Feb 1994 A
5282861 Kaplan Feb 1994 A
5284655 Bogdansky et al. Feb 1994 A
5285655 Sung-Il et al. Feb 1994 A
5290249 Foster et al. Mar 1994 A
5290281 Tschakaloff Mar 1994 A
5295994 Bonutti Mar 1994 A
5298254 Prewett et al. Mar 1994 A
2696338 Perrin Apr 1994 A
5304119 Balaban et al. Apr 1994 A
5304181 Caspari et al. Apr 1994 A
5306280 Bregen et al. Apr 1994 A
5306301 Graf et al. Apr 1994 A
5312438 Johnson May 1994 A
5315741 Dubberke May 1994 A
5318588 Horzewski et al. Jun 1994 A
5320611 Bonutti et al. Jun 1994 A
5322505 Krause et al. Jun 1994 A
5324308 Pierce Jun 1994 A
5326361 Hollister Jul 1994 A
5328480 Melker et al. Jul 1994 A
5329846 Bonutti Jul 1994 A
5329924 Bonutti Jul 1994 A
5330468 Burkhart Jul 1994 A
5330476 Hiot et al. Jul 1994 A
5330486 Wilk Jul 1994 A
5330497 Freitas et al. Jul 1994 A
5331975 Bonutti Jul 1994 A
5334146 Ozasa Aug 1994 A
5336231 Adair Aug 1994 A
5336240 Metzler et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5345927 Bonutti Sep 1994 A
5349956 Bonutti Sep 1994 A
5352229 Goble et al. Oct 1994 A
5354298 Lee et al. Oct 1994 A
5354302 Ko Oct 1994 A
5356413 Martins et al. Oct 1994 A
5360450 Giannini Nov 1994 A
5366480 Corriveau et al. Nov 1994 A
5370646 Reese et al. Dec 1994 A
5370660 Weinstein et al. Dec 1994 A
5370662 Stone et al. Dec 1994 A
5372146 Branch Dec 1994 A
5374235 Ahrens Dec 1994 A
5376101 Green et al. Dec 1994 A
5376126 Lin Dec 1994 A
5379759 Sewell, Jr. Jan 1995 A
5382254 McGarry et al. Jan 1995 A
5383883 Wilk et al. Jan 1995 A
5383905 Golds et al. Jan 1995 A
5383937 Mikhail Jan 1995 A
RE34866 Kensey et al. Feb 1995 E
5390683 Pisharodi Feb 1995 A
5391171 Schmieding Feb 1995 A
5391173 Wilk Feb 1995 A
RE34871 McGuire et al. Mar 1995 E
5395308 Fox et al. Mar 1995 A
5395376 Caspari et al. Mar 1995 A
5397311 Walker et al. Mar 1995 A
5397331 Himpens et al. Mar 1995 A
5400805 Warren Mar 1995 A
5403312 Yates et al. Apr 1995 A
5403317 Bonutti Apr 1995 A
5403348 Bonutti Apr 1995 A
5405359 Pierce Apr 1995 A
5411523 Goble May 1995 A
5413585 Pagedas May 1995 A
5415663 Luckman et al. May 1995 A
5417691 Hayhurst May 1995 A
5417700 Egan May 1995 A
5417701 Holmes May 1995 A
5417712 Whittaker et al. May 1995 A
5423796 Shikhman et al. Jun 1995 A
5423819 Small et al. Jun 1995 A
5423860 Lizardi et al. Jun 1995 A
5425733 Schmieding Jun 1995 A
5431670 Holmes Jul 1995 A
5439470 Li Aug 1995 A
5441502 Bartlett Aug 1995 A
5441538 Bonutti Aug 1995 A
5443482 Stone et al. Aug 1995 A
5443512 Parr et al. Aug 1995 A
5445615 Yoon Aug 1995 A
5447503 Miller Sep 1995 A
5449372 Schmaltz et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5451235 Lock Sep 1995 A
5453090 Martinez et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5456722 McLeod et al. Oct 1995 A
5458653 Davidson Oct 1995 A
5462549 Glock Oct 1995 A
5462561 Voda Oct 1995 A
5464424 O'Donnell, Jr. Nov 1995 A
5464425 Skiba Nov 1995 A
5464426 Bonutti Nov 1995 A
5464427 Curtis et al. Nov 1995 A
5470337 Moss Nov 1995 A
5472444 Huebner et al. Dec 1995 A
5474554 Ku Dec 1995 A
5474559 Bertin et al. Dec 1995 A
5478351 Meade et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5480403 Lee et al. Jan 1996 A
5484437 Michelson Jan 1996 A
5486197 Le et al. Jan 1996 A
5487844 Fujita Jan 1996 A
5488958 Topel et al. Feb 1996 A
5492697 Boyan et al. Feb 1996 A
5496292 Burnham Mar 1996 A
5496335 Thomason et al. Mar 1996 A
5496348 Bonutti Mar 1996 A
5500000 Feagin et al. Mar 1996 A
5501700 Hirata Mar 1996 A
5504977 Weppner et al. Apr 1996 A
5505735 Li Apr 1996 A
5507754 Green et al. Apr 1996 A
5514091 Yoon May 1996 A
5514153 Bonutti May 1996 A
5520700 Beyar et al. May 1996 A
5522844 Johnson Jun 1996 A
5522845 Wenstrom, Jr. Jun 1996 A
5522846 Bonutti Jun 1996 A
5527341 Gogolewski et al. Jun 1996 A
5527342 Pietrzak et al. Jun 1996 A
5527343 Bonutti Jun 1996 A
5529075 Clark Jun 1996 A
5531759 Kensey et al. Jul 1996 A
5534012 Bonutti Jul 1996 A
5534028 Bao et al. Jul 1996 A
5540718 Bartlett Jul 1996 A
5542423 Bonutti Aug 1996 A
5542947 Treacy Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5545206 Carson Aug 1996 A
5545222 Bonutti Aug 1996 A
5549630 Bonutti Aug 1996 A
5549631 Bonutti Aug 1996 A
5549689 Epstein et al. Aug 1996 A
5550172 Regula et al. Aug 1996 A
2215943 Collette Sep 1996 A
5556402 Xu Sep 1996 A
5562668 Johnson Oct 1996 A
5562684 Kammerer Oct 1996 A
5562688 Riza Oct 1996 A
5569252 Justin et al. Oct 1996 A
5569259 Ferrante et al. Oct 1996 A
5569305 Bonutti Oct 1996 A
5569306 Thal Oct 1996 A
5571139 Jenkins, Jr. Nov 1996 A
5571196 Stein Nov 1996 A
5573517 Bonutti et al. Nov 1996 A
5573538 Laboureau Nov 1996 A
5573542 Stevens Nov 1996 A
5575801 Habermeyer Nov 1996 A
5577517 Bonutti Nov 1996 A
5580344 Hasson Dec 1996 A
5584835 Greenfield Dec 1996 A
5584860 Goble et al. Dec 1996 A
5584862 Bonutti Dec 1996 A
5591206 Moufarrege Jan 1997 A
5593422 Muijs Van De Moer et al. Jan 1997 A
5593425 Bonutti et al. Jan 1997 A
5593625 Riebel et al. Jan 1997 A
5601557 Hayhurst Feb 1997 A
5601558 Torrie et al. Feb 1997 A
5601565 Huebner Feb 1997 A
5601595 Smith Feb 1997 A
5607427 Tschakaloff Mar 1997 A
5609595 Pennig Mar 1997 A
5609635 Michelson Mar 1997 A
5618314 Harwin et al. Apr 1997 A
5620448 Puddu Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5624462 Bonutti Apr 1997 A
5624463 Stone et al. Apr 1997 A
5626612 Bartlett May 1997 A
5626614 Hart May 1997 A
5626718 Philippe et al. May 1997 A
5628751 Sander et al. May 1997 A
5630824 Hart May 1997 A
5634926 Jobe Jun 1997 A
5643274 Sander et al. Jul 1997 A
5643293 Kogasaka et al. Jul 1997 A
5643295 Yoon Jul 1997 A
5643320 Lower et al. Jul 1997 A
5643321 McDevitt Jul 1997 A
5644002 Cooper et al. Jul 1997 A
5645553 Kolesa et al. Jul 1997 A
5645588 Graf et al. Jul 1997 A
5645597 Krapiva Jul 1997 A
5645599 Samani Jul 1997 A
5649955 Hashimoto et al. Jul 1997 A
5649963 McDevitt Jul 1997 A
5651377 O'Donnell, Jr. Jul 1997 A
5658313 Thal Aug 1997 A
5660225 Saffran Aug 1997 A
5662658 Wenstrom, Jr. Sep 1997 A
5662710 Bonutti Sep 1997 A
5665089 Dall et al. Sep 1997 A
5665109 Yoon Sep 1997 A
5665112 Thal Sep 1997 A
5667513 Torrie et al. Sep 1997 A
5667520 Bonutti Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5674240 Bonutti Oct 1997 A
5681310 Yuan et al. Oct 1997 A
5681333 Burkhart et al. Oct 1997 A
5681351 Jamiolkowski et al. Oct 1997 A
5681352 Clancy, III et al. Oct 1997 A
5682886 Delp et al. Nov 1997 A
5683401 Schmieding et al. Nov 1997 A
5683418 Luscombe et al. Nov 1997 A
5683469 Johnson et al. Nov 1997 A
5685820 Riek et al. Nov 1997 A
5685826 Bonutti Nov 1997 A
5688283 Knapp Nov 1997 A
5690654 Ovil Nov 1997 A
5690655 Hart et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5690676 DiPoto et al. Nov 1997 A
5693055 Zahiri et al. Dec 1997 A
5694951 Bonutti Dec 1997 A
5697950 Fucci et al. Dec 1997 A
5702397 Goble et al. Dec 1997 A
5702462 Oberlander Dec 1997 A
5707390 Bonutti Jan 1998 A
5707395 Li Jan 1998 A
5713897 Goble et al. Feb 1998 A
5713903 Sander et al. Feb 1998 A
5713921 Bonutti Feb 1998 A
5715836 Kliegis et al. Feb 1998 A
5716325 Bonutti Feb 1998 A
5718717 Bonutti Feb 1998 A
5720747 Burke Feb 1998 A
5720753 Sander et al. Feb 1998 A
5722978 Jenkins, Jr. Mar 1998 A
5723016 Minns et al. Mar 1998 A
5725529 Nicholson et al. Mar 1998 A
5725541 Anspach, III et al. Mar 1998 A
5725556 Moser et al. Mar 1998 A
5725557 Gatturna et al. Mar 1998 A
5725582 Bevan Mar 1998 A
5730747 Ek et al. Mar 1998 A
5733306 Bonutti Mar 1998 A
5735875 Bonutti et al. Apr 1998 A
5735877 Pagedas Apr 1998 A
5735899 Schwartz et al. Apr 1998 A
5741268 Schutz Apr 1998 A
5741282 Anspach, III et al. Apr 1998 A
5752952 Adamson May 1998 A
5752974 Rhee et al. May 1998 A
5755809 Cohen et al. May 1998 A
5762458 Wang et al. Jun 1998 A
5763416 Bonadio et al. Jun 1998 A
5766221 Benderev et al. Jun 1998 A
5766251 Koshino Jun 1998 A
5769854 Bastian et al. Jun 1998 A
5769894 Ferragamo Jun 1998 A
5772672 Toy et al. Jun 1998 A
5776151 Chan Jul 1998 A
5779706 Tschakaloff Jul 1998 A
5779719 Klein et al. Jul 1998 A
5779728 Lunsford et al. Jul 1998 A
5782862 Bonutti Jul 1998 A
5782925 Collazo et al. Jul 1998 A
5785713 Jobe Jul 1998 A
5792096 Rentmeester et al. Aug 1998 A
5797931 Bito et al. Aug 1998 A
5797963 McDevitt Aug 1998 A
5800537 Bell Sep 1998 A
5800544 Demopulos Sep 1998 A
5806518 Mittelstadt Sep 1998 A
5807403 Beyar et al. Sep 1998 A
5810827 Haines et al. Sep 1998 A
5810849 Kontos Sep 1998 A
5810853 Yoon Sep 1998 A
5810884 Kim Sep 1998 A
5814071 McDevitt et al. Sep 1998 A
5814072 Bonutti Sep 1998 A
5814073 Bonutti Sep 1998 A
5817107 Schaller Oct 1998 A
5823994 Sharkey et al. Oct 1998 A
5824009 Fukuda et al. Oct 1998 A
5827318 Bonutti Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836897 Sakural et al. Nov 1998 A
5836948 Zucherman et al. Nov 1998 A
5839899 Robinson Nov 1998 A
5843178 Vanney et al. Dec 1998 A
5845645 Bonutti Dec 1998 A
5851185 Berns Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5860997 Bonutti Jan 1999 A
5865834 McGuire Feb 1999 A
5866634 Tokushige Feb 1999 A
5868749 Reed Feb 1999 A
5871018 Delp et al. Feb 1999 A
5873891 Sohn Feb 1999 A
5874235 Chan Feb 1999 A
5879372 Bartlett Mar 1999 A
5888196 Bonutti Mar 1999 A
5888219 Bonutti Mar 1999 A
5891166 Schervinsky Apr 1999 A
5891168 Thal Apr 1999 A
5893880 Egan et al. Apr 1999 A
5895426 Scarborough et al. Apr 1999 A
5897559 Masini Apr 1999 A
5897574 Bonutti Apr 1999 A
5899911 Carter May 1999 A
5899921 Caspari et al. May 1999 A
5902321 Caspari et al. May 1999 A
5906579 Vander Salm et al. May 1999 A
5906616 Pavlov et al. May 1999 A
5906625 Bito et al. May 1999 A
5908429 Yoon Jun 1999 A
5911721 Nicholson et al. Jun 1999 A
5916221 Hodorek et al. Jun 1999 A
5918604 Whelan Jul 1999 A
5919193 Slavitt Jul 1999 A
5919194 Anderson Jul 1999 A
5919208 Valenti Jul 1999 A
5919215 Wiklund et al. Jul 1999 A
5921986 Bonutti Jul 1999 A
5925064 Meyers et al. Jul 1999 A
5928244 Tovey et al. Jul 1999 A
5928267 Bonutti et al. Jul 1999 A
5931838 Vito Aug 1999 A
5931869 Boucher et al. Aug 1999 A
5935094 Zupkas Aug 1999 A
5935131 Bonutti Aug 1999 A
5935149 Ek Aug 1999 A
5940942 Fong Aug 1999 A
5941900 Bonutti Aug 1999 A
5941901 Egan Aug 1999 A
5947982 Duran Sep 1999 A
5948000 Larsen et al. Sep 1999 A
5948001 Larsen Sep 1999 A
5948002 Bonutti Sep 1999 A
5951590 Goldfarb Sep 1999 A
5954739 Bonutti Sep 1999 A
5957953 DiPoto et al. Sep 1999 A
5961499 Bonutti Oct 1999 A
5961521 Roger Oct 1999 A
5961538 Pedlick et al. Oct 1999 A
5961554 Janson et al. Oct 1999 A
5964765 Fenton, Jr. et al. Oct 1999 A
5964769 Wagner et al. Oct 1999 A
5968044 Nicholson et al. Oct 1999 A
5968046 Castleman Oct 1999 A
5968047 Reed Oct 1999 A
5980520 Vancaillie Nov 1999 A
5980558 Wiley Nov 1999 A
5980559 Bonutti Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
5984967 Zdeblick et al. Nov 1999 A
5989282 Bonutti Nov 1999 A
5989289 Coates et al. Nov 1999 A
5993458 Vaitekunas et al. Nov 1999 A
5993477 Vaitekunas et al. Nov 1999 A
6007537 Burkinshaw et al. Dec 1999 A
6007567 Bonutti Dec 1999 A
6007580 Lehto et al. Dec 1999 A
6008433 Stone Dec 1999 A
6010525 Bonutti et al. Jan 2000 A
6010526 Sandstrom et al. Jan 2000 A
6013853 Athanasiou et al. Jan 2000 A
6017305 Bonutti Jan 2000 A
6017321 Boone Jan 2000 A
6024746 Katz Feb 2000 A
6033410 McLean et al. Mar 2000 A
6033429 Magovern Mar 2000 A
6033430 Bonutti Mar 2000 A
6042596 Bonutti Mar 2000 A
6045551 Bonutti Apr 2000 A
6050998 Fletcher et al. Apr 2000 A
6056751 Fenton, Jr. May 2000 A
6056754 Haines et al. May 2000 A
6056772 Bonutti May 2000 A
6056773 Bonutti May 2000 A
6059797 Mears May 2000 A
6059817 Bonutti et al. May 2000 A
6059827 Fenton May 2000 A
6059831 Braslow et al. May 2000 A
6063095 Wang et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6066160 Colvin et al. May 2000 A
6066166 Bischoff et al. May 2000 A
6066175 Henderson et al. May 2000 A
6068637 Popov et al. May 2000 A
6068648 Cole et al. May 2000 A
6074409 Goldfarb Jun 2000 A
6077277 Mollenauer et al. Jun 2000 A
6077292 Bonutti Jun 2000 A
6080161 Eaves, III et al. Jun 2000 A
6083244 Lubbers et al. Jul 2000 A
6083522 Chu et al. Jul 2000 A
6086593 Bonutti Jul 2000 A
6086608 Ek et al. Jul 2000 A
6090072 Kratoska et al. Jul 2000 A
6099531 Bonutti Aug 2000 A
6099537 Sugai et al. Aug 2000 A
6099547 Gellman et al. Aug 2000 A
6099550 Yoon Aug 2000 A
6099552 Adams Aug 2000 A
6102850 Wang et al. Aug 2000 A
6102928 Bonutti Aug 2000 A
6102950 Vaccaro Aug 2000 A
6102955 Mendes et al. Aug 2000 A
6106529 Techiera Aug 2000 A
6106545 Egan Aug 2000 A
6110188 Narciso, Jr. Aug 2000 A
6110207 Eichhorn et al. Aug 2000 A
6117160 Bonutti Sep 2000 A
6120536 Ding et al. Sep 2000 A
6123710 Pinczewski et al. Sep 2000 A
6125574 Ganaja et al. Oct 2000 A
6126677 Ganaja et al. Oct 2000 A
6132468 Mansmann Oct 2000 A
6132472 Bonutti Oct 2000 A
6139320 Hahn Oct 2000 A
RE36974 Bonutti Nov 2000 E
6146385 Torrie et al. Nov 2000 A
6149669 Li Nov 2000 A
6152949 Bonutti Nov 2000 A
6155756 Mericle et al. Dec 2000 A
6156070 Incavo et al. Dec 2000 A
6159224 Yoon Dec 2000 A
6159234 Bonutti et al. Dec 2000 A
6171236 Bonutti Jan 2001 B1
6171299 Bonutti Jan 2001 B1
6171307 Orlich Jan 2001 B1
6171340 McDowell Jan 2001 B1
6174313 Bonutti Jan 2001 B1
6174314 Waddell Jan 2001 B1
6174324 Egan et al. Jan 2001 B1
6179840 Bowman Jan 2001 B1
6179850 Goradia Jan 2001 B1
6187008 Hamman Feb 2001 B1
6187023 Bonutti Feb 2001 B1
6190400 Van De Moer et al. Feb 2001 B1
6190401 Green Feb 2001 B1
6193754 Seedhom Feb 2001 B1
6200322 Branch et al. Mar 2001 B1
6200329 Fung et al. Mar 2001 B1
6203565 Bonutti et al. Mar 2001 B1
6214051 Badorf et al. Apr 2001 B1
6217591 Egan et al. Apr 2001 B1
6217617 Bonutti Apr 2001 B1
6224593 Ryan May 2001 B1
6224630 Bao et al. May 2001 B1
6228086 Wahl et al. May 2001 B1
6231592 Bonutti et al. May 2001 B1
6235057 Roger et al. May 2001 B1
6238395 Bonutti May 2001 B1
6241749 Rayhanabad Jun 2001 B1
6241771 Gresser et al. Jun 2001 B1
6258091 Sevrain et al. Jul 2001 B1
6261295 Nicholson Jul 2001 B1
6264675 Brotz Jul 2001 B1
6267761 Ryan Jul 2001 B1
6273717 Hahn et al. Aug 2001 B1
6277136 Bonutti Aug 2001 B1
6280474 Cassidy et al. Aug 2001 B1
6286746 Egan et al. Sep 2001 B1
6287325 Bonutti Sep 2001 B1
6293961 Schwartz et al. Sep 2001 B2
6296646 Williamson Oct 2001 B1
6306159 Schwartz et al. Oct 2001 B1
6309405 Bonutti Oct 2001 B1
6312448 Bonutti Nov 2001 B1
6319252 McDevitt et al. Nov 2001 B1
6319271 Schwartz et al. Nov 2001 B1
6325806 Fox Dec 2001 B1
6338730 Bonutti et al. Jan 2002 B1
6340365 Dittrich et al. Jan 2002 B2
6342075 Macarthur Jan 2002 B1
6348056 Bates et al. Feb 2002 B1
6358252 Shapira Mar 2002 B1
6358266 Bonutti Mar 2002 B1
6358271 Egan et al. Mar 2002 B1
6361565 Bonutti Mar 2002 B1
6364897 Bonutti Apr 2002 B1
6368325 McKinley et al. Apr 2002 B1
6368326 Dakin et al. Apr 2002 B1
6368343 Bonutti et al. Apr 2002 B1
6371957 Amrein et al. Apr 2002 B1
6398797 Bombard et al. Jun 2002 B2
6409742 Fulton, III Jun 2002 B1
6409743 Fenton, Jr. Jun 2002 B1
6409764 White et al. Jun 2002 B1
6419704 Ferree Jul 2002 B1
6423063 Bonutti Jul 2002 B1
6423088 Fenton Jul 2002 B1
6425919 Lambrecht Jul 2002 B1
6428562 Bonutti Aug 2002 B2
6432115 Mollenauer et al. Aug 2002 B1
6447516 Bonutti Sep 2002 B1
6450985 Schoelling et al. Sep 2002 B1
6451042 Bonutti Sep 2002 B1
6461360 Adams Oct 2002 B1
6464713 Bonutti Oct 2002 B2
6468289 Bonutti Oct 2002 B1
6468293 Bonutti et al. Oct 2002 B2
6471715 Weiss Oct 2002 B1
6471724 Zdeblick et al. Oct 2002 B2
6475230 Bonutti Nov 2002 B1
6482209 Engh et al. Nov 2002 B1
6488196 Fenton Dec 2002 B1
6500179 Masini Dec 2002 B1
6500195 Bonutti Dec 2002 B2
6503259 Huxel et al. Jan 2003 B2
6503267 Bonutti et al. Jan 2003 B2
6503277 Bonutti Jan 2003 B2
6527774 Lieberman Mar 2003 B2
6530933 Yeung et al. Mar 2003 B1
6535764 Imran et al. Mar 2003 B2
6540786 Chibrac et al. Apr 2003 B2
6543455 Bonutti Apr 2003 B2
6544267 Cole et al. Apr 2003 B1
6545390 Hahn et al. Apr 2003 B1
6547792 Tsuji et al. Apr 2003 B1
6551304 Whalen et al. Apr 2003 B1
6554852 Oberlander Apr 2003 B1
6557426 Reinemann et al. May 2003 B2
6558390 Cragg May 2003 B2
6562043 Chan May 2003 B1
6568313 Fukui et al. May 2003 B2
6569167 Bobechko et al. May 2003 B1
6569187 Bonutti May 2003 B1
6572635 Bonutti Jun 2003 B1
6575980 Robie et al. Jun 2003 B1
6575982 Bonutti Jun 2003 B1
D477776 Pontaoe Jul 2003 S
6585750 Bonutti Jul 2003 B2
6585764 Wright et al. Jul 2003 B2
6589248 Hughes Jul 2003 B1
6589281 Hyde, Jr. Jul 2003 B2
6592531 Bonutti Jul 2003 B2
6592609 Bonutti Jul 2003 B1
6594517 Nevo Jul 2003 B1
6605090 Trieu et al. Aug 2003 B1
6607534 Bonutti Aug 2003 B2
6610080 Morgan Aug 2003 B2
6616696 Merchant Sep 2003 B1
6618910 Pontaoe Sep 2003 B1
6620181 Bonutti Sep 2003 B1
6623486 Weaver Sep 2003 B1
6623487 Goshert Sep 2003 B1
6626944 Taylor Sep 2003 B1
6630000 Bonutti Oct 2003 B1
6632245 Kim Oct 2003 B2
6635073 Bonutti Oct 2003 B2
6638279 Bonutti Oct 2003 B2
6638309 Bonutti Oct 2003 B2
6641592 Sauer et al. Nov 2003 B1
6645227 Fallin et al. Nov 2003 B2
6652532 Bonutti Nov 2003 B2
6652587 Felt et al. Nov 2003 B2
6666877 Morgan et al. Dec 2003 B2
6669705 Westhaver et al. Dec 2003 B2
6679888 Green et al. Jan 2004 B2
6685750 Plos et al. Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6702821 Bonutti Mar 2004 B2
6702856 Bonutti Mar 2004 B2
6705179 Mohtasham Mar 2004 B1
6709457 Otte Mar 2004 B1
6719765 Bonutti Apr 2004 B2
6719797 Ferree Apr 2004 B1
6719803 Bonutti Apr 2004 B2
6722552 Fenton Apr 2004 B2
6723102 Johnson et al. Apr 2004 B2
6733506 McDevitt et al. May 2004 B1
6733531 Trieu May 2004 B1
6736853 Bonutti May 2004 B2
6755865 Tarabishy Jun 2004 B2
6764514 Li et al. Jul 2004 B1
6770078 Bonutti Aug 2004 B2
6776938 Bonutti Aug 2004 B2
6780198 Gregoire et al. Aug 2004 B1
6786989 Torriani et al. Sep 2004 B2
6796003 Marvel Sep 2004 B1
6818010 Eichhorn et al. Nov 2004 B2
6823871 Schmieding Nov 2004 B2
6827723 Carson Dec 2004 B2
6835198 Bonutti Dec 2004 B2
6860885 Bonutti Mar 2005 B2
6860904 Bonutti Mar 2005 B2
6878167 Ferree Apr 2005 B2
6890334 Brace et al. May 2005 B2
6893434 Fenton et al. May 2005 B2
6899722 Bonutti May 2005 B2
6905517 Bonutti Jun 2005 B2
6908466 Bonutti et al. Jun 2005 B1
6913666 Aeschlimann et al. Jul 2005 B1
6916321 TenHuisen Jul 2005 B2
6921264 Mayer et al. Jul 2005 B2
6923824 Morgan et al. Aug 2005 B2
6932835 Bonutti Aug 2005 B2
6942684 Bonutti Sep 2005 B2
6944111 Nakamura et al. Sep 2005 B2
6955540 Mayer et al. Oct 2005 B2
6955683 Bonutti Oct 2005 B2
6958077 Suddaby Oct 2005 B2
6981983 Rosenblatt et al. Jan 2006 B1
6989029 Bonutti Jan 2006 B2
6990982 Bonutti Jan 2006 B1
6997940 Bonutti Feb 2006 B2
7001385 Bonutti Feb 2006 B2
7001411 Dean Feb 2006 B1
7004959 Bonutti Feb 2006 B2
7008226 Mayer et al. Mar 2006 B2
7018380 Cole Mar 2006 B2
7033379 Peterson Apr 2006 B2
7048741 Swanson May 2006 B2
7048755 Bonutti May 2006 B2
7066960 Dickman Jun 2006 B1
7070557 Bonutti Jul 2006 B2
7087073 Bonutti Aug 2006 B2
7090111 Egan et al. Aug 2006 B2
7094251 Bonutti Aug 2006 B2
7104996 Bonutti Sep 2006 B2
7114500 Bonutti Oct 2006 B2
7128753 Bonutti et al. Oct 2006 B1
7128763 Blatt Oct 2006 B1
7134437 Bonutti Nov 2006 B2
7147652 Bonutti et al. Dec 2006 B2
7153312 Torrie et al. Dec 2006 B1
7160405 Aeschlimann et al. Jan 2007 B2
7179259 Gibbs Feb 2007 B1
7192448 Ferree Mar 2007 B2
7208013 Bonutti Apr 2007 B1
7217273 Bonutti May 2007 B2
7217279 Reese May 2007 B2
7217290 Bonutti May 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7250051 Francischelli Jul 2007 B2
7252685 Bindseil et al. Aug 2007 B2
7273497 Ferree Sep 2007 B2
7311719 Bonutti Dec 2007 B2
7329263 Bonutti Feb 2008 B2
7335205 Aeshclimann Feb 2008 B2
7371240 Pinczewski et al. May 2008 B2
7429266 Bonutti Sep 2008 B2
7445634 Trieu Nov 2008 B2
7462200 Bonutti Dec 2008 B2
7481825 Bonutti Jan 2009 B2
7481831 Bonutti Jan 2009 B2
7510557 Bonutti Mar 2009 B1
7510895 Raterman Mar 2009 B2
7610557 McLennan et al. Oct 2009 B2
7615054 Bonutti Nov 2009 B1
7635390 Bonutti Dec 2009 B1
7708740 Bonutti May 2010 B1
7708741 Bonutti May 2010 B1
7727283 Bonutti Jun 2010 B2
7749229 Bonutti Jul 2010 B1
7780670 Bonutti Aug 2010 B2
7806896 Bonutti Oct 2010 B1
7806897 Bonutti Oct 2010 B1
7828852 Bonutti Nov 2010 B2
7837736 Bonutti Nov 2010 B2
7854750 Bonutti Dec 2010 B2
7879072 Bonutti Feb 2011 B2
7891691 Bearey Feb 2011 B2
7892236 Bonutti Feb 2011 B1
7892261 Bonutti Feb 2011 B2
7896880 Bonutti Mar 2011 B2
7931690 Bonutti Apr 2011 B1
7959635 Bonutti Jun 2011 B1
7967820 Bonutti Jun 2011 B2
RE43143 Hayhurst Jan 2012 E
8092462 Pinczewski et al. Jan 2012 B2
8128669 Bonutti Mar 2012 B2
8133229 Bonutti Mar 2012 B1
8140982 Hamilton, II et al. Mar 2012 B2
8147514 Bonutti Apr 2012 B2
8162977 Bonutti et al. Apr 2012 B2
8425522 Bonutti Apr 2013 B2
8486066 Bonutti Jul 2013 B2
8496657 Bonutti et al. Jul 2013 B2
8617185 Bonutti Dec 2013 B2
8623030 Bonutti Jan 2014 B2
8632552 Bonutti Jan 2014 B2
8641726 Bonutti Feb 2014 B2
8690944 Bonutti Apr 2014 B2
20010002440 Bonutti May 2001 A1
20010009250 Herman et al. Jul 2001 A1
20010023371 Bonutti Sep 2001 A1
20010041916 Bonutti Nov 2001 A1
20020016593 Hearn et al. Feb 2002 A1
20020016633 Lin et al. Feb 2002 A1
20020019649 Sikora Feb 2002 A1
20020026244 Trieu Feb 2002 A1
20020029055 Bonutti Mar 2002 A1
20020029083 Zucherman et al. Mar 2002 A1
20020029084 Paul et al. Mar 2002 A1
20020040246 Bonutti Apr 2002 A1
20020045902 Bonutti Apr 2002 A1
20020062153 Paul et al. May 2002 A1
20020103495 Cole Aug 2002 A1
20020123750 Eisermann et al. Sep 2002 A1
20020138150 Leclercq Sep 2002 A1
20020183762 Anderson et al. Dec 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20030009147 Bonutti Jan 2003 A1
20030023260 Bonutti Jan 2003 A1
20030032975 Bonutti Feb 2003 A1
20030039196 Nakamura et al. Feb 2003 A1
20030040758 Wang et al. Feb 2003 A1
20030065361 Dreyfuss Apr 2003 A1
20030105474 Bonutti Jun 2003 A1
20030118518 Hahn et al. Jun 2003 A1
20030158582 Bonutti et al. Aug 2003 A1
20030167072 Oberlander Sep 2003 A1
20030181800 Bonutti Sep 2003 A1
20030195530 Thill Oct 2003 A1
20030195565 Bonutti Oct 2003 A1
20030204204 Bonutti Oct 2003 A1
20030216742 Wetzler et al. Nov 2003 A1
20030225438 Bonutti et al. Dec 2003 A1
20030229361 Jackson Dec 2003 A1
20040010287 Bonutti Jan 2004 A1
20040030341 Aeschlimann et al. Feb 2004 A1
20040034357 Beane et al. Feb 2004 A1
20040097794 Bonutti May 2004 A1
20040097939 Bonutti May 2004 A1
20040098016 Bonutti May 2004 A1
20040098050 Foerster et al. May 2004 A1
20040127930 Bonutti Jul 2004 A1
20040138689 Bonutti Jul 2004 A1
20040138690 Bonutti Jul 2004 A1
20040138703 Alleyne Jul 2004 A1
20040143285 Bonutti Jul 2004 A1
20040143334 Ferree Jul 2004 A1
20040167548 Bonutti Aug 2004 A1
20040172033 Bonutti Sep 2004 A1
20040193181 Bonutti Sep 2004 A1
20040220616 Bonutti Nov 2004 A1
20040225325 Bonutti Nov 2004 A1
20040230223 Bonutti Nov 2004 A1
20040236374 Bonutti et al. Nov 2004 A1
20040254582 Bonutti Dec 2004 A1
20050033366 Cole Feb 2005 A1
20050038514 Helm et al. Feb 2005 A1
20050043796 Grant et al. Feb 2005 A1
20050071012 Serhan et al. Mar 2005 A1
20050090827 Gedebou Apr 2005 A1
20050096699 Wixey et al. May 2005 A1
20050110214 Shank et al. May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050126680 Aeschlimann et al. Jun 2005 A1
20050143826 Zucherman et al. Jun 2005 A1
20050149024 Ferrante et al. Jul 2005 A1
20050149029 Bonutti Jul 2005 A1
20050203521 Bonutti Sep 2005 A1
20050216059 Bonutti Sep 2005 A1
20050216087 Zucherman et al. Sep 2005 A1
20050222620 Bonutti Oct 2005 A1
20050240190 Gall et al. Oct 2005 A1
20050240227 Bonutti Oct 2005 A1
20050246021 Ringeisen et al. Nov 2005 A1
20050261684 Shaolian et al. Nov 2005 A1
20050267481 Carl et al. Dec 2005 A1
20050267534 Bonutti Dec 2005 A1
20060009855 Goble et al. Jan 2006 A1
20060015101 Warburton et al. Jan 2006 A1
20060015108 Bonutti Jan 2006 A1
20060024357 Carpenter et al. Feb 2006 A1
20060026244 Watson Feb 2006 A1
20060064095 Senn et al. Mar 2006 A1
20060089646 Bonutti Apr 2006 A1
20060122600 Cole Jun 2006 A1
20060122704 Vresilovic et al. Jun 2006 A1
20060142799 Bonutti Jun 2006 A1
20060167495 Bonutti Jul 2006 A1
20060200199 Bonutti Sep 2006 A1
20060212073 Bonutti Sep 2006 A1
20060217765 Bonutti Sep 2006 A1
20060229623 Bonutti Oct 2006 A1
20060235470 Bonutti Oct 2006 A1
20060241695 Bonutti Oct 2006 A1
20060265009 Bonutti Nov 2006 A1
20060265011 Bonutti Nov 2006 A1
20070032825 Bonutti et al. Feb 2007 A1
20070088362 Bonutti et al. Apr 2007 A1
20070102005 Bonutti May 2007 A1
20070118129 Fraser et al. May 2007 A1
20070198555 Friedman et al. Aug 2007 A1
20070208378 Bonutti et al. Sep 2007 A1
20070265561 Yeung Nov 2007 A1
20070270833 Bonutti Nov 2007 A1
20080021474 Bonutti et al. Jan 2008 A1
20080039845 Bonutti Feb 2008 A1
20080039873 Bonutti Feb 2008 A1
20080046090 Paul et al. Feb 2008 A1
20080047567 Bonutti Feb 2008 A1
20080051799 Bonutti Feb 2008 A1
20080058822 Bonutti Mar 2008 A1
20080065140 Bonutti Mar 2008 A1
20080097448 Binder et al. Apr 2008 A1
20080103519 Bonutti May 2008 A1
20080108897 Bonutti et al. May 2008 A1
20080108916 Bonutti May 2008 A1
20080114399 Bonutti May 2008 A1
20080132950 Lange Jun 2008 A1
20080140116 Bonutti Jun 2008 A1
20080140117 Bonutti Jun 2008 A1
20080195145 Bonutti Aug 2008 A1
20080269753 Cannestra Oct 2008 A1
20080269808 Gall et al. Oct 2008 A1
20090024161 Bonutti Jan 2009 A1
20090093684 Schorer Apr 2009 A1
20090138014 Bonutti May 2009 A1
20090194969 Bearey Aug 2009 A1
20100211120 Bonutti Aug 2010 A1
20100312350 Bonutti Dec 2010 A1
20110060375 Bonutti Mar 2011 A1
20110295253 Bonutti et al. Dec 2011 A1
20120010623 Bonutti Jan 2012 A1
20120165841 Bonutti Jun 2012 A1
20120191140 Bonutti Jul 2012 A1
20120215226 Bonutti Aug 2012 A1
20120215233 Bonutti et al. Aug 2012 A1
20120221017 Bonutti Aug 2012 A1
20130144389 Bonutti Jun 2013 A1
20130226185 Bonutti Aug 2013 A1
20130226311 Bonutti Aug 2013 A1
20140018852 Bonutti Jan 2014 A1
20140018853 Bonutti Jan 2014 A1
20140018854 Bonutti Jan 2014 A1
20140025110 Bonutti Jan 2014 A1
20140025111 Bonutti Jan 2014 A1
20140025112 Bonutti Jan 2014 A1
Foreign Referenced Citations (77)
Number Date Country
1312518 Jan 1993 CA
2641580 Aug 2007 CA
2680827 Sep 2008 CA
2698057 Mar 2009 CA
117960 May 1927 CH
337437 May 1921 DE
605255 Nov 1934 DE
1903016 Oct 1964 DE
1903316 Oct 1964 DE
1903016 Aug 1970 DE
2411226 Sep 1974 DE
32 11 682 Oct 1983 DE
3517204 Nov 1986 DE
37 07 787 Sep 1988 DE
3722538 Jan 1989 DE
90 02 844.9 Jan 1991 DE
9002844 Jan 1991 DE
0 010 650 May 1980 EP
0 192 576 Aug 1986 EP
0 283 661 Sep 1988 EP
0 287 998 Oct 1988 EP
0 418 147 Mar 1991 EP
0 699 416 Mar 1996 EP
784454 May 1996 EP
773004 May 1997 EP
1614525 Jan 2006 EP
1988837 Aug 2007 EP
2134294 Dec 2009 EP
325846 May 1903 FR
726041 May 1932 FR
1 111 677 Mar 1956 FR
2 344 267 Oct 1977 FR
2 580 504 Oct 1986 FR
2 682 287 Apr 1993 FR
2717368 Mar 1994 FR
2 696 338 Apr 1994 FR
2696338 Apr 1994 FR
2728779 Jan 1995 FR
2736257 Jul 1995 FR
2750031 Jun 1996 FR
2771621 Nov 1997 FR
2785171 Oct 1998 FR
214913 May 1924 GB
2093701 Sep 1982 GB
2306110 Apr 1997 GB
S6429266 Jan 1989 JP
8140982 Jun 1996 JP
H08173436 Jul 1996 JP
3738221 Jan 2006 JP
184396 Jul 1966 SU
1323090 Jul 1987 SU
1367947 Jan 1988 SU
WO 8701270 Mar 1987 WO
WO 8801517 Mar 1988 WO
9112779 Sep 1991 WO
9323094 Nov 1993 WO
WO 9323094 Nov 1993 WO
WO9408642 Apr 1994 WO
9516398 Jun 1995 WO
WO 9516398 Jun 1995 WO
WO 9531941 Nov 1995 WO
WO9614802 May 1996 WO
WO 9629029 Sep 1996 WO
WO9712779 Apr 1997 WO
WO 9720522 Jun 1997 WO
WO 9739700 Oct 1997 WO
9749347 Dec 1997 WO
WO 9749347 Dec 1997 WO
WO9811838 Mar 1998 WO
WO9826720 Jun 1998 WO
WO0253011 Jul 2002 WO
2007092869 Aug 2007 WO
2007092869 Aug 2007 WO
WO 2007092869 Aug 2007 WO
2008116203 Sep 2008 WO
2009029908 Mar 2009 WO
WO2010099222 Feb 2010 WO
Non-Patent Literature Citations (392)
Entry
Copending U.S. Appl. No. 11/932,907—RCE Response Sep. 15, 2011.
Copending U.S. Appl. No. 11/258,795 Non-Final Office Action mailed Apr. 26, 2011.
Copending U.S. Appl. No. 11/689,670, RCE Response Sep. 19, 2011.
European Search Report dated Sep. 10, 2012 for EP08732724.3.
Copending U.S. Appl. No. 10/614,352, Final Office Action Jul. 12, 2010.
Copending U.S. Appl. No. 11/932,602 Final Response to Office Action Jun. 10, 2011.
Copending U.S. Appl. No. 11/671,556 Response filed Aug. 23, 2010.
Co-pending U.S. Appl. No. 11/438,537, Supplemental Final Rejection mailed Sep. 25, 2009.
Petition for Inter Partes Review of U.S. Patent No. 5,980,559, IPR 2013-00603, Filing Date Sep. 24, 2013.
Petition for Inter Partes Review of U.S. Patent No. 7,087,073, IPR 2013-00604, Filing Date Sep. 24, 2013.
Declaration of Wayne J. Sebastianelli, MD Regarding U.S. Patent No. 7,087,073, Sep. 24, 2013, IPR 2013-00604.
Petition for Inter Partes Review of U.S. Patent No. 6,500,195, IPR 2013-00624, Filing Date Oct. 2, 2013.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Patent No. 6,500,195, IPR 2013-00624,.
Petition for Inter Partes Review of U.S. Patent No. 5,527,343, IPR 2013-00628, Filing Date Sep. 26, 2013, Sep. 25, 2013.
Corrected Petition for Inter Partes Review of US Patent No. 5,921,986, IPR 2013-00631, Filing Date Sep. 27, 2013.
Expert Declaration of Steve E. Jordan, MD, for Inter Partes Review of US Patent No. 5,921,986, IPR 2013-00631, Sep. 24, 2013.
Corrected Petition for Inter Partes Review of US Patent No. 8,147,514, IPR 2013-00632, Filing Date Sep. 27, 2013.
Declaration of Steve Jordan for USP 8,147,514, from IPR 2013-00632, dated Sep. 23, 2013 (exhibit 1009).
Corrected Petition for Inter Partes Review of US Patnet No. 8,147,514, IPR 2013-00633, Filing Date Sep. 27, 2013.
Declaration of Steve Jordan for USP 8,147,514, from IPR 2013-00633, dated Sep. 23, 2013 (exhibit 1006).
Flory, Principles of Polymer Chemistry, 1953, selected pages (cited in IPR 2013-00603, exhibit 1012).
Grizzi, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 1995, vol. 16, No. 4, p. 305-11 (cited in IPR 2013-00603, exhibit 1006).
Gopferich, Mechanisms of polymer degradation and erosion, Biomaterials, 1996, vol. 17, No. 2, p. 103-114 (cited in IPR 2013-00603, exhibit 1013).
Gao et el, Swelling of Hydroxypropyl Methylcellulose Matrix Tablets . . . , J. of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, p. 732-740 (cited in IPR 2013-00603, exhibit 1014).
Linvatec, Impact Suture Anchor brochure, 2004 (cited in IPR 2013-00628, exhibit 1010).
Seitz et al, Repair of the Tibiofibular Syndesmosis with a Flexible Implant, J. of Orthopaedic Trauma, vol. 5, No. 1, p. 78-82, 1991 (cited in IPR 2013-00631, exhibit 1007) (cited in 2013-00632).
Translation of FR2696338 with translators certificate dated Sep. 17, 2013 (cited in IPR 2013-00631, 2013-00632).
Translation of DE9002844.9 with translator's certificate dated Sep. 26, 2013 (cited in IPR 2013-00631, 2013-00632).
Declaration of Steve Jordan for USP 5921986, from IPR 2013-00632, dated Sep. 24, 2013 (exhibit 1010).
Declaration of Steve Jordan for USP 5921986, from IPR 2013-00633, dated Sep. 24, 2013 (exhibit 1007).
Declaration of Dr. Steve E. Jordan for USP 8,147,514, from IPR 2013-00631, dated Sep. 23, 2013.
IPR—International Publication WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948.
ISR—International Search Report WO/2008/116203, published Dec. 24, 2008 for PCT/US08/57948.
IPER—Internation Preliminary Report on Patentability, WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948.
Written Opinion WO/2008/116203 dated Oct. 23, 2008 for PCT/US08/57948.
IPR—International Publication WO2009/029908, published May 3, 2009 for PCT/US08/74941.
ISR—International Search Report, WO2009/029908, published May 3, 2009 for PCT/US08/74941.
IPER—Internation Preliminary Report on Patentability, WO2009/029908, published Mar. 2, 2010 for PCT/US08/74941.
Written Opinion WO2009/029908 dated Feb. 28, 2010 for PCT/US08/74941.
International Search Report PCT/US2010/025263 completed Apr. 13, 2010.
Written Opinion for PCT/US2010/025263 completed Apr. 13, 2010.
Arthrex, Protect your graft, Am J Sports Med, vol. 22, No. 4, Jul.-Aug. 1994.
Barrett et al, T-Fix endoscopic meniscal repair: technique and approach to different types of tears, Apr-95, Arthroscopy vol. 11 No. 2 p. 245-51.
Cope, Suture Anchor for Visceral Drainage, AJR, vol. 148 p. 160-162, Jan. 1986.
Gabriel, Arthroscopic Fixation Devices, Wiley Enc. of Biomed Eng., 2006.
Innovasive, We've got you covered, Am J Sports Med, vol. 26, No. 1, Jan.-Feb. 1998.
510k—TranSet Fracture Fixation System, Feb. 24, 2004, k033717.
510k—Linvatec Biomaterials modification of Duet and impact Suture Anchor, Nov. 19, 2004, k042966.
510k, arthrex pushlock, Jun. 29, 2005, K051219.
510k, mitek micro anchor, Nov. 6, 1996, K962511.
510k, Multitak Suture System, Jan. 10, 1997, K964324.
510k, Modified Mitek 3.5mm Absorbable Suture Anchor System, Jun. 9, 1997, K970896.
510K, Summary for Arthrex Inc.'s Bio-Interference Screw, Jul. 9, 1997, K971358.
510k, Surgicraft Bone Tie, Sep. 25, 1998, K982719.
Karlsson et al, Repair of Bankart lesions with a suture anchor in recurrent dislocation of the shoulder, Scand. j. of Med & Science in Sports, 1995, 5:170-174.
Madjar et al, Minimally Invasive Pervaginam Procedures, for the Treatment of Female Stress Incontinence . . . , Artificial Organs, 22 (10) 879-885, 1998.
Nowak et al, Comparative Study of Fixation Techniques in the Open Bankart Operation Using Either a Cannulated Screw or Suture-Anchors, Acta Orthopcedica Belgica, vol. 64-2-1998.
Packer et al, Repair of Acute Scapho-Lunate Dissociation Facilitated by the “Tag” Suture Anchor, Journal of Hand Surgery (British and European Volume, 1994) 19B: 5: 563-564.
Shea et al, Technical Note: Arthroscopic Rotator Cuff Repair Using a Transhumeral Approach to Fixation, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 14, No. 1 (Jan.-Feb. 1998), pp. 118-122.
Tfix, Acufex just tied the knot . . . , Am. J. Sports Med., vol. 22, No. 3, May-Jun. 1994.
Wong et al, Case Report: Proper Insertion Angle Is Essential to Prevent Intra-Articular Protrusion of a Knotless Suture Anchor in Shoulder Rotator Cuff Repair, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 26, No. 2 (Feb. 2010), pp. 286-290.
Cobb et al, Late Correction of Malunited Intercondylar Humeral Fractures Intra-Articular Osteotomy and Tricortical Bone Grafting, J BoneJointSurg [Br] 1994; 76-B:622-6.
Fellinger, et al, Radial avulsion of the triangular fibrocartilage complex in acute wrist trauma: a new technique for arthroscopic repair, Jun. 1997, Arthroscopy vol. 13 No. 3 p. 370-4.
Hecker et al , Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs, Nov.-Dec. 1993 , The American Journal of Sports Medicine, vol. 21 No. 6 p. 874-9.
Hernigou et al , Proximal Tibial Osteotomy for Osteoarthritis with Varus Deformity A Ten to Thirteen-Year Follow-Up Study, J Bone Joint Surg, vol. 69-A, No. 3. Mar. 1987, p. 332-354.
Ibarra et al, Glenoid Replacement in Total Shoulder Arthroplasty, The Orthopedic Clinics of Northamerica: Total Shoulder Arthroplasty, vol. 29 No. 3, Jul. 1998 p. 403-413.
Mosca et al, Calcaneal Lengthening for Valgus Deformity of the Hindfoot: Results in Children Who Had Severe, Symptomatic fLATFOOT and Skewfoot, J Bone Joint Surg,, 1195- p. 499-512.
Murphycet al , Radial Opening Wedge Osteotomy in Madelung's Deformity, J. Hand Surg, vol. 21 A No. 6 Nov. 1996, p. 1035-44.
Biomet, Stanmore Modular Hip, J. Bone Joint Surg., vol. 76-B : No. Two, Mar. 1994.
Intl Prelim Rep on Patentability and Written Opinion for PCT/US10/25263 dated Aug. 30, 2011.
The Search for the Holy Grail: A Centrury of Anterior Cruciate Ligament Reconstruction, R. John Naranja, American Journal of Orthopedics, Nov. 1997.
Femoral Bone Plug Recession in Endoscope Anterior Cruciate Ligament Reconstruction, David E. Taylor, Arthroscopy: The Journal of Arthroscopic and Related Surgery, Aug. 1996.
Meniscus Replacement with Bone Anchors: A Surgical Technique, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 1994.
Problem Solving Report Question No. 1014984.066, Ultrasonic Welding, (c) 1999.
Guide to Ultrasound Plastic Assembly, Ultrasonic Division Publication, (c) 1995.
Branson, Polymers: Characteristics and Compatibility for Ultrasonic Assembly, Applied Technologies Group, Publication unknown.
Enabling Local Drug Delivery-Implant Device Combination Therapies, Surmodics, Inc., (c) 2003.
Stent Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Takeshi Suzuki, American Heart Association, Inc. (c) 2001.
Why Tie a Knot When You Can Use Y-Knot?, Innovasive Devices Inc., (c) 1998.
Ask Oxford, compact Oxford English dictionary: projection, Mar. 30, 2009.
Ask Oxford, compact Oxford English dictionary: slit, Mar. 30, 2009.
Textured Surface Technology, Branson Technolog, Branson Ultrasonics Copr., (c) 1992.
IPR—International Publication WO/2007/092869, published Aug. 16, 2007 for PCT/US2007/061730.
ISR—International Search Report WO/2007/092869, published Dec. 13, 2007 for PCT/US2007/061730.
Intl Prelim Report on Patentability, WO/2007/092869, published Aug. 12, 2008 for PCT/US2007/061730.
Written Opinion WO/2007/092869 dated Aug. 7, 2008 for PCT/US2007/061730.
U.S. Appl. No. 13/221,043, filed Jun. 2001, Bonutti.
Copending U.S. Appl. No. 09/556,458, Non-Final Rejection mailed Sep. 25, 2002.
Copending U.S. Appl. No. 09/556,458, Response to Office Action Dec. 26, 2002.
Copending U.S. Appl. No. 10/614,352, Examiner Interview Summary Jul. 31, 2007.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Jan. 25, 2007.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Apr. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Final Rejection mailed Oct. 2, 2007.
Copending U.S. Appl. No. 10/614,352, non Final Office Action Aug. 10, 2011.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Jan. 15, 2008.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Apr. 17, 2007.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Aug. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Aug. 21, 2008.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Nov. 24, 2009.
Copending U.S. Appl. No. 10/614,352, Non-Final Rejection mailed Dec. 1, 2005.
Copending U.S. Appl. No. 10/614,352, Request for Continued Examination Sep. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Request for Continued Examination Oct. 30, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Mar. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Mar. 26, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Apr. 26, 2010.
Copending U.S. Appl. No. 10/614,352, Response to Office Action May 15, 2008.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Jul. 17, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Sep. 14, 2009.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Oct. 30, 2007.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Nov. 1, 2006.
Copending U.S. Appl. No. 10/614,352, Response to Office Action Dec. 22, 2008.
Copending U.S. Appl. No. 11/931,823, final Office Action mailed Aug. 2, 2011.
Copending U.S. Appl. No. 11/931,823, Office Action mailed Nov. 24, 2010.
Copending U.S. Appl. No. 11/931,823, Response to Office Action Aug. 9, 2010.
Copending U.S. Appl. No. 11/931,823, RestrictionElect dated Jun. 8, 2010.
Copending U.S. Appl. No. 11/187,482, Response to Office Action Jun. 21. 2011.
Copending U.S. Appl. No. 10/413,696, Non-Final Rejection mailed Sep. 23, 2005.
Copending U.S. Appl. No. 10/413,696, Requirement for Restriction Jun. 8, 2005.
Copending U.S. Appl. No. 10/413,696, Response to Office Action Jul. 5, 2005.
Copending U.S. Appl. No. 10/413,696, Response to Office Action Dec. 20, 2005.
Copending U.S. Appl. No. 11/460,650, Examiner Interview Summary mailed Dec. 23, 2009.
Copending U.S. Appl. No. 11/460,650, Final Rejection mailed Apr. 20, 2010.
Copending U.S. Appl. No. 11/460,650, Final Rejection mailed Aug. 29, 2008.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed Mar. 10, 2009.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed May 30, 2007.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed Sep. 16, 2009.
Copending U.S. Appl. No. 11/460,650, Non-Final Rejection mailed Dec. 28, 2007.
Copending U.S. Appl. No. 11/460,650, Request for Continued Examination Jan. 29, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jan. 12, 2010.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jan. 29, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Mar. 28, 2008.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Jun. 10, 2009.
Copending U.S. Appl. No. 11/460,650, Response to Office Action Oct. 1, 2007.
Copending U.S. Appl. No. 11/461,110, Final Rejection mailed Dec. 8, 2009.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed Apr. 22, 2009.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed Jun. 6, 2008.
Copending U.S. Appl. No. 11/461,110, Request for Continued Examination Mar. 12, 2008.
Copending U.S. Appl. No. 11/461,110, Request for Continued Examination Jun. 8, 2010.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Mar. 12, 2008.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Jun. 8, 2010.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Sep. 22, 2009.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Oct. 6, 2008.
Copending U.S. Appl. No. 11/461,110, Response to Office Action Oct. 15, 2007.
Copending U.S. Appl. No. 11/461,110, Final Rejection mailed Dec. 12, 2007.
Copending U.S. Appl. No. 11/461,110, Non-Final Rejection mailed May 14, 2007.
Copending U.S. Appl. No. 11/930,621, Final Rejection Jun. 22, 2010.
Copending U.S. Appl. No. 11/930,621, Non-Final Rejection mailed Sep. 21, 2009.
Copending U.S. Appl. No. 11/930,621, Response to Office Action Mar. 22, 2010.
Copending U.S. Appl. No. 09/524,397, Final Rejection mailed Jun. 15, 2001.
Copending U.S. Appl. No. 09/524,397, Non-Final Rejection mailed Dec. 18, 2000.
Copending U.S. Appl. No. 09/524,397, Response to Office Action Mar. 19, 2001.
Copending U.S. Appl. No. 09/524,397, Response to Office Action Oct. 15, 2001.
Copending U.S. Appl. No. 10/458,117, Advisory Action Jan. 20, 2006.
Copending U.S. Appl. No. 10/458,117, Examiner Interview Summary mailed May 16, 2008.
Copending U.S. Appl. No. 10/458,117, Non-Final Rejection mailed Mar. 22, 2005.
Copending U.S. Appl. No. 10/458,117, Non-Final Rejection mailed Nov. 15, 2006.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Feb. 26, 2008.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Feb. 21, 2006.
Copending U.S. Appl. No. 10/458,117, Request for Continued Examination Aug. 3, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Feb. 13, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Jun. 22, 2005.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Aug. 3, 2007.
Copending U.S. Appl. No. 10/458,117, Response to Office Action Nov. 8, 2005.
Copending U.S. Appl. No. 10/458,117, Final Rejection mailed May 3, 2007.
Copending U.S. Appl. No. 10/458,117, Final Rejection mailed Sep. 8, 2005.
Copending U.S. Appl. No. 11/370,775, Examiner Interview Summary mailed Oct. 29, 2007.
Copending U.S. Appl. No. 11/370,775, Examiner Interview Summary mailed Apr. 24, 2008.
Copending U.S. Appl. No. 11/370,775, Examiner Interview Summary mailed Feb. 27, 2009.
Copending U.S. Appl. No. 11/370,775, Examiner Interview Summary mailed Aug. 28, 2009.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Feb. 6, 2007.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Jan. 22, 2008.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Oct. 15, 2008.
Copending U.S. Appl. No. 11/370,775, Non-Final Rejection mailed Nov. 6, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Jun. 4, 2007.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Oct. 26, 2007.
Copending U.S. Appl. No. 11/370,775, Response to Office Action May 22, 2008.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Jan. 15, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action Aug. 13, 2009.
Copending U.S. Appl. No. 11/370,775, Response to Office Action May 6, 2010.
Copending U.S. Appl. No. 11/370,775, Supplemental Response to Office Action Jan. 30, 2009.
Copending U.S. Appl. No. 11/370,775, Final Rejection mailed Aug. 31, 2007.
Copending U.S. Appl. No. 11/370,775, Final Rejection mailed Mar. 13, 2009.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Oct. 26, 2007.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Jan. 10, 2011.
Copending U.S. Appl. No. 11/370,775, Request for Continued Examination Aug. 13, 2009.
Copending U.S. Appl. No. 11/456,132, Examiner Interview Summary mailed Aug. 28, 2009.
Copending U.S. Appl. No. 11/456,132, Request for Continued Examination Jun. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Jan. 7, 2009.
Copending U.S. Appl. No. 11/456,132, Response filed Jan. 18, 2012.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Apr. 14, 2011.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Apr. 19, 2010.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Jun. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Aug. 13, 2009.
Copending U.S. Appl. No. 11/456,132, Response to Office Action Nov. 19, 2007.
Copending U.S. Appl. No. 11/456,132, Final Rejection mailed Mar. 11, 2008.
Copending U.S. Appl. No. 11/456,132, Final Rejection mailed Dec. 18, 2009.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Mar. 13, 2009.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Jun. 18, 2007.
Copending U.S. Appl. No. 11/456,132, Non-Final Rejection mailed Oct. 7, 2008.
Copending U.S. Appl. No. 11/456,221, Final Rejection mailed Feb. 22, 2008.
Copending U.S. Appl. No. 11/456,221, Final Rejection mailed Mar. 24, 2010.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Jul. 6, 2009.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Jul. 9, 2007.
Copending U.S. Appl. No. 11/456,221, Non-Final Rejection mailed Oct. 29, 2008.
Copending U.S. Appl. No. 11/456,221, Request for Continued Examintation Jun. 19, 2008.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Jan. 6, 2010.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Mar. 30, 2009.
Copending U.S. Appl. No. 11/456,221, Response to Office Action May 22, 2008.
Copending U.S. Appl. No. 11/456,221, Response to Office Action Nov. 9, 2007.
Copending U.S. Appl. No. 11/932,051, Final Office Action mailed Jun. 9, 2011.
Copending U.S. Appl. No. 11/932,051, RCE Response Dec. 9, 2011.
Copending U.S. Appl. No. 11/932,051, Requirement for Restriction Jan. 22, 2010.
Copending U.S. Appl. No. 10/228,855, Non-Final Rejection mailed Sep. 28, 2005.
Copending U.S. Appl. No. 10/228,855, Response to Office Action Dec. 28, 2005.
Copending U.S. Appl. No. 11/465,199, Response to Office Action Jun. 28, 2010.
Copending U.S. Appl. No. 11/465,199, Non-Final Rejection mailed Dec. 28, 2009.
Copending U.S. Appl. No. 11/932,602, non final Office Action Oct. 6, 2010.
Copending U.S. Appl. No. 11/932,602, Response to Office Action Apr. 6, 2011.
Copending U.S. Appl. No. 12/359,364, Final Office Action Apr. 7, 2011.
Copending U.S. Appl. No. 11/438,537, RCE Response Nov. 21, 2011.
Copending U.S. Appl. No. 11/932,907, non-final Office Action Nov. 17, 2010.
Copending U.S. Appl. No. 11/932,907, Response to Office Action Apr. 18, 2011.
Copending U.S. Appl. No. 11/133,730, Final Office action Aug. 17, 2011.
Copending U.S. Appl. No. 11/169,475, Response Sep. 2, 2011.
Copending U.S. Appl. No. 11/169,475, Office Action Mar. 2, 2011.
Copending U.S. Appl. No. 11/126,543, non Final Office Action Aug. 10, 2011.
Copending U.S. Appl. No. 11/126,543, RCE Response filed Jun. 30, 2011.
Copending U.S. Appl. No. 10/780,444, Examiner Interview Summary mailed Nov. 20, 2009.
Copending U.S. Appl. No. 10/780,444, Final Rejection mailed Mar. 30, 2010.
Copending U.S. Appl. No. 10/780,444, Final Rejection mailed Dec. 23, 2008.
Copending U.S. Appl. No. 10/780,444, nonFinal Office Action Aug. 9, 2011.
Copending U.S. Appl. No. 10/780,444, Non-Final Rejection mailed Mar. 11, 2008.
Copending U.S. Appl. No. 10/780,444, Non-Final Rejection mailed Jul. 7, 2009.
Copending U.S. Appl. No. 10/780,444, Request for Continued Examination Apr. 23, 2009.
Copending U.S. Appl. No. 10/780,444, Requirement for Restriction Sep. 12, 2007.
Copending U.S. Appl. No. 10/780,444, Requirement for Restriction Apr. 10, 2007.
Copending U.S. Appl. No. 10/780,444, Response filed Feb. 9, 2012.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Apr. 23, 2009.
Copending U.S. Appl. No. 10/780,444, Response to Office Action May 10, 2007.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Jul. 9, 2008.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Oct. 12, 2007.
Copending U.S. Appl. No. 10/780,444, Response to Office Action Dec. 4, 2009.
Copending U.S. Appl. No. 10/779,978, Non-Final Office Action mailed Jan. 13, 2011.
Copending U.S. Appl. No. 10/779,978, Final Rejection mailed Feb. 3, 2009.
Copending U.S. Appl. No. 10/779,978, Final Rejection mailed May 14, 2010.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Jun. 18, 2008.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Aug. 3, 2007.
Copending U.S. Appl. No. 10/779,978, Non-Final Rejection mailed Oct. 1, 2009.
Copending U.S. Appl. No. 10/779,978, Request for Continued Examination Jul. 6, 2009.
Copending U.S. Appl. No. 10/779,978, Requirement for Restriction Apr. 20, 2007.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Feb. 1, 2010.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Mar. 25, 2008.
Copending U.S. Appl. No. 10/779,978, Response to Office Action May 21, 2007.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Jul. 6, 2009.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Jul. 13, 2011.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Oct. 20, 2008.
Copending U.S. Appl. No. 10/779,978, Response to Office Action Dec. 3, 2007.
Copending U.S. Appl. No. 10/797,685, Examiner Interview Summary mailed Sep. 11, 2007.
Copending U.S. Appl. No. 10/797,685, Final Rejection mailed Apr. 25, 2007.
Copending U.S. Appl. No. 10/797,685, Non-Final Rejection mailed Nov. 17, 2006.
Copending U.S. Appl. No. 10/797,685, Response to Office Action Feb. 20, 2007.
Copending U.S. Appl. No. 10/797,685, Response to Office Action Aug. 27, 2007.
Copending U.S. Appl. No. 11/874,323, Office Action mailed Jul. 6, 2011.
Copending U.S. Appl. No. 11/874,323, Response filed Jun. 21, 2011.
Copending U.S. Appl. No. 11/202,294, Office Action mailed Jun. 24, 2011.
Copending U.S. Appl. No. 11/202,294, Response filed Dec. 24, 2011.
Copending U.S. Appl. No. 11/358,399, non Final Office Action Jan. 3, 2011.
Copending U.S. Appl. No. 11/358,399, Response filed Jul. 5, 2011.
Copending U.S. Appl. No. 11/671,556, Final Office Action mailed Nov. 12, 2010.
Copending U.S. Appl. No. 11/671,556, Non-Final Rejection mailed Feb. 22, 2010.
Copending U.S. Appl. No. 11/671,556, Requirement for Restriction Sep. 1, 2009.
Copending U.S. Appl. No. 11/671,556, Response to Office Action Nov. 2, 2009.
Copending U.S. Appl. No. 11/416,618, Examiner Interview Summary mailed Apr. 15, 2010.
Copending U.S. Appl. No. 11/416,618, Final Rejection mailed Jun. 24, 2009.
Copending U.S. Appl. No. 11/416,618, Non-Final Rejection mailed Oct. 13, 2009.
Copending U.S. Appl. No. 11/416,618, Non-Final Rejection mailed Nov. 26, 2008.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Mar. 15, 2010.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Mar. 26, 2009.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Apr. 16, 2010.
Copending U.S. Appl. No. 11/416,618, Response to Office Action Sep. 24, 2009.
Copending U.S. Appl. No. 11/416,618, Request for Continued Examination Dec. 8, 2010.
Copending U.S. Appl. No. 11/689,670, Final Office Action mailed Mar. 17, 2011.
Copending U.S. Appl. No. 11/689,670, Requirement for Restriction Mar. 15, 2010.
Copending U.S. Appl. No. 11/689,670, Response to Office Action Jan. 3, 2011.
Copending U.S. Appl. No. 11/689,670, Response to Office Action Apr. 15, 2010.
Copending U.S. Appl. No. 12/202,210, Requirement for Restriction mailed Aug. 16, 2011.
Copending U.S. Appl. No. 12/202,210, Response filed Dec. 16, 2011.
File History of U.S. Patent No. 5,403,348; U.S. Appl. No. 08/062,295; filed May 14, 1993; 231 pages.
File History of U.S. Patent No. 5,522,846; U.S. Appl. No. 08/402,352; filed Mar. 10, 1995; 215 pages.
File History of U.S. Patent No. 5,527,343; U.S. Appl. No. 08/344,466; filed Nov. 23, 1994; 246 pages.
File History of U.S. Patent No. 5,549,630; U.S. Appl. No. 08/291,970; filed Aug. 17, 1994; 276 pages.
File History of U.S. Patent No. 5,980,559; U.S. Appl. No. 08/964,167; filed Nov. 4, 1997; 57 pages.
File History of U.S. Patent No. 6,500,195; U.S. Appl. No. 09/872,033; filed Jun. 1, 2001; 522 pages.
File History of U.S. Patent No. 7,087,073; U.S. Appl. No. 10/413,696; filed Apr. 14, 2003; 13 pages.
Petition for Inter Partes Review of U.S. Patent No. 5,980,559 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 24, 2013; IPR2013-00603; with exhibits, 382 pages.
Declaration of David Kaplan, PH.D. Regarding U.S. Patent No. 5,980,559, IPR 2013-00603, Sep. 24, 2013.
Petition for Inter Partes Review of U.S. Patent No. 7,087,073 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 24, 2013; IPR2013-00604; with exhibits, 243 pages.
Declaration of Wayne J. Sebastianelli, MD Regarding U.S. Patent No. 7,087,073, Sep. 24, 2013,IPR 2013-00604.
Petition for Inter Partes Review of U.S. Patent No. 6,500,195 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 25, 2013; IPR2013-00624; with exhibits, 1152 pages.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Patent No. 6,500,195, IPR 2013-00624.
Petition for Inter Partes Review of U.S. Patent No. 5,527,343 Under 35 U.S.C. § 312 and 37 C.F.R. § 42.104; filed Sep. 26, 2013; IPR2013-00628; with exhibits, 882 pages.
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Patent No. 5,527,343, IPR 2013-00628, Sep. 25, 2013.
Corrected Petition for Inter Partes Review of U.S. Patent No. 5,921,986 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et Seq.; filed Oct. 11, 2013; IPR2013-00631; with exhibits, 285 pages.
Expert Declaration of Steve E. Jordan, MD, for Inter Partes Review of U.S. Patent No. 5,921,986, IPR 2013-00631, Sep. 24, 2013.
Corrected Petition for Inter Partes Review of U.S. Patent No. 8,147,514 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et Seq.; filed Oct. 11, 2013; IPR2013-00632; with exhibits, 268 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 8,147,514, IPR 2013-00631, dated Sep. 23, 2013.
Declaration of Steve E. Jordan for U.S. Patent No. 8,147,514, IPR 2013-00632 and IPR 2013-00633, Sep. 23, 2013; (exhibits 1006 & 1009); 61 pages.
Declaration of Steve E. Jordan for U.S. Patent No. 5,921,986, from IPR 2013-00632, dated Sep. 24, 2013 (exhibit 1010).
Declaration of Steve E. Jordan for U.S. Patent No. 5,921,986, from IPR 2013-00633, dated Sep. 24, 2013 (exhibit 1007).
Corrected Petition for Inter Partes Review of U.S. Patent No. 8,147,514 Under 35 U.S.C. §§ 311-319 and 37 C.F.R. § 42.100 Et. Seq.; filed Oct. 11, 2013; IPR2013-00633; with exhibits, 248 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants Linvatec and ConMed Corporation's Invalidity Contentions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Sep. 30, 2013; 2703 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants Linvatec and ConMed Corporation's Non-Infringement Contentions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Sep. 30, 2013; 310 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants' Proposed Claim Term Constructions;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 1, 2013; 53 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Defendants' Proposed Terms for Construction;” Case No. 6:12-cv-01379; M.D. Florida; Oct. 10, 2013; 9 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Joint Claim Construction Statement;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 15, 2013; 55 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Plaintiff Bonutti Skeletal Innovations LLC's Initial Identification of Disputed Claim Terms;” Case No. 6:12-cv-01379; M.D. Florida; Oct. 10, 2013; 3 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Plaintiff Bonutti Skeletal Innovations LLC's Proposed Interpretations of Disputed Claim Terms;” With Exhibits; Case No. 6:12-cv-01379; M.D. Florida; Nov. 1, 2013; 35 pages.
Bonutti Skeletal Innovations LLC v. Linvatec Corporation and ConMed Corporation; “Order;” Case No. 6:12-cv-1379-Orl-22TBS; M.D. Florida; Mar. 25, 2014; 22 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex Inc.'s Preliminary Identification of Proposed Claim Terms for Construction by the Court;” Case No. 6:12-cv-01380; M.D. Florida; Mar. 15, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex Inc.'s Preliminary Identification of Proposed Claim Terms for Construction by the Court;” Case No. 6:13-cv-00620; M.D. Florida; Oct. 16, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Disclosure of Preliminary Non-Infringement and Invalidity Contentions;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Sep. 23, 2013; 1751 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Notice of a First Supplemental Disclosure of Preliminary Invalidity Contentions;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Oct. 24, 2013; 660 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Preliminary Constructions of Terms Proposed for Construction by the Court;” Case No. 6:13-cv-01380; M.D. Florida; Mar. 25, 2013; 11 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Preliminary Constructions of Terms Proposed for Construction by the Court;” With Exhibit; Case No. 6:12-cv-00620; M.D. Florida; Nov. 1, 2013; 27 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Defendant Arthrex, Inc.'s Supplemental Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Nov. 15, 2013; 9 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “First Amended Complaint with Exhibits” Case No. 6:12-cv-01380; M.D. Florida; Sep. 21, 2012; 259 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Joint Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Nov. 15, 2013; 25 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Consent Joint Motion for Leave to File Corrected Joint Claim Construction Statement Exhibit;” Case No. 6:13-cv-00620; M.D. Florida; Dec. 12, 2013; 23 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Notice of Filing Corrected Joint Claim Construction Statement;” Case No. 6:13-cv-00620; M.D. Florida; Dec. 23, 2013; 21 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Plaintiff Bonutti Skeletal Innovations LLC's Proposed Interpretations of Disputed Claim Terms;” With Exhibits; Case No. 6:13-cv-00620; M.D. Florida; Nov. 1, 2013; 34 pages.
Bonutti Skeletal Innovations LLC v. Arthrex; “Plaintiffs Initial Preliminary Identification of Claim Terms and Phrases Potentially Needing Interpretation by the Court;” Case No. 6:13-cv-01380; M.D. Florida; Mar. 15, 2013; 5 pages.
Bonutti Skeletal Innovations LLC v. Arthrex, “Order,” Case No. 6:13-cv-620; M.D. Florida, Mar. 25, 2014, 29 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Declaration of Stephen M. Belkoff, PH.D in Support of Plaintiff Bonutti Skeletal Innovations LLC's Preliminary Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 49 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' List of Proposed Claim Terms and Phrases for Interpretation;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 3, 2013; 6 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Preliminary Invalidity Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Aug. 29, 2013; 73 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Preliminary Non-Infringement Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Aug. 29, 2013; 86 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Defendants' Proposed Claim Constructions;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 10, 2013; 7 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Depuy's Opening Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 35 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Joint Appendices A through I;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 413 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's Claim Construction Reply Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Jan. 16, 2014; 24 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's List of Proposed Claim Terms and Phrases for Interpretation;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 3, 2013; 4 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's Preliminary Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Dec. 9, 2013; 27 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff Bonutti Skeletal Innovations LLC's Response to Defendants' Proposed Claim Constructions;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Oct. 30, 2013; 14 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Plaintiff's Initial Preliminary Infringement Disclosures;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; May 30, 2013; 8 pages.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “DePuy's Reply Claim Construction Brief;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; Jan. 16, 2014; 23 pages.
Amis, Andrew A.; “Anterior Cruciate Ligament Graft Positioning, Tensioning, and Twisting;” Knee Surgery, Sports Traumatology, Arthroscopy, 6 [Suppl. 1]; 1998; pp. S2-S12.
Amis, Andrew A.; “Anterior Cruciate Ligament Replacement, Knee Stability and the Effects of Implants;” The Journal of Bone and Joint Surgery, 71-B; 1989; pp. 819-824.
Andersen, Henrik Norholm, et al.; “The Immediate Postoperative Kinematic State After Anterior Cruciate Ligament Reconstruction with Increasing Peroperative Tension;” Knee Surger, Sports Traumatology, Arthroscopy, 6[Suppl. 1]; 1998; pp. S62-S69.
Barber, F. Alan, et al.; “Suture Anchor Failure Strength—An In Vivo Study;” Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 9, No. 6; 1993; pp. 647-652.
Barber, F. Alan; “The Ultimate Strength of Suture Anchors;” Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 11, No. 1; Feb. 1995, pp. 21-28.
Barrett, Gene R., et al.; “T-Fix Endoscopic Meniscal Repair: Technique and Approach to Different Types of Tears;” Arthroscopy, vol. 11, No. 2; pp. 245-251.
Barrows, Thomas H., et al.; “Synthetic Bioabsorbable Polymers;” High Performance Biomaterials: A Comprehensive Guide to Medical and Pharmaceutical Applications 243 (Michael Szycher ed.); 1991.
Bylski-Austrow, D.I., et al.; “Anterior Cruciate Ligament Replacements: A Mechanical Study of Femoral Attachment Location, Flexion Angle at Tensioning, and Initial Tension;” Journal of Orthopaedic Research, 8; 1990; pp. 522-531.
Diduch, et al.; “Modern Concepts in Arthroscopic Bankart Repair;” Journal of Long Term Effects of Medical Implants, 9(2&3); 1999; pp. 377-393.
Escalas, F., et al.; “T-Fix Anchor Sutures for Arthroscopic Meniscal Repair;” Knee Surgery, Sports Traumatol, Arthroscopy; 1997, vol. 5, pp. 72-76.
Flory, Principles of Polymer Chemisty, 1953, selected pages.
Gao et al., Swelling of Hydroxypropyl Methycellulose Matrix Tablets . . . , J. of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, p. 732-740.
Gopferich, Mechanisms of polymer degradation and erosion, Biomaterials, 1996, vol. 17, No. 2, p. 103-114.
Grizzi; “Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence;” Biomaterials, 1995, vol. 16, No. 4; pp. 305-11.
Grumbine, et al.; “Grappling Suture Fixation Technique;” Clin Podiatr Med Surg. 3(2); 1986; pp. 235-239.
Hanna, et al.; “Repair of Distal Tendo Achillis Rupture With the Use of the Mitek Anchor System;” J Am Podiatr Med Assoc, 83(12); Dec. 1993; pp. 663-668.
Hecker et al.; Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs, Nov.-Dec. 1993, The American Journal of Sports Medicine, vol. 21, No. 6 p. 874-9.
ISR—International Search Report, WO/2009/029908, published Oct. 28, 2008 for PCT/US2008/074941.
Karlsson, J. et al; “Repair of Bankart Lesions With a Suture Anchor in Recurrent Dislocation of the Shoulder;” Scand. J. of Med & Science in Sports, 1995, 5:170-174.
Kurosaka, Masahiro, et al.; “A Biomechanical Comparison of Different Surgical Techniques of Graft Fixation in Anterior Cruciate Ligament Reconstruction;” The American Journal of Sports Medicine, vol. 15, No. 3; 1987; pp. 225-229.
Lambert, Kenneth L.; “Vascularized Patellar Tendon Graft with Rigid Internal Fixation for Anterior Cruciate Ligament Insufficiency;” Clinical Orthopaedics and Related Research, No. 172; Jan.-Feb. 1983; pp. 85-89.
Linvatec, Impact Suture Anchor brochure, 2004.
Markolf, Keith L., et al.; “Biomechanical Consequences of Replacement of the Anterior Cruciate Ligament with a Patellar Ligament Allograft;” The Journal of Bone and Joint Surgery, vol. 78-A, No. 11; Nov. 1996; pp. 1720-1727.
Ming Li; Structure-Property Relationships in the Case of the Degradation of Massive Aliphatic Poly-(α-Hydroxy Acids) in Aqueous Media (Parts 1-3) Journals of Materials Science: Materials in Medicine 1; 1990; pp. 123-139 and 198-206.
Nabors, Eric D., et al.; “Anterior Cruciate Ligament Graft Tensioning in Full Extension;” The American Journal of Sports Medicine, vol. 23, No. 4; 1995; pp. 488-492.
Nativ, O., et al.; “Bladder Neck Suspension Using Bone Anchors for the Treatment of Female Stress Incontinence;” ASAIO J., 43(3); May-Jun. 1997; pp. 204-208.
Obrist, J. et al.; “Bankart Operation With the Mitek Anchor System;” Unfallchirurgie, 17(4); Aug. 1991; pp. 208-212.
Pol E. Huijsmans, et al., “Arthroscopic Rotator Cuff Repair with Double Row Fixation,” The Journal of Bone and Joint Surgery, Jun. 2007, vol. 89-A, No. 6, pp. 1248-1257.
Richmond, Modificatio of the Bankart Reconstruction with a Suture Anchor, Am J Sports Med, vol. 19, No. 4, p. 343-346, 1991.
Rodgers, et al.; “The Use of Osseous Suture Anchors in the Treatment of Severe, Complicated Elbow Dislocations;” Am J. Orthrop, 25(11); Nov. 1996; pp. 794-798.
Seitz et al.; “Repair of the Tibiofibular Syndesmosis with a Flexible Implant;” Journal of Orthopaedic Trama, vol. 5, No. 1; p. 78-82, 1991.
Meniscus Replacement with Bone Anchors: A Surgical Technique, Arthroscopy: The Journal of Arcioscopic and Related Surgery, 1994.
Snyder, SJ; “Evaluation and Treatment of the Rotator Cuff;” Orthop Clin North Am, 24(1); Jan. 1993; pp. 173-192.
Steiner, Mark E., et al.; “Anterior Cruciate Ligament Graft Fixation;” The American Journal of Sports Medicine, vol. 22, No. 2; 1994; pp. 240-247.
Suchenski, Maureen, et al.; “Material Properties and Composition of Soft-Tissue Fixation;” 26 Arthroscopy: The Journal of Arthroscopy and Related Surgery 822, vol. 26, No. 6; 2010, pp. 821-831.
Taylor, David E., et al.; “Femoral Bone Plug Recession in Endoscopic Anterior Cruciate Ligament Reconstruction;” Arthoscopy: The Journal of Arthroscopic and Related Surgery, vol. 12, No. 4; Aug. 1996; pp. 513-515.
Tohyama, Harukazu, et al.; “Significance of Graft Tension in Anterior Cruciate Ligament Reconstruction;” Knee Surgery, Sports Traumatology, Arthroscopy, 6 [Suppl. 1]; 1998; pp. S30-S37.
Verhaven, E., et al.; “Surgical Treatment of Acute Biceps Tendon Ruptures With a Suture Anchor;” Acta Orthop Belg, 59(4); 1993; pp. 426-429.
Van Heerwaarden, R.J., et al.; “Effect of Pretension in Reconstructions of the Anterior Cruciate Ligament With a Dacron Prosthesis;” Knee Surgery, Sports Traumatology, Arthroscopy, 3; 1996; pp. 202-208.
Van Kampen, Albert, et al.; “The Effect of Different Graft Tensioning in Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Study;” The Journal of Arthroscopy and Related Surgery, vol. 14, No. 8; Nov.-Dec. 1998; 1998; pp. 845-850.
Weinraub, et al.; “A New Method for Reattachment of the Tendo Achillis Following Retrocalcaneal Exostectomy;” J Foot Ankle Surg, 37(2); Mar.-Apr. 1998; pp. 86-95.
Westrich, et al.; “Isolated Rupture and Repair of the Popliteus Tendon;” Arthoscopy, 11(5); Oct. 1995; pp. 628-632.
Yamamoto, Yuhei, et al.; “Application of a Suture Anchor Technique for Flap Fixation to Bone;” Journal of Reconstructive Microsurgery; Jul. 1996, vol. 12, No. 5, pp. 313-315.
Yoshiya, Shinichi, et al.; “Graft Tension in Anterior Cruciate Ligament Reconstruction;” The American Journal of Sports Medicine, vol. 15, No. 5; 1987, pp. 464-470.
Copending U.S Appl. No. 11/230,020, Final Office Action dated Aug. 2, 2011.
Copending U.S. Appl. No. 12/030,728, Response to Office Action Sep. 21, 2011.
Bonutti Skeletal Innovations LLC v. DePuy Mitek LLC, et al.; “Memorandum and Order on Claim Construction;” Civil Action No. 1:12-cv-11667; United States District Court District of Massachusetts; May 2, 2014; 22 pages.
Related Publications (1)
Number Date Country
20120191140 A1 Jul 2012 US
Continuations (6)
Number Date Country
Parent 12359364 Jan 2009 US
Child 13438720 US
Parent 10685117 Oct 2003 US
Child 12359364 US
Parent 09835473 Apr 2001 US
Child 10685117 US
Parent 09532942 Mar 2000 US
Child 09835473 US
Parent 09363707 Jul 1999 US
Child 09532942 US
Parent 09019977 Feb 1998 US
Child 09323488 US
Continuation in Parts (1)
Number Date Country
Parent 09323488 Jun 1999 US
Child 09363707 US